{"id":17325,"date":"2025-05-20T15:29:41","date_gmt":"2025-05-20T12:29:41","guid":{"rendered":"https:\/\/anadolumedicalcenter.uk\/lp\/?page_id=17325"},"modified":"2025-10-30T14:30:25","modified_gmt":"2025-10-30T12:30:25","slug":"prostate-cancer-center","status":"publish","type":"page","link":"https:\/\/anadolumedicalcenter.uk\/lp\/","title":{"rendered":"Prostate Cancer Center"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"17325\" class=\"elementor elementor-17325\">\n\t\t\t\t<div class=\"elementor-element elementor-element-41bb40f elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"41bb40f\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-610e054 elementor-widget elementor-widget-text-editor\" data-id=\"610e054\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tWelcome to <a href=\"https:\/\/anadolumedicalcenter.uk\/\" target=\"_blank\" rel=\"noopener\">Anadolu Medical Center<\/a> &#8211; Prostate Cancer Center\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bc2418a e-con-full e-flex e-con e-child\" data-id=\"bc2418a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-056ccd2 elementor-shape-rounded elementor-grid-0 elementor-widget elementor-widget-social-icons\" data-id=\"056ccd2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"social-icons.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-social-icons-wrapper elementor-grid\" role=\"list\">\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-youtube elementor-repeater-item-b2029b6\" href=\"https:\/\/www.youtube.com\/@AnadoluMedicalCenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Youtube<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-youtube\" viewBox=\"0 0 576 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-facebook elementor-repeater-item-4209e29\" href=\"https:\/\/www.facebook.com\/AnadoluMedicalCenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Facebook<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-facebook\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256C504 119 393 8 256 8S8 119 8 256c0 123.78 90.69 226.38 209.25 245V327.69h-63V256h63v-54.64c0-62.15 37-96.48 93.67-96.48 27.14 0 55.52 4.84 55.52 4.84v61h-31.28c-30.8 0-40.41 19.12-40.41 38.73V256h68.78l-11 71.69h-57.78V501C413.31 482.38 504 379.78 504 256z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-instagram elementor-repeater-item-cd6498c\" href=\"https:\/\/www.instagram.com\/anadolumedicalcenter?igsh=OG1wNWV5NWk4ZmNt\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Instagram<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-instagram\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-tiktok elementor-repeater-item-ddae380\" href=\"https:\/\/www.tiktok.com\/@anadolumedicalcenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Tiktok<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-tiktok\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M448,209.91a210.06,210.06,0,0,1-122.77-39.25V349.38A162.55,162.55,0,1,1,185,188.31V278.2a74.62,74.62,0,1,0,52.23,71.18V0l88,0a121.18,121.18,0,0,0,1.86,22.17h0A122.18,122.18,0,0,0,381,102.39a121.43,121.43,0,0,0,67,20.14Z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c975af5 elementor-widget elementor-widget-button\" data-id=\"c975af5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#msoform\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Send Free Inquiry<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e6d2431 e-flex e-con-boxed e-con e-parent\" data-id=\"e6d2431\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-9340c87 e-con-full e-flex e-con e-child\" data-id=\"9340c87\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b2bb2a8 elementor-widget elementor-widget-image\" data-id=\"b2bb2a8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"289\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png\" class=\"attachment-large size-large wp-image-12889\" alt=\"pdf anadolu\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png 1200w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_-600x217.png 600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-33421d6 e-con-full elementor-hidden-mobile e-flex e-con e-child\" data-id=\"33421d6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8ef6334 elementor-position-inline-start elementor-view-default elementor-mobile-position-block-start elementor-widget elementor-widget-icon-box\" data-id=\"8ef6334\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-box-wrapper\">\n\n\t\t\t\t\t\t<div class=\"elementor-icon-box-icon\">\n\t\t\t\t<span  class=\"elementor-icon\">\n\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-map-marker\" viewBox=\"0 0 384 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M172.268 501.67C26.97 291.031 0 269.413 0 192 0 85.961 85.961 0 192 0s192 85.961 192 192c0 77.413-26.97 99.031-172.268 309.67-9.535 13.774-29.93 13.773-39.464 0z\"><\/path><\/svg>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t<div class=\"elementor-icon-box-content\">\n\n\t\t\t\t\t\t\t\t\t<h3 class=\"elementor-icon-box-title\">\n\t\t\t\t\t\t<span  >\n\t\t\t\t\t\t\tAddress\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h3>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<p class=\"elementor-icon-box-description\">\n\t\t\t\t\t\t\u0130stanbul \/ Turkey\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e720fc2 elementor-widget elementor-widget-button\" data-id=\"e720fc2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"tel:+905373180696\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">+90 537 318 0696<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-93ea27b elementor-widget-tablet__width-initial elementor-hidden-desktop hfe-nav-menu__align-left hfe-submenu-icon-arrow hfe-submenu-animation-none hfe-link-redirect-child hfe-nav-menu__breakpoint-tablet elementor-widget elementor-widget-navigation-menu\" data-id=\"93ea27b\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;menu_space_between&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:20,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_space_between_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_space_between_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;dropdown_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;dropdown_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;dropdown_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;width_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;220&quot;,&quot;sizes&quot;:[]},&quot;width_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;width_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"navigation-menu.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"hfe-nav-menu hfe-layout-horizontal hfe-nav-menu-layout horizontal hfe-pointer__none\" data-layout=\"horizontal\">\n\t\t\t\t<div role=\"button\" class=\"hfe-nav-menu__toggle elementor-clickable\" tabindex=\"0\" aria-label=\"Menu Toggle\">\n\t\t\t\t\t<span class=\"screen-reader-text\">Menu<\/span>\n\t\t\t\t\t<div class=\"hfe-nav-menu-icon\">\n\t\t\t\t\t\t<svg aria-hidden=\"true\"  class=\"e-font-icon-svg e-fas-align-justify\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M432 416H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16A16 16 0 0 0 0 48v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16V48a16 16 0 0 0-16-16z\"><\/path><\/svg>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<nav class=\"hfe-nav-menu__layout-horizontal hfe-nav-menu__submenu-arrow\" data-toggle-icon=\"&lt;svg aria-hidden=&quot;true&quot; tabindex=&quot;0&quot; class=&quot;e-font-icon-svg e-fas-align-justify&quot; viewBox=&quot;0 0 448 512&quot; xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;&gt;&lt;path d=&quot;M432 416H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16A16 16 0 0 0 0 48v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16V48a16 16 0 0 0-16-16z&quot;&gt;&lt;\/path&gt;&lt;\/svg&gt;\" data-close-icon=\"&lt;svg aria-hidden=&quot;true&quot; tabindex=&quot;0&quot; class=&quot;e-font-icon-svg e-far-window-close&quot; viewBox=&quot;0 0 512 512&quot; xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;&gt;&lt;path d=&quot;M464 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h416c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm0 394c0 3.3-2.7 6-6 6H54c-3.3 0-6-2.7-6-6V86c0-3.3 2.7-6 6-6h404c3.3 0 6 2.7 6 6v340zM356.5 194.6L295.1 256l61.4 61.4c4.6 4.6 4.6 12.1 0 16.8l-22.3 22.3c-4.6 4.6-12.1 4.6-16.8 0L256 295.1l-61.4 61.4c-4.6 4.6-12.1 4.6-16.8 0l-22.3-22.3c-4.6-4.6-4.6-12.1 0-16.8l61.4-61.4-61.4-61.4c-4.6-4.6-4.6-12.1 0-16.8l22.3-22.3c4.6-4.6 12.1-4.6 16.8 0l61.4 61.4 61.4-61.4c4.6-4.6 12.1-4.6 16.8 0l22.3 22.3c4.7 4.6 4.7 12.1 0 16.8z&quot;&gt;&lt;\/path&gt;&lt;\/svg&gt;\" data-full-width=\"yes\">\n\t\t\t\t\t<ul id=\"menu-1-93ea27b\" class=\"hfe-nav-menu\"><li id=\"menu-item-17336\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#prostatecancer\" class = \"hfe-menu-item\">Comprehensive Care<\/a><\/li>\n<li id=\"menu-item-17337\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#options\" class = \"hfe-menu-item\">Prostate Cancer Treatment<\/a><\/li>\n<li id=\"menu-item-17338\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#doctors\" class = \"hfe-menu-item\">Our doctors<\/a><\/li>\n<li id=\"menu-item-17339\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#testimonials\" class = \"hfe-menu-item\">Our patients\u2019 stories<\/a><\/li>\n<li id=\"menu-item-17335\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#about\" class = \"hfe-menu-item\">About Us<\/a><\/li>\n<li id=\"menu-item-17340\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#msoform\" class = \"hfe-menu-item\">Contact Us<\/a><\/li>\n<\/ul> \n\t\t\t\t<\/nav>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bf6302a elementor-hidden-tablet elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"bf6302a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9301cf7 hfe-nav-menu__align-left hfe-submenu-icon-arrow hfe-submenu-animation-none hfe-link-redirect-child hfe-nav-menu__breakpoint-tablet elementor-widget elementor-widget-navigation-menu\" data-id=\"9301cf7\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;menu_space_between&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:20,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_menu_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_menu_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_space_between_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_space_between_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;menu_row_space_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;dropdown_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;dropdown_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;dropdown_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;width_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;220&quot;,&quot;sizes&quot;:[]},&quot;width_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;width_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_horizontal_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:15,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;padding_vertical_dropdown_item_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_size_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_width_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;toggle_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"navigation-menu.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"hfe-nav-menu hfe-layout-horizontal hfe-nav-menu-layout horizontal hfe-pointer__none\" data-layout=\"horizontal\">\n\t\t\t\t<div role=\"button\" class=\"hfe-nav-menu__toggle elementor-clickable\" tabindex=\"0\" aria-label=\"Menu Toggle\">\n\t\t\t\t\t<span class=\"screen-reader-text\">Menu<\/span>\n\t\t\t\t\t<div class=\"hfe-nav-menu-icon\">\n\t\t\t\t\t\t<svg aria-hidden=\"true\"  class=\"e-font-icon-svg e-fas-align-justify\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M432 416H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16A16 16 0 0 0 0 48v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16V48a16 16 0 0 0-16-16z\"><\/path><\/svg>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<nav class=\"hfe-nav-menu__layout-horizontal hfe-nav-menu__submenu-arrow\" data-toggle-icon=\"&lt;svg aria-hidden=&quot;true&quot; tabindex=&quot;0&quot; class=&quot;e-font-icon-svg e-fas-align-justify&quot; viewBox=&quot;0 0 448 512&quot; xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;&gt;&lt;path d=&quot;M432 416H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16a16 16 0 0 0-16 16v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16v-32a16 16 0 0 0-16-16zm0-128H16A16 16 0 0 0 0 48v32a16 16 0 0 0 16 16h416a16 16 0 0 0 16-16V48a16 16 0 0 0-16-16z&quot;&gt;&lt;\/path&gt;&lt;\/svg&gt;\" data-close-icon=\"&lt;svg aria-hidden=&quot;true&quot; tabindex=&quot;0&quot; class=&quot;e-font-icon-svg e-far-window-close&quot; viewBox=&quot;0 0 512 512&quot; xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;&gt;&lt;path d=&quot;M464 32H48C21.5 32 0 53.5 0 80v352c0 26.5 21.5 48 48 48h416c26.5 0 48-21.5 48-48V80c0-26.5-21.5-48-48-48zm0 394c0 3.3-2.7 6-6 6H54c-3.3 0-6-2.7-6-6V86c0-3.3 2.7-6 6-6h404c3.3 0 6 2.7 6 6v340zM356.5 194.6L295.1 256l61.4 61.4c4.6 4.6 4.6 12.1 0 16.8l-22.3 22.3c-4.6 4.6-12.1 4.6-16.8 0L256 295.1l-61.4 61.4c-4.6 4.6-12.1 4.6-16.8 0l-22.3-22.3c-4.6-4.6-4.6-12.1 0-16.8l61.4-61.4-61.4-61.4c-4.6-4.6-4.6-12.1 0-16.8l22.3-22.3c4.6-4.6 12.1-4.6 16.8 0l61.4 61.4 61.4-61.4c4.6-4.6 12.1-4.6 16.8 0l22.3 22.3c4.7 4.6 4.7 12.1 0 16.8z&quot;&gt;&lt;\/path&gt;&lt;\/svg&gt;\" data-full-width=\"yes\">\n\t\t\t\t\t<ul id=\"menu-1-9301cf7\" class=\"hfe-nav-menu\"><li id=\"menu-item-17336\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#prostatecancer\" class = \"hfe-menu-item\">Comprehensive Care<\/a><\/li>\n<li id=\"menu-item-17337\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#options\" class = \"hfe-menu-item\">Prostate Cancer Treatment<\/a><\/li>\n<li id=\"menu-item-17338\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#doctors\" class = \"hfe-menu-item\">Our doctors<\/a><\/li>\n<li id=\"menu-item-17339\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#testimonials\" class = \"hfe-menu-item\">Our patients\u2019 stories<\/a><\/li>\n<li id=\"menu-item-17335\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#about\" class = \"hfe-menu-item\">About Us<\/a><\/li>\n<li id=\"menu-item-17340\" class=\"menu-item menu-item-type-custom menu-item-object-custom parent hfe-creative-menu\"><a href=\"#msoform\" class = \"hfe-menu-item\">Contact Us<\/a><\/li>\n<\/ul> \n\t\t\t\t<\/nav>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-92622cc e-flex e-con-boxed e-con e-parent\" data-id=\"92622cc\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;video&quot;,&quot;background_video_link&quot;:&quot;https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/anadolu-saglik-merkezi-hastanesini-taniyin-8448728.webm&quot;,&quot;background_video_start&quot;:0,&quot;background_video_end&quot;:24,&quot;background_play_on_mobile&quot;:&quot;yes&quot;,&quot;background_privacy_mode&quot;:&quot;yes&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-background-video-container\">\n\t\t\t\t\t\t\t<video class=\"elementor-background-video-hosted\" role=\"presentation\" autoplay muted playsinline loop><\/video>\n\t\t\t\t\t<\/div><div class=\"elementor-element elementor-element-fdb025d e-con-full e-flex e-con e-child\" data-id=\"fdb025d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9685348 elementor-widget elementor-widget-heading\" data-id=\"9685348\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">From Diagnosis to Recovery:<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a66b7a2 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"a66b7a2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Comprehensive Prostate Cancer Care You Can Trust <\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b69383a elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"b69383a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Fast and Advanced Diagnosis \u2013 Experienced Specialists \u2013 Robotic Surgery- Radionuclide Therapies<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1af813b elementor-widget elementor-widget-button\" data-id=\"1af813b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"#about\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">About Us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-381279a prostatelpform e-flex e-con-boxed e-con e-parent\" data-id=\"381279a\" data-element_type=\"container\" data-e-type=\"container\" id=\"msoform\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-35f3851 e-con-full e-flex e-con e-child\" data-id=\"35f3851\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-46cf5e5 elementor-widget elementor-widget-heading\" data-id=\"46cf5e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Send us your message!<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ea94232 elementor-widget elementor-widget-heading\" data-id=\"ea94232\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">You will receive a specialized medical opinion within 48 hours!<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c90d49a elementor-widget elementor-widget-shortcode\" data-id=\"c90d49a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f22518-o1\" lang=\"en-US\" dir=\"ltr\" data-wpcf7-id=\"22518\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/lp\/wp-json\/wp\/v2\/pages\/17325#wpcf7-f22518-o1\" method=\"post\" class=\"wpcf7-form init\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"22518\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.1.6\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"en_US\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f22518-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<style>\n.iti__selected-country {padding: 0 3px !important;}\n.wpcf7-form div.label {z-index:9 !important;}\n.wpcf7-form div.label {border-radius: 5px !important; }\n.select2-container--default .select2-selection--single, input.wpcf7-form-control, select.wpcf7-form-control {border-radius: 11px !important; border: 1px solid #dedede !important;}\n.select2-container--default .select2-selection--single .select2-selection__rendered {line-height: 24px !important;}\n.select2-container--default .select2-selection--single .select2-selection__arrow, .select2-container--default .select2-selection--single, .select2-container--default .select2-selection--single .select2-selection__rendered {height: 40px !important;}\n.select2-container--default .select2-selection--single .select2-selection__arrow b:before {display: none !important;}\n.wpcf7-list-item-label {color: #fff !important;}\n<\/style>\n<div class=\"mzr-row mb-0 mt-5\">\n\t<div class=\"col-md-5 mb-0\">\n\t\t<div class=\"mzr-row\">\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Firstname <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-firstname\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"text\" name=\"your-firstname\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Lastname <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-lastname\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"text\" name=\"your-lastname\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Email <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-email\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"email\" name=\"your-email\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Phone <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-phone\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-tel wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-tel mzrcf7-phone\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"tel\" name=\"your-phone\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-0\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Country <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-country\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required mzrcf7-country\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Country...\" value=\"\" type=\"text\" name=\"your-country\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t<div class=\"col-md-7 mb-0\">\n\t\t<div class=\"mzr-row\">\n\t\t\t<div class=\"col-md-12 mb-2\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Message <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-message\"><textarea cols=\"40\" rows=\"10\" maxlength=\"2000\" class=\"wpcf7-form-control wpcf7-textarea wpcf7-validates-as-required mzrcf7-textarea\" aria-required=\"true\" aria-invalid=\"false\" name=\"your-message\"><\/textarea><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-2\">\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-agreements\"><span class=\"wpcf7-form-control wpcf7-acceptance\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"your-agreements\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I authorize Anadolu Medical Center to use and store my personal data.<\/span><\/label><\/span><\/span><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-0\">\n\t\t\t\t<p><input type=\"hidden\" name=\"action\" value=\"mzr_store_the_lead\" \/><input type=\"hidden\" name=\"your-source\" value=\"UK\" \/><input type=\"hidden\" name=\"your-url\" value=\"https:\/\/\" \/><input class=\"wpcf7-form-control wpcf7-submit has-spinner btn btn-style-default btn-style-round btn-color-primary btn-submit\" type=\"submit\" value=\"SEND MESSAGE\" \/>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-16af49b e-flex e-con-boxed e-con e-parent\" data-id=\"16af49b\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-41bae50 e-con-full e-flex e-con e-child\" data-id=\"41bae50\" data-element_type=\"container\" data-e-type=\"container\" id=\"prostatecancer\">\n\t\t\t\t<div class=\"elementor-element elementor-element-73df03a elementor-widget elementor-widget-heading\" data-id=\"73df03a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Comprehensive Prostate Cancer Care You Can Trust<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-75f3dfc elementor-widget elementor-widget-text-editor\" data-id=\"75f3dfc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Prostate cancer is the most common type of cancer in men. At Anadolu Medical Center, we provide accurate and fast diagnosis, and apply the most up-to-date treatment methods including robotic surgery and personalized treatment plans. Our expert medical team ensures a comprehensive and patient-oriented approach at every stage of care.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96c62e5 elementor-widget elementor-widget-text-editor\" data-id=\"96c62e5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Early and Accurate Diagnosis<\/strong><\/p><p>We offer the latest technologies for detecting prostate cancer:<\/p><ul><li><strong>PSA Blood Test and MRI (including Multiparametric)<\/strong><\/li><li><strong>MR-Fusion Prostate Biopsy<\/strong> \u2013 under anesthesia for comfort and precision<\/li><li><strong>Gallium-68 PSMA PET\/CT<\/strong> \u2013 state-of-the-art imaging to detect cancer spread<\/li><li><strong>Multidisciplinary Evaluation<\/strong> \u2013 involving specialists from urology, oncology, nuclear medicine, radiology, pathology, and radiation oncology<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-071bd72 e-con-full e-flex e-con e-child\" data-id=\"071bd72\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fdd9d84 elementor-widget elementor-widget-image\" data-id=\"fdd9d84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1-1024x576.jpg\" class=\"attachment-large size-large wp-image-17355\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1-1024x576.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1-600x338.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1-768x432.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1-1536x864.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v1.jpg 1600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-73827ee elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-image\" data-id=\"73827ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2-1024x576.jpg\" class=\"attachment-large size-large wp-image-17363\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2-1024x576.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2-600x338.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2-768x432.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2-1536x864.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/GEHC-Omni-Legend-PWP-Summary-Rendering-v2.jpg 1600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-efd292c e-flex e-con-boxed e-con e-parent\" data-id=\"efd292c\" data-element_type=\"container\" data-e-type=\"container\" id=\"options\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-c45f83b e-con-full e-flex e-con e-child\" data-id=\"c45f83b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0492ac8 elementor-widget elementor-widget-image\" data-id=\"0492ac8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"450\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-1024x576.jpg\" class=\"attachment-large size-large wp-image-17429\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-1024x576.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-600x338.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-768x432.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-1536x864.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/prostate-2048x1152.jpg 2048w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1ea6dda e-con-full e-flex e-con e-child\" data-id=\"1ea6dda\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-738da07 elementor-widget elementor-widget-heading\" data-id=\"738da07\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Personalized Treatment Options<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b64fd7f elementor-widget elementor-widget-text-editor\" data-id=\"b64fd7f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Treatment options for prostate cancer vary depending on the stage and progression of the disease. At Anadolu Medical Center, we offer:<\/p><ul><li><strong>Robotic Radical Prostatectomy<\/strong>: Minimally invasive robotic surgery performed by experienced surgeons.<\/li><li><strong>Radiotherapy and Hormone Therapy<\/strong>: For patients who are not suitable for surgery or have locally advanced cancer.<\/li><li><strong>Chemotherapy, Immunotherapy &amp; Hormonal Treatment<\/strong>: For advanced-stage or metastatic prostate cancer.<\/li><li><strong>Radionuclide Therapies for <\/strong>Advanced or Metastatic Prostate Cancer<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4ae0ce2 e-flex e-con-boxed e-con e-parent\" data-id=\"4ae0ce2\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-9cac687 e-con-full e-flex e-con e-child\" data-id=\"9cac687\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1c0c0ab elementor-widget elementor-widget-image\" data-id=\"1c0c0ab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"534\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center-1024x684.jpg\" class=\"attachment-large size-large wp-image-17434\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center-1024x684.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center-600x401.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center-768x513.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center-1536x1025.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/davinci-anadolu-medical-center.jpg 1600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-0d26f7e e-con-full e-flex e-con e-child\" data-id=\"0d26f7e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d3e84dc elementor-widget elementor-widget-heading\" data-id=\"d3e84dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Minimally Invasive Robotic Surgery for Prostate Cancer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-176eee1 elementor-widget elementor-widget-heading\" data-id=\"176eee1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Faster recovery \u2013 Less pain \u2013 Greater precision<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7529e20 elementor-widget elementor-widget-text-editor\" data-id=\"7529e20\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>For patients diagnosed with localized prostate cancer, <strong>robotic-assisted radical prostatectomy<\/strong> is one of the most effective surgical treatment options. At Anadolu Medical Center, our expert urologic surgeons perform this operation using the <strong>Da Vinci\u00ae XI Robotic Surgery System<\/strong>, which offers several advantages over traditional open surgery:<\/p><ul><li>Smaller incisions and minimal blood loss<\/li><li>Reduced post-operative pain<\/li><li>Lower risk of complications and shorter hospital stay<\/li><li>Faster return to normal activities<\/li><li>Enhanced precision for preserving nerves that control continence and sexual function<\/li><\/ul><p>Our surgical team has extensive experience in robotic procedures and tailors each operation to the patient\u2019s individual needs. We also use advanced imaging and diagnostic techniques to ensure the best possible surgical outcomes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-51b03c2 e-flex e-con-boxed e-con e-parent\" data-id=\"51b03c2\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-f980fc1 e-con-full e-flex e-con e-child\" data-id=\"f980fc1\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b9a243b elementor-widget elementor-widget-heading\" data-id=\"b9a243b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Next Generation Radiotherapy with MR Linac<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d554232 elementor-widget elementor-widget-heading\" data-id=\"d554232\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Real-time imaging \u2013 Higher precision \u2013 Fewer side effects<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4585421 elementor-widget elementor-widget-text-editor\" data-id=\"4585421\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>At Anadolu Medical Center, we offer <strong>MR Linac<\/strong>, one of the most advanced radiotherapy technologies in the world. It combines <strong>real-time MRI imaging with linear accelerator radiation<\/strong>, allowing doctors to visualize the tumor during treatment and adjust radiation delivery with incredible precision.<\/p><p>This is especially important for prostate cancer, where nearby organs (such as the bladder and rectum) can shift daily. MR Linac is ideal for patients who are not surgical candidates or prefer non-surgical treatment options.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-63a7c3b e-con-full e-flex e-con e-child\" data-id=\"63a7c3b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0d2a020 elementor-widget elementor-widget-image\" data-id=\"0d2a020\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-1024x1024.jpg\" class=\"attachment-large size-large wp-image-17541\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-1024x1024.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-300x300.jpg 300w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-100x100.jpg 100w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-600x600.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-768x768.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image-1536x1536.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/Elekta-Unity-Full-Room-Side-View-Image.jpg 1600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c115d1c e-flex e-con-boxed e-con e-parent\" data-id=\"c115d1c\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-e373f1f e-con-full e-flex e-con e-child\" data-id=\"e373f1f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-895a972 elementor-widget elementor-widget-heading\" data-id=\"895a972\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Radionuclide Therapies for Advanced or Metastatic Prostate Cancer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-45c5f61 elementor-widget elementor-widget-text-editor\" data-id=\"45c5f61\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>When prostate cancer is advanced or has spread (metastasized), conventional treatments may not be effective. In such cases, radionuclide therapies offer a targeted, less toxic alternative. Please contact us to find out your eligibility for different types of radionuclide treatments!<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e39f469 elementor-widget elementor-widget-n-accordion\" data-id=\"e39f469\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;expanded&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accordion. Open links with Enter or Space, close with Escape, and navigate with Arrow Keys\">\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-2380\" class=\"e-n-accordion-item\" open>\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"e-n-accordion-item-2380\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Lutetium-177 PSMA Therapy <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-2380\" class=\"elementor-element elementor-element-39bdd5f e-con-full e-flex e-con e-child\" data-id=\"39bdd5f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-66ba098 elementor-widget elementor-widget-text-editor\" data-id=\"66ba098\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Targets and binds to prostate cancer cells, delivering radiation precisely to the tumor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f22bc36 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"f22bc36\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Helps shrink tumors and control disease progression<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Reduces symptoms such as bone pain and fatigue<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Used when other treatments (e.g., chemotherapy) are not tolerated<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-2381\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-2381\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Actinium-225 PSMA Therapy <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-2381\" class=\"elementor-element elementor-element-9a8675f e-con-full e-flex e-con e-child\" data-id=\"9a8675f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7118960 elementor-widget elementor-widget-text-editor\" data-id=\"7118960\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>An advanced targeted alpha therapy for patients who do not respond to Lutetium therapy.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e2789c9 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"e2789c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Higher effectiveness in resistant or aggressive cancers<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Increasingly preferred in international clinical practice<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-2382\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"3\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-2382\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Radium Therapy <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-2382\" class=\"elementor-element elementor-element-40ec7a4 e-con-full e-flex e-con e-child\" data-id=\"40ec7a4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fafb436 elementor-widget elementor-widget-text-editor\" data-id=\"fafb436\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Especially effective for bone metastases.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a71071c elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"a71071c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Relieves bone pain<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Helps reduce tumor burden in skeletal system<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-2383\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"4\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-2383\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Gallium-68 PSMA PET\/CT <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-2383\" class=\"elementor-element elementor-element-e29811c e-con-full e-flex e-con e-child\" data-id=\"e29811c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f6d31af elementor-widget elementor-widget-text-editor\" data-id=\"f6d31af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Advanced imaging for staging and monitoring treatment response.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3eaa0a4 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"3eaa0a4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Low radiation dose<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M173.898 439.404l-166.4-166.4c-9.997-9.997-9.997-26.206 0-36.204l36.203-36.204c9.997-9.998 26.207-9.998 36.204 0L192 312.69 432.095 72.596c9.997-9.997 26.207-9.997 36.204 0l36.203 36.204c9.997 9.997 9.997 26.206 0 36.204l-294.4 294.401c-9.998 9.997-26.207 9.997-36.204-.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">High accuracy in identifying cancer spread<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c565383 e-con-full e-flex e-con e-child\" data-id=\"c565383\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bdaffd9 elementor-widget elementor-widget-image\" data-id=\"bdaffd9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"596\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi-1024x763.jpg\" class=\"attachment-large size-large wp-image-17400\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi-1024x763.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi-600x447.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi-768x572.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi-1536x1144.jpg 1536w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/radionuclizi.jpg 1600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bbdb42a e-flex e-con-boxed e-con e-parent\" data-id=\"bbdb42a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4a99826 elementor-widget elementor-widget-heading\" data-id=\"4a99826\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Mayo Clinic Partnership<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c3d27f9 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"c3d27f9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>One of the most famous and prestigious urology clinics in the USA has been referring a high number of prostate cancer patients to Anadolu Medical Center to receive Lutetium and Actinium treatments.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9626e8f e-con-full e-flex e-con e-child\" data-id=\"9626e8f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-0f7bc55 e-con-full e-flex e-con e-child\" data-id=\"0f7bc55\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-602f3a7 elementor-widget elementor-widget-video\" data-id=\"602f3a7\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=nQvKj7DpP28&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-be4b108 e-con-full e-flex e-con e-child\" data-id=\"be4b108\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4128f51 elementor-widget elementor-widget-video\" data-id=\"4128f51\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=Fr3boD4HObI&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-92d1021 e-flex e-con-boxed e-con e-parent\" data-id=\"92d1021\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2f3ee53 e-con-full e-flex e-con e-child\" data-id=\"2f3ee53\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ea2023 elementor-widget elementor-widget-heading\" data-id=\"6ea2023\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Other Urooncological Diseases We Treat<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4dbb761 elementor-widget elementor-widget-text-editor\" data-id=\"4dbb761\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>In addition to prostate cancer, we also diagnose and treat:<\/p><ul><li><strong>Kidney Cancer<\/strong>: Detected early with advanced imaging; treated with kidney-sparing robotic surgery when appropriate.<\/li><li><strong>Bladder Cancer<\/strong>: Diagnosed with cystoscopy; treated using endoscopic techniques, immunotherapy, or radical surgery.<\/li><li><strong>Testicular Tumors<\/strong>: Highly treatable cancers managed with surgery and chemotherapy, often affecting young men.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-13d17e5 e-con-full e-flex e-con e-child\" data-id=\"13d17e5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2c7f585 elementor-widget elementor-widget-image\" data-id=\"2c7f585\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2021\/05\/Tot-ce-trebuie-s-----tii-despre-cancerul-de-vezic---urinar---1024x512.png\" class=\"attachment-large size-large wp-image-13871\" alt=\"cancerul de vezic\u0103 urinar\u0103\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2021\/05\/Tot-ce-trebuie-s-----tii-despre-cancerul-de-vezic---urinar---1024x512.png 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2021\/05\/Tot-ce-trebuie-s-----tii-despre-cancerul-de-vezic---urinar---600x300.png 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2021\/05\/Tot-ce-trebuie-s-----tii-despre-cancerul-de-vezic---urinar---768x384.png 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2021\/05\/Tot-ce-trebuie-s-----tii-despre-cancerul-de-vezic---urinar--.png 1200w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-30b8af5 e-flex e-con-boxed e-con e-parent\" data-id=\"30b8af5\" data-element_type=\"container\" data-e-type=\"container\" id=\"doctors\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-45000bb elementor-widget elementor-widget-heading\" data-id=\"45000bb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">Our Urooncology Center<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-12e5d5d elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"12e5d5d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ff908ec elementor-widget elementor-widget-heading\" data-id=\"ff908ec\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Meet our Expert Team<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f2f706a e-con-full e-flex e-con e-child\" data-id=\"f2f706a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-801c49f elementor-widget elementor-widget-triumf_lightbox\" data-id=\"801c49f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-801c49f-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"801c49f\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. \u0130lker Tinay<\/h2><p><strong>Specialty<\/strong><\/p><p>Rich experience in academic urological oncology, publication, teaching and guest speaker experiences<br \/>Urological oncology opinion leader in Turkey<br \/>Clinical experience in phase 3 urological oncology<br \/>Deep understanding and experience with liquid biomarkers, namely microRNA in prostate and urothelial carcinoma<br \/>Minimally invasive and open tumor surgery with special expertise;<br \/>\u2013 In prostate cancer<br \/>\u2013 In kidney cancer<br \/>\u2013 Urothelial carcinoma of the bladder and upper urinary tract<br \/>\u2013 Germ cell tumors after retroperitoneal chemotherapy (RPLND)<\/p><p><strong>Education<\/strong><\/p><p>1997-2003: Istanbul Faculty of Medicine, Istanbul University Turkey<br \/>July-August 2000: Cleveland Clinic Foundation, Cleveland USA \u2013 General and Colorectal Surgery<br \/>July-August 1999: Oslo University Hospital, Ulleval Norway \u2013 Basic and Clinical Microbiology<\/p><p><strong>Institutions he works for<\/strong><\/p><p>Bal\u0131kesir Military Hospital<\/p><p>Kurtalan Municipality Hospital in Siirt<\/p><p>Marmara University Faculty of Medicine<\/p><p>Harvard Medical School, Brigham and Women's Hospital<\/p><p>Anadolu Medical Center<\/p><p><strong>Awards<\/strong><\/p><p>Marmara University Science Encouragement Award for Medical Residency Students, 2008<\/p><p>Presentation Award for Young Academicians at the National Urological Surgery Congress, 2012<\/p><p>Uro-Oncology Association Scientific Research Award, 2019<\/p><p><strong>Institutional Membership<\/strong><\/p><p>Secretary General of the Turkish Uroncology Association<\/p><p>Member of the International Bladder Cancer Network<\/p><p>Member of the European Association of Urology<\/p><p>Member of the College American of Surgeons<\/p><p><strong>Course Attendance<\/strong><\/p><p>November 2008: Board Certified Urology (Turkey, active)<br \/>June 2010: Fellow of European Board of Urology (FEBU)<br \/>October 2018: Fellow of American College of Surgeons (FACS)<\/p><p><strong>Scientific Publications<\/strong><\/p><p>https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=tinay+i&amp;sort=date <\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cdf47b9 elementor-widget elementor-widget-triumf_lightbox\" data-id=\"cdf47b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-cdf47b9-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"cdf47b9\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>MD. Surgeon Muhammed Sulukaya<\/h2><p><strong>Specialty<\/strong><\/p><p>Female Urinary Incontinence<\/p><p>Stone Surgery<br \/>Benign Prostate Diseases<\/p><p>Uro-Oncology Surgery<\/p><p>Testicular Pathologies<\/p><p><strong>Education<\/strong><\/p><p>2011\u00a0\u00a0 University: Marmara University Faculty of Medicine (English)<\/p><p>2017\u00a0\u00a0 Specialty: Marmara University Faculty of Medicine Department of Urology<\/p><p>Specialty: \u00a0Female Urinary Incontinence Stone Surgery Benign Prostate Diseases,<\/p><p><strong>Institutions he works for<\/strong><\/p><p>Malatya Education and Research Hospital<br \/>Beykoz State Hospital<br \/>\u00dcmraniye Education and Research Hospital<br \/>Medivia \u00c7engelk\u00f6y Private Hospital<\/p><p><strong>Membership of the Institution<\/strong><\/p><p>Association of Urological Surgery<br \/>European Association of Urology (EAU)<\/p><p><strong>Course Attendance<\/strong><\/p><p>Oncotherm Hyperthermic Oncology Training Course (Bad Aibling, Munich, January 16, 2018)<br \/>Course Adrenalectomy Live 1 to 1 (Endourology Association, April 18, 2019)<br \/>Laparoscopic Nephrectomy Live 1 to 1 Course (Endourology Association, June 20, 2019)<br \/>3D Laparoscopy Live 1 to 1 Course (Endourology Association, October 25, 2019)<br \/>Bristol Urodynamics Course (November 28-29, 2020)<br \/>Bristol Advanced Urodynamics Course (June 12, 2021)<\/p><p><strong>Scientific Publications<\/strong><\/p><p>erhan Cimen, Murat Dursun, Muhammed Sulukaya &amp; Huseyin Besiroglu<br \/>\"Could the monocyte\/HDL cholesterol ratio be an early marker of erectile dysfunction?\"<br \/>The Aging Male, DOI: 10.1080\/13685538.2019.1574735<\/p><p>Dursun M, Cimen S, Sulukaya M, Bugday MS, Besiroglu H<br \/>\"The predictive value of red blood cell distribution width on erectile dysfunction.\"<br \/>Andrology, 2019;00<\/p><p>. DOI: 10.1111\/and.13374<\/p><p>Yiloren Tanidir, Naside Mangir, Ahmet Sahan, Muhammed Sulukaya<br \/>\"Turkish version of the Ureteral Stent Symptom Questionnaire: linguistic and psychometric validation.\"<br \/>World J Urol, DOI: 10.1007\/s00345-016-1958-4<\/p><p>Safety and efficacy of retropubic or transobturator midurethral slings in a randomized cohort of Turkish women<br \/>Tufan Tarcan, Naside Mangir, Ahmet Sahan, Yiloren Tanidir, Muhammed Sulukaya, Yalcin \u0130lker.<br \/>Urol Int, 2014;93:449\u2013453 DOI: 10.1159\/000364952<\/p><p>Sperm concentration and sperm volume increase after smoking cessation in infertile men<br \/>Deniz Kulaksiz, Tuncay Toprak, Eda Tokat, Mehmet Yilmaz, Mehmet Akif Ramazanoglu, Asgar Garayev, Muhammed Sulukaya, Recep Burak Degirmentepe, Elnur Allahverdiyev, Murat Gul and Ayhan Verit.<br \/>IJIR: Your Sexual Medicine Journal, 2022, 34:614\u2013619; DOI: 10.1038\/s41443-022-00605-0<\/p><p>Design and validation of the Marmara Post-Prostatectomy Symptom Score<br \/>Murat Akg\u00fcl, Muhammed Sulukaya, Ahmet \u015eahan, Nural Bekiro\u011flu, \u0130lker Tinay, Levent T\u00fcrkeri, Tufan Tarcan.<br \/>Journal of Urological Surgery, 2017;4:1-7 DOI: 10.4274\/jus.1097<\/p><p>Differential Renal Function Assessment in Children with Hydronephrosis: Comparison of DMSA and MAG-3<br \/>Cem Akbal, Ahmet \u015eahan, Asgar Garayev, \u00c7a\u011fr\u0131 Ak\u0131n \u015eekerci, Muhammed Sulukaya, Harika Alpay, Tufan Tarcan, Ferruh \u015eim\u015fek.<br \/>Journal of Urological Surgery, 2015; 3: 129-134 DOI: 10.4274\/jus.366<\/p><p>Types of urodynamic detrusor overactivity and their relationship with neurological diseases. 10-year follow-up of 1000 invasive urodynamic studies<br \/>Alkan \u00c7ubuk, Ahmet Sahan, Orkunt \u00d6zkaptan, Berkan \u015eim\u015fek, Muhammed Sulukaya, Fatih Tarhan.<br \/>East J Med, 26(1): 139-144, 2021 DOI: 10.5505\/ejm.2021.92678<\/p><p>NEGATIVE EFFECTS OF SMOKING ON SEMEN PARAMETERS AFTER VARICOCELECTOMY<br \/>Muhammet Serdar Bugday, Ersoy \u00d6ks\u00fcz, Murat Dursun, Serhan \u00c7imen, Muhammed Sulukaya, Battal Sel\u00e7uk \u00c7akmak.<br \/>Journal of Inonu University Health Services Vocational School, ISSN: 2147-7892, Volume 11, Issue 1 (2023) 1297-1303 DOI: 10.33715\/inonusaglik.1198321<\/p><p>Can surgical technique affect the success of endoscopic treatment in children with vesicoureteral reflux and overactive bladder syndrome?<br \/>Ahmet \u015eahan, Cem Akbal, Asgar Garayev, \u00c7a\u011fr\u0131 Ak\u0131n \u015eekerci, Muhammed Sulukaya, Y\u0131l\u00f6ren Tan\u0131d\u0131r, \u0130lker Tinay, Tufan Tarcan, Ferruh \u015eim\u015fek.<br \/>Journal of Urological Surgery, 2015; 3: 135-140 DOI: 10.4274\/jus.367<\/p><p>Super-selective embolization of vesical arteries with micro-catheter technique in the treatment of uncontrollable bleeding due to bladder cancer<br \/>Bahad\u0131r \u015eahin, Muhammed Sulukaya, \u0130lker Tinay, Y\u0131l\u00f6ren Tan\u0131d\u0131r, Feyyaz Baltac\u0131o\u011flu, Levent T\u00fcrkeri.<br \/>Bulletin of Urooncology, 2016; 15:1-3 DOI: 10.4274\/uob.448<\/p><p>Nephron-rupturing surgery for localized renal tumors - Quality of life in brief<br \/>Y\u0131l\u00f6ren Tan\u0131d\u0131r, Ferhad Talibzade, Muhammed Sulukaya.<br \/>Bulletin of Urooncology, 2014; 13:201-205 DOI: 10.4274\/uob.160<\/p><p><strong>Book Chapters<\/strong><\/p><p>Basic Approach and Management in Urology<br \/>https:\/\/doi.org\/10.37609\/akya.1251<br \/>Approach and Management of Urethral Diseases, Muhammed Sulukaya<\/p><p>Approach to Urological Cases According to the Literature<br \/>https:\/\/doi.org\/10.37609\/akya.2183<br \/>Vesikovaginal Reflux: A Case Report and Literature Review, Muhammed Sulukaya<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f6d228c elementor-widget elementor-widget-triumf_lightbox\" data-id=\"f6d228c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-f6d228c-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"f6d228c\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. Hale Ba\u015fak \u00c7a\u011flar<\/h2><p><strong>Specialty<\/strong><\/p><p>Varian Linear Accelerators (Trilogy-TrueBeam)<br \/>CyberKnife (including VSI-M6-MLC)<br \/>Gamma Knife (C and Perfexion models)<br \/>Oncology Center<\/p><p><strong>Education<\/strong><\/p><p>University<\/p><p>Gazi University, Faculty of Medicine, Ankara 1998<\/p><p>Specialized Training<\/p><p>Marmara University, Faculty of Medicine, Department of Radiation Oncology, Istanbul 2003<\/p><p>Associate Professor<\/p><p>Marmara University, Faculty of Medicine, Department of Radiation Oncology, Istanbul 2010<\/p><p>Professor<\/p><p>Medipol University, Faculty of Medicine Department of Radiation Oncology, Istanbul 2015<\/p><p><strong>Affiliations<\/strong><\/p><p>Hacettepe University Faculty of Medicine<br \/>Marmara University Faculty of Medicine<br \/>Dana Farber Cancer Institute \/ Brigham and Women's Hospital<br \/>Harvard University, Harvard Joint Committee<br \/>University Faculty of Medicine Acibadem<br \/>Medipol University, Faculty of Medicine<br \/>Anadolu Health Center<\/p><p><strong>Institutional Membership<\/strong><\/p><p>ASTRO (American Society for Therapeutic Radiation Oncology)<br \/>ESTRO (European Society for Therapeutic Radiation Oncology)<br \/>EORTC (European Agency for Research and Treatment of Cancer)<br \/>Radiosurgery Society (Board of Directors)<br \/>Turkish Lung Cancer Association<br \/>Turkish Radiation Oncology Association<br \/>Turkish Medical Association, Turkish Society of Oncology<\/p><p><strong>Scientific Publications<\/strong><\/p><p><strong>A. Uluslararas\u0131 dergiler<\/strong><\/p><p>A1. Yumuk PF, Abac\u0131o\u011flu U, \u00c7a\u011flar H, G\u00fcm\u00fc\u015f M, \u015eeng\u00f6z M, Turhal NS. Outcome of Rectal and Sigmoid Carcinoma Patients Receiving Adjuvant Chemoradiotherapy in Marmara University Hospital. J. Chemotherapy, 15(6), 603-606, (2003).<br \/>A2. G\u00fcm\u00fc\u015f M, Yumuk PF, Atalay G, Aliustao\u011flu M, Macunluo\u011flu B, Dane F, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal S. What is the optimal number of lymph nodes dissected in colorectal cancer surgery? Tumori (91:168-172, 2005)<br \/>A3. Abac\u0131o\u011flu U, Yumuk PF, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal NS. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. BMC Cancer, Vol 5:71, 2005.<br \/>A4. \u00c7a\u011flar H, Allen AM. Intensity Modulated Radiotherapy for Head and Neck Cancer. Clinical Advances in Hematology &amp; Oncology. 2007 Jun;5(6):425-31.<br \/>A5. Batirel HF, Metintas M, \u00c7a\u011flar HB, Y\u0131ld\u0131zzeli B, Lacin T, Bostanc\u0131 K, Akgul AG, Evman S, Yuksel M. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2008 May;3(5):499-504. <br \/>A6. \u00c7a\u011flar HB, Tishler RB, Othus M, Burke E, Li Y; Goguen L, Wirth LJ, Haddad RI, Norris CM, Court LE, Aninno DJ, Posner MR, Allen AM. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. November 2008;72(4):1110-1118.<br \/>A7. Demiral AN, Al\u0131c\u0131ku\u015f ZA, Ugur VI, Karado\u011fan I, Yoney A, Andrieu MN, Yalman D, Pak Y, Aksu G, \u00d6zyi\u011fit G, \u00d6zkan L, K\u0131l\u00e7\u0131ks\u0131z S, Koca S, Calo\u011flu M, Yavuz AA, \u00c7a\u011flar HB, Beyzadeo\u011flu M, Igdem S, Serin M, Kaplan B, et al. Patterns of Care for Lung Cancer in Radiation Oncology Departments of Turkey. Int J Radiat Oncol Biol Phys. 72(5):1530-1537, May 2008.<br \/>A8. Akkiprik M, S\u00f6nmez O, G\u00fcll\u00fco\u011flu BM, \u00c7a\u011flar HB, Kaya H, Demirkalem P, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, Sav A, Ozer A. Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer. Pathology and Oncology Research, (Epub ahead of print), (2008).<br \/>A9. \u00c7a\u011flar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, J\u00e4nne PA, Johnson BE, Allen AM. Outcomes of Patients with Stage III Nonsmall Cell Lung Cancer Treated With Chemotherapy and Radiation With and Without Surgery. Cancer, 2009 Sep 23;115(18):4156-4166.<br \/>A10. Basaran G, Devrim C, \u00c7a\u011flar HB, G\u00fcll\u00fco\u011flu B, Kaya H, Seber S, Korkmaz T, Telli F, Ko\u00e7ak M, Dane F, Yumuk FP, Turhal SN. Clinical outcome of breast cancer patients with N3a (&gt;\/=10 positive lymph nodes) disease: has it changed over years? Med Oncol. 2011 Sep;28(3):726-32.<br \/>A11 Abac\u0131o\u011flu U, \u00c7a\u011flar H, Atasoy BM, Abdulloev T, Akg\u00fcn Z, K\u0131l\u0131\u00e7T. Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors. J BUON. 2010 Apr-Jun;15(2):274-80.<br \/>A12 Alexander BM, Othus M, \u00c7a\u011flar HB, Allen AM. Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1381-7<br \/>A13 \u00c7a\u011flar HB, Othus M, Allen AM. Esophagus in-field: a new predictor for esophagitis. Radiother Oncol. 2010 Oct;97(1):48-53.<br \/>A14 Abac\u0131o\u011flu U, \u00c7a\u011flar HB, Yumuk PF, Akg\u00fcn Z, Atasoy BM, \u015eeng\u00f6z M. Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma. J Neurooncol. 2010 Sep 29. [Epub ahead of print].<br \/>A15 Atasoy BM, Dane F, \u00dc\u00e7\u00fcnc\u00fc Kefeli A, Ca\u011flar H, C\u0131ng\u0131 A, Turhal NS, Abac\u0131o\u011flu U, Ye\u011fen C. Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer. Turk J Gastroenterol. 2011 Feb;22(1):60-4.<br \/>A16 Allen AM, Albert M, \u00c7a\u011flar HB, Zygmanski P, Soto R, Killoran J, Sun Y. Can Hyperpolarized Helium MRI add to radiation planning and follow-up in lung cancer? J Appl Clin Med Phys. 2011 Jan 31;12(2):3357.<br \/>A17 Midi A, Belirgen M, \u00c7a\u011flar H, Sav A. Investigation of The Effect of Radiotherapy on The Proliferative Index (Ki-67) in Recurring Diffuse Glial Tumors. Journal of Neurological Sciences (Turkish), 28(1).<br \/>A18 Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, \u00c7a\u011flar H, \u00d6zsaranZ, L\u00f6ssl. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e757-63.<br \/>A19 \u00d6zyar E, \u00c7a\u011flar HB, Atalar B. In regard to Zhou et al \"Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis\" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365). Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):482-3.<br \/>A20 Lyatskaya Y, Rehfeld K, Kadam DV, \u00c7a\u011flar H, Allen A, Chin LM, Killoran JH. Comparison of two techniques for target motion evaluation based on 4DCT images. International Journal of Biomedical Engineering and Technology 8.2-3 (2012): 117-137.<br \/>A21 Atalar B, G\u00fcng\u00f6r G , \u00c7a\u011flar H, Ayd\u0131n G, Yap\u0131c\u0131B, \u00d6zyarE. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer. Tumori 2012, 98(3):331-336. <br \/>A22 Atalar B, \u00c7a\u011flar H, \u00d6zyarE. Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011; 79: 660\u2013669. <br \/>A23 Bozcuk H, Abali H, Coskun S; Lung Cancer Committee of Turkish Oncology Group. The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis. World J Surg Oncol. 2012 Aug 9;10(1):161.<br \/>A24 Atalar B, Ayd\u0131n G, G\u00fcng\u00f6r G, \u00c7a\u011flar H, Yap\u0131c\u0131B, \u00d6zyarE. Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer. Technol Cancer Res Treat. 2012 Jun;11(3):249-55.<br \/>A24 Erpolat OP, Alco G, \u00c7a\u011flar HB, Igdem S, Saran A, Dago\u011flu N, Aslay I, \u00d6zsaran Z, Demirci S, Keven E, Guney Y, Akmansu M, K\u0131l\u0131\u00e7D, Bayman E, Etiz D, Mandel NM. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. Eur J Gynaecol Oncol. 2014;35(1):62-6.<br \/>A25 Mahadevan A, Bucholz R, Gaya AM, Kresl JJ, Mantz C, Minnich DJ, Muacevic A, Medbery C 3rd, Yang J, \u00c7a\u011flar HB, Davis JN. Best of the Radiosurgery Society\u00ae Scientific Meeting 2014: stereotactic radiosurgery\/stereotactic body radiotherapy treatment of extracranial and intracranial lesions. Future Oncol. 2014 Dec;10(15):2307-10.<br \/>A26 Bat\u0131rel HF, Metinta\u015f M, \u00c7a\u011flar HB, Ak G, Yumuk FP, Y\u0131ld\u0131zeli B, Y\u00fcksel M, Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2016 Feb;151(2):478-84.<br \/>A27 Zwahlen DR, Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, \u00c7a\u011flar H, \u00d6zsaranZ, Loessl K, Belkaaloul KK, Villette S, Vees H. Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study. Rare Tumors. 2016 Jun 29;8(2):6052.<br \/>A28. Acar H, Alt\u0131nok AY, K\u00fc\u00e7\u00fckmorko\u00e7 E, \u00c7a\u011flar M, Sut PA, K\u00fc\u00e7\u00fck N, Doyuran M, \u00c7a\u011flar HB. \"Dosimetric Comparison of IMRT and VMAT Techniques using RTOG 0631 Guidelines in Spine Sterotactic Body Radiosurgery.\" Cancer ResOncol 2, no. 007 (2016).<\/p><p><strong>B. International Proceedings<\/strong><\/p><p>B1. \u00c7a\u011flar H, U, Ar\u0131bal E, \u015eeng\u00f6z M, \u00c7etin \u0130, G\u00fcll\u00fco\u011flu B. Survival Comparison and Characteristics of Adjuvantly Irradiated Breast Cancer Patients Diagnosed with Lump in Breast or Screening Mammogram. The Breast Journal 2001; Vol 7(5) Suppl:41, OP-76. <br \/>B2. \u015eeng\u00f6z M, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Atasoy B, Turhal S, G\u00fcll\u00fco\u011flu B. Patient Characteristics and Treatment Results of Postoperatively Irradiated Breast Cancer Patients. The Breast Journal 2001; Vol 7(5) Suppl:42, OP-77. <br \/>B3. \u00c7a\u011flar H, \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Kodalli N. The Early Treatment of Radiation Pneumonitis in Patients After Adjuvant Radiotherapy for Breast Cancer. European Journal of Cancer. Vol 37 (Supp. 6); S184-185, 2001.<br \/>B4. G\u00fcm\u00fc\u015f M, Aliustao\u011flu M, Atalay G, Macunluo\u011flu B, Dane F, \u00c7a\u011flar HB, \u015eeng\u00f6z M, Turhal NS. The Extension of Nodal Sampling in Colorectal Cancer Patients in Marmara University Hospital, Istanbul. Proc Am Soc Clin Oncol 21: 2002 (abstr 2345)<br \/>B5. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Turhal S, \u015eeng\u00f6z M. Gemcitabine (GEMZAR) as a Radiosensitizer in Stage III Non Small Cell Lung Cancer. The Fourth Annual Global Oncology Young Investigators\u2019 Meeting, Abstract Book, Lilly Oncology, Indianapolis, 2002.<br \/>B6. Abac\u0131o\u011flu U, Yumuk PF, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal NS. Results of Concurrent Chemoradiotherapy (CRT) With Low Dose Weekly Gemcitabine (G) in Stage III Non-Small Cell Lung Cancer (NSCLC). Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7318<br \/>B7. Abac\u0131o\u011flu MU, Akg\u00fcn Z, \u00c7a\u011flar H. Factors Affecting Brain Metastases Development in Stage III Non Small Cell Lung Cancer Patients Treated With Definitive Treatment. 25th ESTRO Annual Meeting, Leipzig, Radiother Oncol, Vol. 81 (Suppl. 1), S388, 2006.<br \/>B8. Basaran GA, \u00c7abuk D, \u00c7a\u011flar HB, Iyikesici S, Tebessum \u00c7, G\u00fcll\u00fco\u011flu B, Kaya H, Dane F, Yumuk PF, Turhal NS. Stage I (T1N0M0) Breast Cancer (BC): Pathological Characteristics and Clinical Outcome. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix113, 2006.<br \/>B9. Dane F, G\u00fcm\u00fc\u015f M, Yumuk PF, \u0130yikesici S, \u00d6zt\u00fcrk A, Basaran G, \u00c7a\u011flar HB, \u00c7abuk D, Teomete M, Turhal NS. Outcome of Colon Cancer Patients Receiving Adjuvant Chemotherapy in Marmara University Hospital. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix130, 2006. <br \/>B10. Teomete M, Yumuk PF, \u0130yikesici MS, Dane F, Ba\u015faran G, \u00c7abuk D, \u00c7a\u011flar HB, Abac\u0131o\u011flu U, Turhal NS. Outcome of Patients With Stage III and IV Non-Small Cell Lung Cancer in Marmara University Hospital, Istanbul, Turkey. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix225, 2006.<br \/>B11. Dane F, Topalo\u011flu N, Abul Y, Yumuk PF, Turhal NS, Ceyhan B, Celikel T, \u00c7a\u011flar H, Basaran G, Ahiskali R. Interstitial Penumonitis Associated with Docetaxel Administration. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix307, 2006. <br \/>B12. \u00d6zen Z, \u00c7a\u011flar H, Akg\u00fcn Z, Abac\u0131o\u011flu U. Three dimensional non coplanar irradiation for right hemithoracic tumors of operated malignant mesothelioma. Radiotherapy and Oncology, Volume 84, Supplement 1, P S275 (September 2007).<br \/>B13. \u00c7a\u011flar HB, Allen AM, Burke E, Posner M, Haddad R, Norris C, Annino D, Wirth L, Tishler R. Swallowing Function After Intensity Modulated Radiotherapy (IMRT) and Chemotherapy for Head and Neck Cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 6046. <br \/>B14. \u00c7a\u011flar HB, Allen AM, Othus M, Li Y, Burke E, Wirth L, Gougen LA, Haddad RI, Posner MR, Tishler RB. Dose to the Larynx Predicts for Swallowing Complications Following IMRT and Chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2007, Vol. 69, Issue 3, S53-S54.<br \/>B15. Allen AM, Othus M, Baldini EH, Mentzer SJ, Bueno R, Sugarbaker DJ, Colson YL, Marcoux JP, Johnson BE, \u00c7a\u011flar HB. Prognostic factors for radical treatment of stage III NSCLC. European J Cancer Supp, September 2007, Volume 5, Issue 4,392 Abstract No 6613.<br \/>B16. \u00c7a\u011flar HB, Mentzer S, Lukanich JM, Janne PA, Marcoux PJ, Lathan C, Rabin MS, Colson YL, Allen AM. Full Dose Chemoradiation Followed by Surgical Resection in Locally Advanced NSCLC. 12th World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, S635, P2-166, August 2007. <br \/>B17. Yumuk PF, Teomete M, Dane F, \u00c7abuk D, \u00c7a\u011flar HB, Abac\u0131o\u011flu U, Ba\u015faran G, Turhal NS. Outcome of Patients With Stage III and IV Non-Small Cell Lung Cancer in Marmara University Hospital, Istanbul, Turkey. 12th World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, P2-323, August 2007.<br \/>B18. \u00c7a\u011flar HB, Othus M, Allen AM. Mean In-field Esophagus Dose Predicts for Esophagitis in Lung Cancer Patients Treated with 3D-CRT and Concurrent Chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2008 Vol. 72, Issue 1, Supp 1, S427, 2578. <br \/>B19. Allen AM, Sun Y, \u00c7a\u011flar HB, Zygmanski P, Killoran JH, Albert M. Hyperpolarized Helium MRI and the Importance of Ventilation Tumor Volumes (VTVs) Before and After RT for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics 2008, Vol. 72, Issue 1, Supp 1, S626, 3017. <br \/>B20. Ba\u015faran G, \u00c7a\u011flar H, Bese N, Haydaro\u011flu A, Eralp Y, Abali H. Clinical Outcome of T1N0 Breast Cancer (BC) Patients (pts): A Turkish Oncology Group Retrospective Analysis. Journal of BUON, Proceedings, October 2008.OP-21 <br \/>B21. Abac\u0131o\u011flu U, \u00c7a\u011flar HB, Yumuk F. Efficacy of Protracted Dose-Dense Temozolomide in Patients With Progressive High-Grade Glioma, Schering-Plough Temodal International Research Update Meeting, Cenevre, 11-12 Nisan 2008.<br \/>B22. Alexander BA, Othus M, \u00c7a\u011flar HB, Allen AM. Mediastinal Nodal Volume Predicts For Survival In Stage III NSCLC. Journal of Thoracic Oncology 2008, vol 3(11), supp 4, Abstract No 118. <br \/>B23. Abac\u0131o\u011flu U, Kefeli A, Akg\u00fcn Z, \u00c7a\u011flar H, Atasoy B, Yumuk F, K\u0131l\u0131\u00e7 T. Single Center Survival Outcomes of 167 Glioblastoma Patients: Before and After Temozolomide. The 3rd Quadrennial Meeting of the World Federation of Neuro-Oncology Abstract Book, May 2008, 167, P107. <br \/>B24. Abac\u0131o\u011flu MU, \u00c7a\u011flar HB, Yumuk PF, Akg\u00fcn Z, Atasoy BM, \u015eeng\u00f6z M. Efficacy of Protracted Dose-dense Temozolomide (TMZ) in Patients With Progressive High-grade Glioma. J Clin Oncol June 2009, Volume 27, 18S, e13018. <br \/>B25. \u00d6zen Z, Unal S, \u00c7a\u011flar H, Akg\u00fcn Z. Postmastectomy Radiation Therapy: Dosimetric Differences of Automatic Bolus by Treatment Planning System. Radiotherapy and Oncology, Volume 92, Supplement 1, Pages S251 (August 2009)<br \/>B26. Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Abdah-Bortnyak R, Thariat J, \u00c7a\u011flar H, \u00d6zsaranZ, L\u00f6ssl K, Zwahlen D, Villette S, Vees H.Outcome and pronostic factors in malignant Mixed Mullerian Tumours and endometrial stromal sarcomas: a rare cancer network study. European J Cancer Supp, September 2009, Volume 7, Issue 2, 459 Abstract No 8031.<br \/>B27. Abac\u0131o\u011flu M, Akg\u00fcn Z, Kefeli AU, Atasoy BM, \u00c7a\u011flar HB. Effect of time interval between surgical resection and radiotherapy on survival of patients with glioblastoma. International Journal of Radiation Oncology, Biology, Physics November 2009, Vol. 75, Issue 3, Supp 1, S229, 2106.<br \/>\u00c7a\u011flar, Hale B., Esra K\u00fc\u00e7\u00fckmorkoc, Ay\u015fe Alt\u0131nok, Nadir K\u00fc\u00e7\u00fck, Mine Doyuran, and Hilal Acar. The Effect of Adaptive Planning on Target and Critical Structures During Radiation Treatment for Locally Advanced Lung Cancer. Journal of Thoracic Oncology, vol. 10, no. 9, pp. S449-S449. <br \/>Yumuk PF, Besiro\u011flu M, Dane F, Kanitez M, Aktas B, \u00c7a\u011flar C, Y\u0131ld\u0131zzeli B, Dede F, Atasoy B, Turhal NS. Is PET\/CT a better ttol than CT in response evaluation and follow up of stage III non-small cell lung cancer after chemoradiotherapy? Journal of Thoracic Oncologt, vol. 8, pp. S559-S559. <br \/>Alt\u0131nok A, Doyuran M, \u00c7a\u011flar M, Cano\u011flu D, K\u00fc\u00e7\u00fckmorko\u00e7 E, Acar H, K\u00fc\u00e7\u00fck N, \u00c7a\u011flar H. Boost volume assessment in breast cancer: preop tumor volume vs clips used in oncoplastic surgery. Radiotherapy and Oncology April 2016 , Volume 119 , S566.<br \/>Pa\u00e7ac\u0131 P, Cebe MS, Mabhouti H, Codel G, Serin E, Sanl\u0131 E, Doyuran M et al. \"Dosimetric evaluation of the dose calculation accuracy of different algorithms for two different treatment techniques during whole breast irradiation.\" Physica Medica 32 (2016): 247.<br \/>Serin E, Codel G, Mabhouti H, Cebe M, Sanl\u0131 E, Pa\u00e7ac\u0131 P, K\u00fc\u00e7\u00fck N, K\u00fc\u00e7\u00fckmorko\u00e7 E, Doyuran M, Cano\u011flu C, Alt\u0131nok A, Acar H, \u00c7a\u011flar HO. Accuracy of the Small Field Dosimetry Using the Monte Carlo and Sequential Dose Calculation Algorithms of Multiplan Treatment Planning System Within and Beyond Heterogeneous Media for Cyberknife M6 Unit. Physica Medica 32 (2016): 271.<br \/>Codel G, Serin E, Cebe MS, Mabhouti H, Pa\u00e7ac\u0131 P, Sanl\u0131 E, Doyuran M, K\u00fc\u00e7\u00fckmorko\u00e7 E, Alt\u0131nok A, Cano\u011flu C, K\u00fc\u00e7\u00fck N, Acar H, \u00c7a\u011flar H. Accuracy of the small field dosimetry using Acuros XB and AAA dose calculation algorithms of eclipse treatment planning system within and beyond heterogeneous media for Trubeam 2.0 unit. Physica Medica: European Journal of Medical Physics, Volume 32, 271.<br \/>Mabhouti H, Sanl\u0131 E, Cebe MS, Codel G, Pa\u00e7ac\u0131 P, Serin E, Doyuran M, K\u00fc\u00e7\u00fckmorko\u00e7 E, Alt\u0131nok A, Cano\u011flu D, K\u00fc\u00e7\u00fck N, Acar H, \u00c7a\u011flar H. The dosimetric comparison of Truebeam and Cyberknife treatment planning systems dose calculation accuracy for brain SRS treatment on Randophantom. Physica Medica Volume 32, Supplement 3, September 2016, Pages 273.<\/p><p><strong>C. Uluslararas\u0131 kitap b\u00f6l\u00fcmleri<\/strong><\/p><p>\u00c7a\u011flar, Hale Ba\u015fak, et al. \"and Branislav Jeremic.\" Decision Tools for Radiation Oncology: Prognosis, Treatment Response and Toxicity (2014): 91.<br \/>\u00c7a\u011flar, Hale Ba\u015fak. \"Radiotherapy Options of Brainstem Tumors.\" Posterior Fossa Tumors in Children. Springer International Publishing, 2015. 595-608.<br \/>\u00c7a\u011flar, Hale Ba\u015fak. \"Radiation Therapy in Atypical Teratoid\/Rhabdoid Tumors.\" Posterior Fossa Tumors in Children. Springer International Publishing, 2015. 667-672.<br \/>\u00c7a\u011flar, Hale Ba\u015fak. Radiation Therapy of Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma: Present Status and Future Directions. DOI: 10.2174\/9781681081946116010026<\/p><p><strong>D. Ulusal dergiler<\/strong><\/p><p>D1. \u00c7a\u011flar HB, Abac\u0131o\u011flu U. Evre I Seminomda G\u00fcncel Tedavi Yakla\u015f\u0131mlar\u0131. \u00dcroonkoloji B\u00fclteni, 2, 7-11, (2006).<br \/>D2. Abac\u0131o\u011flu U, \u00c7a\u011flar HB, \u015eeng\u00f6z M. Trakea T\u00fcm\u00f6rlerinin Tedavisinde Radyoterapi. T\u00fcrkiye Klinikleri J Surg Med Sci, 2(29), 131-132 (2006). <br \/>D3. Bat\u0131rel HF, Gemici C, Y\u0131ld\u0131zeli B, La\u00e7in T, Akg\u00fcl AG, Evman S, \u00c7a\u011flar HB, \u0130lhan M, Y\u00fcksel M. Results of Transthoracic Esophagectomy Following Chemoradiation in Locally Advanced Esophageal Cancer. Turkish Journal of Cancer, 38(1): 20-25, 2008 <br \/>D4. Atasoy BM, Dane F, \u00c7a\u011flar H, Tezcanl\u0131 E, Cingi A, Abac\u0131o\u011flu U, Turhal S, Ye\u011fen C. Rezeke Edilebilir Lokal \u0130leri Evre Rektum Kanserinde Floroprimidin Bazl\u0131 Kemoterapi \u0130le E\u015f Zamanl\u0131 Ameliyat \u00d6ncesi Radyoterapi. T\u00fcrk Onkoloji Dergisi 2008;23(4):163-171.<br \/>Atalar B, K\u00fc\u00e7\u00fckmorko\u00e7 E, Doyuran M, G\u00fcng\u00f6r G, Ayd\u0131nG, Yap\u0131c\u0131B, \u00c7a\u011flar H, \u00d6zyarE. Comparisons of static 7 field and dynamic conformal arc techniques for stereotactic lung radiotherapy\/Stereotaktik akciger isinlamalarinda statik 7 alan ve dinamik konformal ark tekniklerinin karsilastirilmasi. Turkish Journal of Oncology 27, no. 3 (2012): 111-119.<br \/>\u00c7etin \u0130A, Yumuk PF, Atasoy BM, Dane F, \u00c7a\u011flar HB, \u0130brahimov R. Bat\u0131rel HF, Abac\u0131o\u011flu U. Lokal \u0130leri Evre \u00d6zefagus Kanserinde Kemoradyoterapi Deneyimimiz \/ Chemoradiotherapy Experience in Locally Advanced Esophageal Cancer. Marmara Medical Journal 2012;25:74-7 <br \/>\u00c7a\u011flar HB. Sa\u011fl\u0131kl\u0131 dokuyu koruyarak lokal kontrol\u00fc art\u0131rmak: Radyoterapide yeni teknikler. Sparing the healthy tissue while increasing the local control: New techniques in radiotherapy. doi:10.5152\/pb.2011.15<\/p><p><strong>E. Ulusal i\u015flemler<\/strong><\/p><p>E1. \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Atasoy B, \u00c7a\u011flar H, \u00c7etin \u0130, Pamir N, Turkan S. Y\u00fcksek Grade\u2019li Gliomalarda Radyoterapi Sonu\u00e7lar\u0131 ve Prognostik Fakt\u00f6rler. XIII. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s24, S95, Antalya, 1999.<\/p><p>E2. Atasoy B, Abac\u0131o\u011flu U, \u00c7a\u011flar H, \u00c7etin \u0130, \u015eeng\u00f6z M. Beyin Metastazlar\u0131n\u0131n Tedavisinde Palyatif Kraniyal Radyoterapi Sonu\u00e7lar\u0131. IV. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s113, P45, Bursa, 2000.<\/p><p>E3. \u015eeng\u00f6z M, Baltalarl\u0131 B, \u00c7etin \u0130, Abac\u0131o\u011flu U, \u015eenkesen \u00d6, \u0130\u015fbakan Z, Atasoy B, \u00c7a\u011flar H, Turkan S. Definitif Radyoterapi Uygulanan Lokalize Prostat Kanserli Olgularda Biyokimyasal N\u00fckss\u00fcz Sa\u011fkal\u0131m. 6. Ege Onkoloji G\u00fcnleri \u2013 \u00dcrogenital Kanserler Sempozyumu, \u00d6zet Kitap\u00e7\u0131\u011f\u0131, \u0130zmir, 2001.<\/p><p>E4. Abac\u0131o\u011flu U, \u015eeng\u00f6z M, \u00c7a\u011flar H, G\u00fcm\u00fc\u015f M, Atalay G, Turhal S. Rektum ve sigmoid Kanserlerinde Adjuvan Kemoradyoterapi Sonu\u00e7lar\u0131. XIV. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s64, SB-07, \u0130stanbul, 2001.<\/p><p>E5. \u00c7a\u011flar H, \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Kodall\u0131 N. Adjuvan Radyoterapi Uygulanan Meme Kanseri Olgular\u0131nda Geli\u015fen Radyasyon Pn\u00f6monisinin Erken Tedavisi. XIV. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s88, SB-15, \u0130stanbul, 2001.<\/p><p>E6. \u015eeng\u00f6z M, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Atasoy B, Turhal S, G\u00fcll\u00fco\u011flu B. Postoperatif Radyoterapi Uygulanan Meme Kanserli Hastalar\u0131m\u0131z\u0131n \u00d6zellikleri ve Tedavi Sonu\u00e7lar\u0131. VI. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Meme Hastal\u0131klar\u0131 Dergisi, Cilt 8(3), s32, P62, \u0130stanbul, 2001.<\/p><p>E7. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Ar\u0131bal E, \u015eeng\u00f6z M, \u00c7etin \u0130, G\u00fcll\u00fco\u011flu B. Memede Kitle Veya Tarama Mamografisi ile Tan\u0131 Konulan Radyoterapi Uygulanm\u0131\u015f Meme Kanserli Hastalar\u0131n Da\u011f\u0131l\u0131m\u0131 ve Sa\u011fkal\u0131m Kar\u015f\u0131la\u015ft\u0131rmas\u0131. VI. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Meme Hastal\u0131klar\u0131 Dergisi, Cilt 8(3), s32, P-63, \u0130stanbul, 2001.<\/p><p>E8. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Turhal S, \u015eeng\u00f6z M. Evre III K\u00fc\u00e7\u00fck H\u00fccre D\u0131\u015f\u0131 Akci\u011fer Kanseri Hastalar\u0131nda Radyoterapi ile E\u015fzamanl\u0131 Gemsitabinin Radyoduyarl\u0131la\u015ft\u0131r\u0131c\u0131 Olarak Kullan\u0131lmas\u0131. V. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitap\u00e7\u0131\u011f\u0131, s214, ATP-6, Ku\u015fadas\u0131, 2002.<\/p><p>E9. Abac\u0131o\u011flu U, Odaba\u015f \u00d6F, Tezcanl\u0131 E, \u00c7a\u011flar H, Yumuk PF, \u015eeng\u00f6z M, Turhal S. Kolorektal Kanserli Hastalar\u0131n Ya\u015fam Kalitesini De\u011ferlendirmede EORTC Kolorektal Kanser Mod\u00fcl\u00fc QLQ-CR38\u2019in T\u00fcrk\u00e7e \u00c7evirisi ve Pilot-Test \u00c7al\u0131\u015fmas\u0131. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131 s161, P45, Antalya, 2004.<\/p><p>E10. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Tezcanl\u0131 E, Yumuk F, Turhal S, \u015eeng\u00f6z M. Lokal \u0130leri Evre Pankreas Kanserli Hastalarda Radyoterapi ve E\u015f Zamanl\u0131 Gemsitabin Tedavisinin Toksisite ve Sa\u011fkal\u0131m Sonu\u00e7lar\u0131. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s164, P48, Antalya, 2004.<\/p><p>E11. Abac\u0131o\u011flu U, \u015eeng\u00f6z M, Tezcanl\u0131 E, \u00c7a\u011flar H, Yumuk PF. Y\u00fcksek Gradeli N\u00fcks Gliomlarda Temozolomidin Tolerabilitesi ve Etkinli\u011fi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s339, P223, Antalya, 2004.<\/p><p>E12. S\u00f6nmez \u00d6, \u00c7a\u011flar H, Demirkaya P, Kaya H, Akkiprikli M, D\u00fc\u015f\u00fcnceli F, Abac\u0131o\u011flu U, G\u00fcll\u00fco\u011flu B, \u015eeng\u00f6z M, \u00d6zer A, Sav A. Meme Kanserinde p53 Geni 3. \u0130ntron B\u00f6lgesindeki 16 BP Duplikasyon Polimorfizm S\u0131kl\u0131\u011f\u0131 ve Prognozla \u0130li\u015fkisi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s366, P250, Antalya, 2004.<\/p><p>E13. \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M. Meme Kanseri Nedeniyle Postoperatif Radyoterapi Uygulanan Hastalarda G\u00f6r\u00fclen Erken D\u00f6nem Yan Etkilerin Hastaya Ve Tedaviye Ba\u011fl\u0131 \u00d6zellikler A\u00e7\u0131s\u0131ndan De\u011ferlendirilmesi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s370, P254, Antalya, 2004.<\/p><p>E14. \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, \u00c7aml\u0131ca H. Meme Kanseri Nedeniyle Postoperatif Radyoterapi Uygulanan Hastalarda G\u00f6r\u00fclen Erken D\u00f6nem Cilt ve Akci\u011fer Toksisiteleri ile Tamoksifen Zamanlamas\u0131n\u0131n De\u011ferlendirilmesi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s371, P255, Antalya, 2004.<\/p><p>E15. S\u00f6nmez \u00d6, Abac\u0131o\u011flu U, Akkiprik M, Kaya H, Demirkalem P, \u00c7a\u011flar H, G\u00fcll\u00fco\u011flu MB, Sav A, \u00d6zer A. Meme Kanserli T\u00fcrk Kad\u0131nlar\u0131nda p53 \u0130ntron 3-16b Duplikasyon Polimorfizmi. VI. Ulusal Prenatal Tan\u0131 ve T\u0131bbi Genetik Kongresi, Bildiri Kitab\u0131, 64-65, Antalya, 2004.<\/p><p>E16. Solmaz \u00d6, Demirkalem P, \u00c7a\u011flar H, Kaya H, Akkiprik M, D\u00fc\u015f\u00fcnceli F, Abac\u0131o\u011flu U, G\u00fcll\u00fco\u011flu BM, \u015eeng\u00f6z M, Sav A, \u00d6zer A. T\u00fcrk Toplumunda Sa\u011fl\u0131kl\u0131 Bireylerde ve Meme Kanseri Olan Hastalarda p53 Geni Polimorfizmi S\u0131kl\u0131\u011f\u0131: Polimorfizm Varl\u0131\u011f\u0131 Sa\u011fkal\u0131m\u0131 Etkiliyor mu? Ulusal Cerrahi Kongresi \u00d6zet Kitab\u0131, s69, s-120 Antalya, May\u0131s 2004.<\/p><p>E17. Kaya H, Erbarut \u0130, G\u00fcll\u00fco\u011flu B, \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u00d6zkan N, Ar\u0131bal E. Memenin \u0130nvaziv Duktal Karsinomlar\u0131nda p53, ve c-erbB-2 Onkogenlerinin Ekspresyonunun \u00d6strojen-Progesteron Resept\u00f6rleri ve Histopatolojik Parametrelerle \u0130li\u015fkisi. XVII Ulusal Patoloji Sempozyumu Bildiri Kitab\u0131, s208, 1-6 Ekim 2004, Gaziantep.<\/p><p>E18. Akg\u00fcn Z, \u00c7etin \u0130, Kara\u00fc\u00e7 G, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Dane F, Yumuk F, \u015eeng\u00f6z M, Turhal S. Mide Adenokarsinomlar\u0131nda Cerrahi Rezeksiyon Sonras\u0131nda Adjuvan Kemoradyoterapi Sonu\u00e7lar\u0131m\u0131z. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s38, ref 708, Antalya, 2005.<\/p><p>E19. \u00c7etin \u0130, Akg\u00fcn Z, \u00c7a\u011flar H, Tezcanl\u0131 E, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, Yumuk F, Turhal S, T\u00fcrkeri L. Mesane T\u00fcm\u00f6rl\u00fc Hastalar\u0131n Kemoradyoterapi Sonu\u00e7lar\u0131. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s60-61 ref 806, Antalya, 2005.<\/p><p>E20. Zorlu F, Pak Y, Kurtman C, Akman F, \u00c7a\u011flar H, Okumu\u015f N\u00d6, Ko\u00e7 M, Soyuer S, Hayran M. T\u00fcrkiye\u2019de Santral Sinir Sistemi T\u00fcm\u00f6rlerinin \u00c7ok Merkezli Kesitsel \u0130ncelemesi: TOG \u2013 Santral Sinir Sistemi Alt Grubu. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s105, ref 818 Antalya, 2005.<\/p><p>E21. Tezcanl\u0131 E, Abac\u0131o\u011flu U, \u00c7a\u011flar H, Yumuk F, \u015eeng\u00f6z M. Y\u00fcksek Gradeli N\u00fcks Gliomlarda Temozolomidin Tolerabilitesi ve Etkinli\u011fi. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s106, ref 631, Antalya, 2005.<\/p><p>E22. G\u00fcll\u00fco\u011flu BM, Sar\u0131kaya \u00d6, Dede F, Barlas A, Bayrami\u00e7li M, \u00c7a\u011flar H, Yumuk F, Ba\u015faran GA, Kaya H, Aktan A\u00d6. Marmara \u00dcniversitesi T\u0131p Fak\u00fcltesi Genel Cerrahi Uzmanl\u0131k E\u011fitimi \u0130\u00e7erisinde Multidisipliner Meme ve Endokrin Cerrahisi E\u011fitimi; E\u011fitim Kalitesini ve \u00d6\u011frenci Memnuniyetini Art\u0131rabilmek i\u00e7in bir Model. Ulusal T\u0131p E\u011fitimi Kongresi \u00d6zet Kitab\u0131, s78, B12, Adana 2006.<\/p><p>E23. Akg\u00fcn Z, \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M. K\u00fcratif Tedavi Uygulanm\u0131\u015f Evre III K\u00fc\u00e7\u00fck H\u00fccreli D\u0131\u015f\u0131 Akci\u011fer Kanseri Hastalar\u0131nda Beyin Metastaz\u0131 Olu\u015fumunu Etkileyen Fakt\u00f6rler. VII. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s85, P007, Fethiye, 2006.<\/p><p>E24. Topalo\u011flu N, Dane F, Balc\u0131 M, Abul Y, Golabi P, Yumuk P, Turhal S, Ceyhan B, \u00c7elikel T, Karakurt S, \u00c7a\u011flar H, Ah\u0131skal\u0131 R. Docetaxel\u2019e Ba\u011fl\u0131 \u0130ntertistel Pn\u00f6monitis. Toraks Dergisi 2006;7(1):106, PS126.<\/p><p>E25. Bat\u0131rel HF, Metinta\u015f M, Y\u0131ld\u0131zeli B, La\u00e7in T, \u00c7a\u011flar HB, Bostanc\u0131 K, Akg\u00fcl AG, Evman S, Y\u00fcksel M. Malign Plevral Mezotelyomada Trimodalite Tedavi Sonu\u00e7lar\u0131. Toraks Dergisi 2007;8(2):166, TP 333.<\/p><p>E26. \u00c7aglar HB, Allen A, Othus M, Burke E, Posner M, Tishler R. Ba\u015f boyun IMRT ve Kemoterapisi Sonras\u0131nda Yutma G\u00fc\u00e7l\u00fc\u011f\u00fcn\u00fc Etkileyen Dozimetrik Parametreler. VIII.Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s79, S0021, Antalya, 2008.<\/p><p>E27. Atasoy BM, Dane F, \u00c7a\u011flar H, Cingi A, Abac\u0131o\u011flu U, Turhal S, \u015eeng\u00f6z M, Ye\u011fen C. Rezeke Edilebilir Lokal \u0130leri Evre Rektum Kanserinde Preoperatif Radyoterapiyle E\u015fzamanl\u0131 Floroprimidin Uygulamas\u0131: Oral mi, \u0130ntraven\u00f6z m\u00fc? 8. Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s184, P0184, Antalya, 2008.<\/p><p>E28. Akg\u00fcn Z, Atasoy B, \u00c7a\u011flar H, \u00c7etin \u0130, Dane F, Abac\u0131o\u011flu U. Anal Kanserlerde Definitif Tedavi Sonu\u00e7lar\u0131m\u0131z. 8. Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s190, P0200, Antalya, 2008.<\/p><p>E29. Sar\u0131kaya \u00d6, Atasoy BM, \u00c7a\u011flar HB, G\u00fcll\u00fco\u011flu B, Dede F, \u00d6ne\u015f T, Yumuk F, Ba\u015faran G, Dane F, Abac\u0131o\u011flu U. Probleme Dayal\u0131 \u00d6\u011frenmede Performans De\u011ferlendirme. V. Ulusal T\u0131p E\u011fitimi Kongresi Bildiri \u00d6zetleri Kitab\u0131, s6, C8, \u0130zmir, 2008.<\/p><p>E30. \u00c7a\u011flar HB, \u0130\u011fdem \u015e, Tezcanl\u0131 E, Al\u00e7o G, Kefeli A\u00dc, Atasoy BM, Dane F, Abac\u0131o\u011flu U. S\u0131n\u0131rl\u0131 Evre K\u00fc\u00e7\u00fck H\u00fccreli Akci\u011fer Kanserinin Multimodalite Tedavi Sonu\u00e7lar\u0131 ve Prognostik Fakt\u00f6r Analizleri. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s4-5, S11, Antalya, 2009.<\/p><p>E31. Ba\u015faran G, Okkan S, \u00c7a\u011flar H, Benekli M, Haydaro\u011flu A, Eralp Y, Abal\u0131 H, Y\u0131ld\u0131z F, Be\u015fe N, G\u00fcrsel B, G\u00fcney N, Derin D. HER-2 Ekspresyonu ve Hormon Resept\u00f6rleri Bilinen T1N0 Meme Kanserli (MK) Hastalar\u0131n Retrospektif Analizi: T\u00fcrk Onkoloji Grubu \u00c7al\u0131\u015fmas\u0131. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s 16, S39, Antalya, 2009.<\/p><p>E32. Kefeli A\u00dc, Akg\u00fcn Z, \u00c7a\u011flar HB, Atasoy BM, Dane F, Yumuk PF, K\u0131l\u0131\u00e7 T, Abac\u0131o\u011flu U. Tek Merkezde Tedavi Edilen 167 Glioblastoma Tan\u0131l\u0131 Hastan\u0131n Sa\u011fkal\u0131m Sonu\u00e7lar\u0131: Temozolomide \u00d6ncesi ve Sonras\u0131. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s18, S44, Antalya, 2009.<\/p><p>E33. Atasoy BM, Dane F, Akg\u00fcn Z, \u00c7abuk D, Kabalay \u0130A, Yumuk F, \u00c7a\u011flar H, Turhal S, Abac\u0131o\u011flu U. Lokal \u0130leri Evre Nazofarenks Kanserinde Dosetaksel ile Sisplatin Bazl\u0131 \u0130nd\u00fcksiyon Kemoterapisi Sonras\u0131 Sisplatinle E\u015f Zamanl\u0131 Kemoradyoterapi:Sa\u011fkal\u0131m ve Yan Etki De\u011ferlendirmesi. VIII.Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s130, P236, Antalya, 2009.<\/p><p>E34. Akg\u00fcn Z, Kefeli A\u00dc, Atasoy BM, \u00c7a\u011flar HB, Abac\u0131o\u011flu U. Glioblastoma Hastalar\u0131nda Cerrahi ile Radyoterapi Aras\u0131 S\u00fcrenin Sa\u011fkal\u0131ma Etkisi. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s134-135, P246, Antalya, 2009.<\/p><p><strong>F. At\u0131flar<\/strong><\/p><p>F1. G\u00fcm\u00fcs M, Yumuk PF, Atalay G, Aliustao\u011flu M, Macunluo\u011flu B, Dane F, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal S. What is the optimal number of lymph nodes dissected in colorectal cancer surgery? Tumori (91:168-172, 2005) 8 at\u0131f.<\/p><p>- GJ Chang GJ, Rodriguez-Bigas MA, Skibber JM et al. Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review. J Natl Cancer Inst. 2007;99:433-41.<\/p><p>- Koppie TJ, Vickers AJ, Vora K et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy. Can we establish a minimum number of lymph nodes that should be removed? Cancer 2006;107(10):2368-74.<\/p><p>- Greco P, Andreola S, Magro G, et al. Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on a resampling of 50 rectal specimens. Virchows Arch 2006;449:647-651.<\/p><p>- Govindarajan A, Baxter NN. Lymph Node Evaluation in Early-Stage Colon Cancer. Clinical Colorectal Cancer 2008;7(4):240-246.<\/p><p>- Dillman RO, Aaron K, Heinemann KS, et al. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 2009;115(9):1840-1848.<\/p><p>- Trueman P, Lowson K, Bending M, et al. Bowel Cancer Services: Costs and Benefits. Lterature Review. Yorl Health Economics Consortium 2007:1-359.<\/p><p>- Norwood MGA, Sutton AJ, West K et al. Lymph node retrieval in colorectal cancer resection specimens: National standards are achievable, and low numbers are associated with reduced survival. Colorectal Disease 2009, epub.<\/p><p>- Mart\u00ednez-Ramos D, Escrig-Sos J, Miralles JM, et al. Is there a minimum number of lymph nodes that should be examined after surgical resection of colorectal cancer? Cir Esp. 2008 Mar;83(3):108-17.<\/p><p>F2. Abac\u0131o\u011flu U, Yumuk PF, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal NS. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. BMC Cancer, Vol 5:71, 2005. 1 at\u0131f.<\/p><p>- Choi B, Robins HI, Schiller J et al. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer. Cancer Chemother Pharmacol 2008;63:175-179.<\/p><p>F3. \u00c7a\u011flar H, Allen AM. Intensity Modulated Radiotherapy for Head and Neck Cancer. Clinical Advances in Hematology &amp; Oncology. 2007 Jun;5(6):425-31. 5 at\u0131f.<\/p><p>- Simo R, Morgan P, Jeannon JP, et al. Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolarngol 2009;266:261-265.<\/p><p>- Diaz R, Blakey MD, Murphy PD, et al. Thyroid Storm After Intensity-Modulated Radiation Therapy: A Case Report and Discussion. Oncologist 2009;14:233-239.<\/p><p>- Kim M, Ghate A, Phillips MH, et al. A Markov decision process approach to temporal modulation of dose fractions in radiation therapy planning. Phys. Med. Biol 2009;54:4455-4476.<\/p><p>- Diaz R, Jaboin JJ, Morales-Paliza M, et al. Hypothyroidism as a Consequence of Intensity-Modulated Radiotherapy with Concurrent Taxane-Based Chemotherapy for Locally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys 2009, epub.<\/p><p>- Salama J, Haddad R, Kies M, et al. Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys 2009;75 (3):725-733.<\/p><p>F4. Batirel HF, Metintas M, \u00c7a\u011flar HB, Y\u0131ld\u0131zzeli B, Lacin T, Bostanc\u0131 K, Akgul AG, Evman S, Yuksel M. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2008 May;3(5):499-504. 9 at\u0131f.<\/p><p>- Krug LM, Pass HI, Rusch VW, et al. Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma. J Clin Oncol 2009 Jun 20;27(18):3007-13.<\/p><p>- Ramalingam SS, Belani CP. Recent Advances in the Treatment of Malignant Pleural Mesothelioma. J Thorac Oncol. 2008 Sep;3(9):1056-64.<\/p><p>- McAleer MF, Tsao AS, Liao Z. Radiotherapy in Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):326-37.<\/p><p>- Buduhan G, Menon S, Aye R, et al. Trimodality Therapy for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2009 Sep;88(3):870-5.<\/p><p>- Trousse DS, Avaro JP, D'Journo XB, et al. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies. Eur J Cardiothorac Surg. 2009 Oct;36(4):759-63.<\/p><p>- Zona A, Bruno C. Health surveillance for subjects with past exposure to asbestos: from international experience and Italian regional practices to a proposed operational model. Ann Ist Super Sanit\u00e0 2009 Vol. 45, No. 2: 147-161.<\/p><p>- Ak G, Metintas S, Metintas M, et al. Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma. J Thorac Oncol 2009, epub.<\/p><p>- A Hasani, JM Alvarez, JM Wyatt, et al. Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia. J Thorac Oncol 2009;4(9):1010-1016.<\/p><p>- Bat\u0131rel HF. Malign Plevral Mezotelyomada Trimodalite Tedavi. T\u00fcrk Toraks Derne\u011fi, Plevra B\u00fclteni, Ocak 2009; 3(1):19-29.<\/p><p>F5. \u00c7a\u011flar HB, Tishler RB, Othus M, Burke E, Li Y; Goguen L, Wirth LJ, Haddad RI, Norris CM, Court LE, Aninno DJ, Posner MR, Allen AM. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. November 2008;72(4):1110-1118. 7 at\u0131f.<\/p><p>- Caudell JJ, Schaner PE, Desmond RA, et al. Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p>- Langendijk JA, Bijl HP. Late Radiation-Induced Side Effects. Functional Preservation and Quality of Life in Head and Neck Radiotherapy, ed: P. M. Harari, N. P. Connor and C. Grau, Springerlink, 2009.<\/p><p>- N Platteaux, P Dirix, E Dejaeger, et al. Dysphagia in Head and Neck Cancer Patients Treated with Chemoradiotherapy. Dysphagia 2009, epub.<\/p><p>- Caudell JJ, Burnett III OL, Schaner PE, et al. Comparison of Methods to Reduce Dose to Swallowing-Related Structures in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p>- Rancati T, Fiorino C, Sanguineti G. NTCP Modeling of Subacute\/Late Laryngeal Edema Scored by Fiberoptic Examination. Int J Radiat Oncol Biol Phys. 2009;75(3):915-23.<\/p><p>- Popovtzer A, Cao Y, Feng FY, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose\u2013effect relationships: MRI-based study. Radiother Oncol 2009, epub.<\/p><p>- Yang ES, Murphy BM, Chung CH, et al. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol. 2009 Jul;71(1):29-42.<\/p><p>F6. Demiral AN, Alicikus ZA, Ugur VI, Karadogan I, Yoney A, Andrieu MN, Yalman D, Pak Y, Aksu G, Ozyigit G, Ozkan L, Kilciksiz S, Koca S, Calo\u011flu M, Yavuz AA, \u00c7a\u011flar HB, Beyzadeo\u011flu M, Igdem S, Serin M, Kaplan B, et al. Patterns of Care for Lung Cancer in Radiation Oncology Departments of Turkey. Int J Radiat Oncol Biol Phys. 2008;72(5):1530-1537. 2 at\u0131f.<\/p><p>- Kepka L, Casas F, Perin B, et al. Radiochemotherapy for Lung Cancer in Developing Countries. Clinical Oncology 2009;21:536-542.<\/p><p>- Tomita N, Kodaira T, Hida T, et al. The Impact of Radiation Dose and Fractionation on Outcomes for Limited-Stage Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p>Bilimsel projeler<\/p><p>1. Management of Anemia Under Radiochemotherapy (MARCH): An Open Randomized, Multicenter Study of the Effect of NEORECORMON on Treatment Outcome in Patients with Advanced Cervical Cancer Stage IIB-IVA Treated With Primary Simultaneous Radiochemotherapy (Radiotherapy Plus Cisplatin) MO16375. International, Multicentric, Co-Investigator.<\/p><p>2. Kemik Metastazl\u0131 Meme Kanserinde Zoledronik Asit Tedavisi Alan Hastalarda Tam Doz Veya Azalt\u0131lm\u0131\u015f Doz Radyoterapinin Ara\u015ft\u0131r\u0131lmas\u0131 (A Randomized Phase IV exploratory trial comparing full dose radiotherapy versus reduced dose in the management of bone metastasis in breast cancer receiving zoledronic acid) Randomized, phase III, multicentric, CZOL446ETR01, National, Co-Investigator.<\/p><p>3. p53 Polimorphisms and Haplotypes in Breast Cancer, Breast Cancer Research Group Study (MEKAG), Co-Investigator<\/p><p>4. A Double Blind, Placebo Controlled, Parallel Group, Multicenter, Randomised Phase III Survival Study Comparing ZD1839 (IRESSATM) (250 mg Tablet) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients with Advanced NSCLC Who Have Received One or Two Prior Chemotherapy Regimens and are Refractory or Intolerant to Their Most Recent Regimen, Co-Investigator<\/p><p>5. FACT: Anastrozole Monotherapy Versus Maximal Oestrogen Blockade with Anastrozole and Fulvestrant Combination Therapy: An Open Randomized, Comparative, Phase III Multicentre Study in Postmenopausal Women with Hormone Receptor Positive Breast Cancer in First Relapse After Primary Treatment of Localised Tumour, Co-Investigator<\/p><p>6. Anastrazol Kullanan Erken Evre Meme Kanseri Hastalar\u0131nda Elektronik Farmakovijilans \u00c7al\u0131\u015fmas\u0131 (Anastrazol monotherapy in early stage breast cancer, electronical farmacovigilance study), National, Co-Investigator.<\/p><p>7. Rek\u00fcrren Y\u00fcksek Dereceli Glial T\u00fcm\u00f6rlerde Standart Doz Temozolomide Sonras\u0131nda Progresyon Geli\u015fiminde Uzam\u0131\u015f Temozolomide \u015eemas\u0131 Etkinlik Ara\u015ft\u0131r\u0131lmas\u0131 (Efficacy of a protracted dose dense temozolamide schedule in patients with progression after standart dose temozolomide for recurrent high grade gliomas), national, Co-Investigator.<\/p><p>8. No Radiotherapy Versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases From Solid Tumour After Surgical Resection or Radiosurgery, A Randomized Phase III Trial, EORTC Protocol 22952-26001, International, Multicentric, Co-Investigator.<\/p><p>9. -EULINT1. International Prophylactic Cranial Irradiation Trial. A Multicenter Randomized Trial of High Versus Standard Doses of Prophylactic Cranial Irradiation in Limited Small Cell Lung Cancer Complete Responders, EORTC Protocol 22003-08004, International, Multicentric study, Co-Investigator.<\/p><p>10. AMAROS After Mapping of the Axilla: Radiotherapy or Surgery, EORTC protocol 10981-22023, International, Multicentric study, Co-Investigator.<\/p><p>11. SUPREMO A Phase III Randomized Trial to Assess the Role of Adjuvant Chest Wall Irradiation in \u201cIntermediate Risk\u201d Operable Breast Cancer Following Mastectomy, EORTC Protocol 22051-10052, International, Multicentric study, Co-Investigator.<\/p><p>12. Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p\/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. EORTC Protocol 26053-22054. International, Multicentric study, Co-Investigator.<\/p><p>13. Adjuvant Postoperative High-dose Radiotherapy for Atypical and Malignant Meningioma: A Phase-II and Observation Study. EORTC protocol 22042-26042 International, Multicentric study, Co-Investigator.<\/p><p>14. Meme Kanseri Tan\u0131s\u0131 ile Takip Edilen Hastalarda Kemik Metastaz\u0131n\u0131n G\u00f6r\u00fclme S\u0131kl\u0131\u011f\u0131n\u0131, Tan\u0131 Y\u00f6ntemlerini ve Tedavi Yakla\u015f\u0131mlar\u0131n\u0131 De\u011ferlendiren G\u00f6zlem \u00c7al\u0131\u015fmas\u0131, ZO-SAFE. (The frequency, diagnostic tools used and treatment modalities of bone metastatic breast cancer: an observation study ZO-SAFE). Protokol no: CZOL446ETR02, National, Multicentric study, Co-Investigator.<\/p><p>15. A Multinational, Randomized, Double-blind Study Comparing Versus Placebo in Patients Treated With Second-line Docetaxel After Failure of one Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). VITAL EFC10261. International, Multicentric study, Co-Investigator.<\/p><p>16. Hormon Resept\u00f6r\u00fc Pozitif Opere Postmenopozal Meme Kanserli Hastalar\u0131n Erken Adjuvan Tedavisinde Aromataz \u0130nhibit\u00f6r\u00fc Kullan\u0131m\u0131n\u0131n G\u00fcvenlili\u011fi ve N\u00fcks Paterni \u00dczerine Etkileri, ERADA. (Aromatase inhibitors in the adjuvant treatment of hormone receptor positive breast cancer: Implications on safety on recurrence patterns, ERADA). Protokol no: CFEM345DTR002. National, Multicentric study, Primary Investigator.<\/p><p>17. Akci\u011fer Kanseri Nedeniyle E\u015f Zamanl\u0131 Kemoradyoterapi + Oral Glutamin Uygulanan Hastalarda Ya\u015fam Kalitesi De\u011ferlendirmesi. (Concuurent chemoradiation + oral glutamine in locally advanced lung cancer: a quality of life study). Primary Investigator.<\/p><p>A. Uluslararas\u0131 dergiler<\/p><p>A1. Yumuk PF, Abac\u0131o\u011flu U, \u00c7a\u011flar H, G\u00fcm\u00fc\u015f M, \u015eeng\u00f6z M, Turhal NS. Outcome of Rectal and Sigmoid Carcinoma Patients Receiving Adjuvant Chemoradiotherapy in Marmara University Hospital. J. Chemotherapy, 15(6), 603-606, (2003).<\/p><p>A2. G\u00fcm\u00fc\u015f M, Yumuk PF, Atalay G, Aliustao\u011flu M, Macunluo\u011flu B, Dane F, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal S. What is the optimal number of lymph nodes dissected in colorectal cancer surgery? Tumori (91:168-172, 2005)<\/p><p>A3. \u00c7a\u011flar H, Allen AM. Intensity Modulated Radiotherapy for Head and Neck Cancer. Clinical Advances in Hematology &amp; Oncology. 2007 Jun;5(6):425-31.<\/p><p>A4. Batirel HF, Metintas M, \u00c7a\u011flar HB, Y\u0131ld\u0131zzeli B, Lacin T, Bostanc\u0131 K, Akgul AG, Evman S, Yuksel M. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2008 May;3(5):499-504.<\/p><p>A5. \u00c7a\u011flar HB, Tishler RB, Othus M, Burke E, Li Y; Goguen L, Wirth LJ, Haddad RI, Norris CM, Court LE, Aninno DJ, Posner MR, Allen AM. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. November 2008;72(4):1110-1118.<\/p><p>A6. Demiral AN, Al\u0131c\u0131ku\u015f ZA, Ugur VI, Karado\u011fan I, Yoney A, Andrieu MN, Yalman D, Pak Y, Aksu G, \u00d6zyi\u011fit G, \u00d6zkan L, K\u0131l\u00e7\u0131ks\u0131z S, Koca S, Calo\u011flu M, Yavuz AA, \u00c7a\u011flar HB, Beyzadeo\u011flu M, Igdem S, Serin M, Kaplan B, et al. Patterns of Care for Lung Cancer in Radiation Oncology Departments of Turkey. Int J Radiat Oncol Biol Phys. 72(5):1530-1537, May 2008.<\/p><p>A7. Akkiprik M, S\u00f6nmez O, G\u00fcll\u00fco\u011flu BM, \u00c7a\u011flar HB, Kaya H, Demirkalem P, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, Sav A, Ozer A. Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer. Pathology and Oncology Research, (Epub ahead of print), (2008).<\/p><p>A10. \u00c7a\u011flar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, J\u00e4nne PA, Johnson BE, Allen AM. Outcomes of Patients with Stage III Nonsmall Cell Lung Cancer Treated With Chemotherapy and Radiation With and Without Surgery. Cancer, 2009 Sep 23;115(18):4156-4166.<\/p><p>A11. Basaran G, Devrim C, \u00c7a\u011flar HB, G\u00fcll\u00fco\u011flu B, Kaya H, Seber S, Korkmaz T, Telli F, Ko\u00e7ak M, Dane F, Yumuk FP, Turhal SN. Clinical outcome of breast cancer patients with N3a (&gt;\/=10 positive lymph nodes) disease: has it changed over years? Med Oncol. 2011 Sep;28(3):726-32.<\/p><p>A12. Abac\u0131o\u011flu U, \u00c7a\u011flar H, Atasoy BM, Abdulloev T, Akg\u00fcn Z, K\u0131l\u0131\u00e7T. Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors. J BUON. 2010 Apr-Jun;15(2):274-80.<\/p><p>A13. Alexander BM, Othus M, \u00c7a\u011flar HB, Allen AM. Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1381-7<\/p><p>A14. \u00c7a\u011flar HB, Othus M, Allen AM. Esophagus in-field: a new predictor for esophagitis. Radiother Oncol. 2010 Oct;97(1):48-53.<\/p><p>A16. Atasoy BM, Dane F, \u00dc\u00e7\u00fcnc\u00fc Kefeli A, Ca\u011flar H, C\u0131ng\u0131 A, Turhal NS, Abac\u0131o\u011flu U, Ye\u011fen C. Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer. Turk J Gastroenterol. 2011 Feb;22(1):60-4.<\/p><p>A17. Allen AM, Albert M, \u00c7a\u011flar HB, Zygmanski P, Soto R, Killoran J, Sun Y. Can Hyperpolarized Helium MRI add to radiation planning and follow-up in lung cancer? J Appl Clin Med Phys. 2011 Jan 31;12(2):3357.<\/p><p>A18. Midi A, Belirgen M, \u00c7a\u011flar H, Sav A. Investigation of The Effect of Radiotherapy on The Proliferative Index (Ki-67) in Recurring Diffuse Glial Tumors. Journal of Neurological Sciences (Turkish), 28(1).<\/p><p>A19. Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, \u00c7a\u011flar H, \u00d6zsaranZ, L\u00f6ssl. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e757-63.<\/p><p>A20. \u00d6zyar E, \u00c7a\u011flar HB, Atalar B. In regard to Zhou et al \"Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis\" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365). Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):482-3.<\/p><p>A21. Lyatskaya Y, Rehfeld K, Kadam DV, \u00c7a\u011flar H, Allen A, Chin LM, Killoran JH. Comparison of two techniques for target motion evaluation based on 4DCT images. International Journal of Biomedical Engineering and Technology 8.2-3 (2012): 117-137.<\/p><p>A22. Atalar B, G\u00fcng\u00f6r G , \u00c7a\u011flar H, Ayd\u0131n G, Yap\u0131c\u0131B, \u00d6zyarE. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer. Tumori 2012, 98(3):331-336.<\/p><p>A23. Atalar B, \u00c7a\u011flar H, \u00d6zyarE. Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets: Results of Consultant Meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011; 79: 660\u2013669.<\/p><p>A24. Bozcuk H, Abali H, Coskun S; Lung Cancer Committee of Turkish Oncology Group. The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis. World J Surg Oncol. 2012 Aug 9;10(1):161.<\/p><p>A25. Atalar B, Ayd\u0131n G, G\u00fcng\u00f6r G, \u00c7a\u011flar H, Yap\u0131c\u0131B, \u00d6zyarE. Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer. Technol Cancer Res Treat. 2012 Jun;11(3):249-55.<\/p><p>A26. Erpolat OP, Alco G, \u00c7a\u011flar HB, Igdem S, Saran A, Dago\u011flu N, Aslay I, \u00d6zsaran Z, Demirci S, Keven E, Guney Y, Akmansu M, K\u0131l\u0131\u00e7D, Bayman E, Etiz D, Mandel NM. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. Eur J Gynaecol Oncol. 2014;35(1):62-6.<\/p><p>A27. Mahadevan A, Bucholz R, Gaya AM, Kresl JJ, Mantz C, Minnich DJ, Muacevic A, Medbery C 3rd, Yang J, \u00c7a\u011flar HB, Davis JN. Best of the Radiosurgery Society\u00ae Scientific Meeting 2014: stereotactic radiosurgery\/stereotactic body radiotherapy treatment of extracranial and intracranial lesions. Future Oncol. 2014 Dec;10(15):2307-10.<\/p><p>A28. Bat\u0131rel HF, Metinta\u015f M, \u00c7a\u011flar HB, Ak G, Yumuk FP, Y\u0131ld\u0131zeli B, Y\u00fcksel M, Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2016 Feb;151(2):478-84.<\/p><p>A29. Zwahlen DR, Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, \u00c7a\u011flar H, \u00d6zsaranZ, Loessl K, Belkaaloul KK, Villette S, Vees H. Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study. Rare Tumors. 2016 Jun 29;8(2):6052.<\/p><p>A30. Acar H, Alt\u0131nok AY, K\u00fc\u00e7\u00fckmorko\u00e7 E, \u00c7a\u011flar M, Sut PA, K\u00fc\u00e7\u00fck N, Doyuran M, \u00c7a\u011flar HB. \"Dosimetric Comparison of IMRT and VMAT Techniques using RTOG 0631 Guidelines in Spine Sterotactic Body Radiosurgery.\" Cancer ResOncol 2, no. 007 (2016).<\/p><p>B. International Proceedings<\/p><p>B1. \u00c7a\u011flar H, U, Ar\u0131bal E, \u015eeng\u00f6z M, \u00c7etin \u0130, G\u00fcll\u00fco\u011flu B. Survival Comparison and Characteristics of Adjuvantly Irradiated Breast Cancer Patients Diagnosed with Lump in Breast or Screening Mammogram. The Breast Journal 2001; Vol 7(5) Suppl:41, OP-76.<\/p><p>B2. \u015eeng\u00f6z M, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Atasoy B, Turhal S, G\u00fcll\u00fco\u011flu B. Patient Characteristics and Treatment Results of Postoperatively Irradiated Breast Cancer Patients. The Breast Journal 2001; Vol 7(5) Suppl:42, OP-77.<\/p><p>B3. \u00c7a\u011flar H, \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Kodalli N. The Early Treatment of Radiation Pneumonitis in Patients After Adjuvant Radiotherapy for Breast Cancer. European Journal of Cancer. Vol 37 (Supp. 6); S184-185, 2001.<\/p><p>B4. G\u00fcm\u00fc\u015f M, Aliustao\u011flu M, Atalay G, Macunluo\u011flu B, Dane F, \u00c7a\u011flar HB, \u015eeng\u00f6z M, Turhal NS. The Extension of Nodal Sampling in Colorectal Cancer Patients in Marmara University Hospital, Istanbul. Proc Am Soc Clin Oncol 21: 2002 (abstr 2345)<\/p><p>B5. Abac\u0131o\u011flu U, Yumuk PF, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal NS. Results of Concurrent Chemoradiotherapy (CRT) With Low Dose Weekly Gemcitabine (G) in Stage III Non-Small Cell Lung Cancer (NSCLC). Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 7318<\/p><p>B6. Abac\u0131o\u011flu MU, Akg\u00fcn Z, \u00c7a\u011flar H. Factors Affecting Brain Metastases Development in Stage III Non Small Cell Lung Cancer Patients Treated With Definitive Treatment. 25th ESTRO Annual Meeting, Leipzig, Radiother Oncol, Vol. 81 (Suppl. 1), S388, 2006.<\/p><p>B7. Basaran GA, \u00c7abuk D, \u00c7a\u011flar HB, Iyikesici S, Tebessum \u00c7, G\u00fcll\u00fco\u011flu B, Kaya H, Dane F, Yumuk PF, Turhal NS. Stage I (T1N0M0) Breast Cancer (BC): Pathological Characteristics and Clinical Outcome. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix113, 2006.<\/p><p>B8. Dane F, G\u00fcm\u00fc\u015f M, Yumuk PF, \u0130yikesici S, \u00d6zt\u00fcrk A, Basaran G, \u00c7a\u011flar HB, \u00c7abuk D, Teomete M, Turhal NS. Outcome of Colon Cancer Patients Receiving Adjuvant Chemotherapy in Marmara University Hospital. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix130, 2006.<\/p><p>B9. Teomete M, Yumuk PF, \u0130yikesici MS, Dane F, Ba\u015faran G, \u00c7abuk D, \u00c7a\u011flar HB, Abac\u0131o\u011flu U, Turhal NS. Outcome of Patients With Stage III and IV Non-Small Cell Lung Cancer in Marmara University Hospital, Istanbul, Turkey. 31st ESMO Congress, Istanbul, Ann Oncol, Vol. 17 (Suppl. 9), ix225, 2006.<\/p><p>B10. \u00d6zen Z, \u00c7a\u011flar H, Akg\u00fcn Z, Abac\u0131o\u011flu U. Three dimensional non coplanar irradiation for right hemithoracic tumors of operated malignant mesothelioma. Radiotherapy and Oncology, Volume 84, Supplement 1, P S275 (September 2007).<\/p><p>B11. \u00c7a\u011flar HB, Allen AM, Burke E, Posner M, Haddad R, Norris C, Annino D, Wirth L, Tishler R. Swallowing Function After Intensity Modulated Radiotherapy (IMRT) and Chemotherapy for Head and Neck Cancer. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 6046.<\/p><p>B12. \u00c7a\u011flar HB, Allen AM, Othus M, Li Y, Burke E, Wirth L, Gougen LA, Haddad RI, Posner MR, Tishler RB. Dose to the Larynx Predicts for Swallowing Complications Following IMRT and Chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2007, Vol. 69, Issue 3, S53-S54.<\/p><p>B13. Allen AM, Othus M, Baldini EH, Mentzer SJ, Bueno R, Sugarbaker DJ, Colson YL, Marcoux JP, Johnson BE, \u00c7a\u011flar HB. Prognostic factors for radical treatment of stage III NSCLC. European J Cancer Supp, September 2007, Volume 5, Issue 4,392 Abstract No 6613.<\/p><p>B14. \u00c7a\u011flar HB, Mentzer S, Lukanich JM, Janne PA, Marcoux PJ, Lathan C, Rabin MS, Colson YL, Allen AM. Full Dose Chemoradiation Followed by Surgical Resection in Locally Advanced NSCLC. 12th World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, S635, P2-166, August 2007.<\/p><p>B15. Yumuk PF, Teomete M, Dane F, \u00c7abuk D, \u00c7a\u011flar HB, Abac\u0131o\u011flu U, Ba\u015faran G, Turhal NS. Outcome of Patients With Stage III and IV Non-Small Cell Lung Cancer in Marmara University Hospital, Istanbul, Turkey. 12th World Conference on Lung Cancer. Journal of Thoracic Oncology, Volume 2, Number 8, Supplement 4, P2-323, August 2007.<\/p><p>B16. \u00c7a\u011flar HB, Othus M, Allen AM. Mean In-field Esophagus Dose Predicts for Esophagitis in Lung Cancer Patients Treated with 3D-CRT and Concurrent Chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2008 Vol. 72, Issue 1, Supp 1, S427, 2578.<\/p><p>B17. Allen AM, Sun Y, \u00c7a\u011flar HB, Zygmanski P, Killoran JH, Albert M. Hyperpolarized Helium MRI and the Importance of Ventilation Tumor Volumes (VTVs) Before and After RT for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics 2008, Vol. 72, Issue 1, Supp 1, S626, 3017.<\/p><p>B18. Ba\u015faran G, \u00c7a\u011flar H, Bese N, Haydaro\u011flu A, Eralp Y, Abali H. Clinical Outcome of T1N0 Breast Cancer (BC) Patients (pts): A Turkish Oncology Group Retrospective Analysis. Journal of BUON, Proceedings, October 2008.OP-21<\/p><p>B19. Alexander BA, Othus M, \u00c7a\u011flar HB, Allen AM. Mediastinal Nodal Volume Predicts For Survival In Stage III NSCLC. Journal of Thoracic Oncology 2008, vol 3(11), supp 4, Abstract No 118.<\/p><p>B20. \u00d6zen Z, Unal S, \u00c7a\u011flar H, Akg\u00fcn Z. Postmastectomy Radiation Therapy: Dosimetric Differences of Automatic Bolus by Treatment Planning System. Radiotherapy and Oncology, Volume 92, Supplement 1, Pages S251 (August 2009)<\/p><p>B21. Schick U, B\u00f6l\u00fckba\u015f\u0131 Y, Abdah-Bortnyak R, Thariat J, \u00c7a\u011flar H, \u00d6zsaranZ, L\u00f6ssl K, Zwahlen D, Villette S, Vees H.Outcome and pronostic factors in malignant Mixed Mullerian Tumours and endometrial stromal sarcomas: a rare cancer network study. European J Cancer Supp, September 2009, Volume 7, Issue 2, 459 Abstract No 8031.<\/p><p>B22. Abac\u0131o\u011flu M, Akg\u00fcn Z, Kefeli AU, Atasoy BM, \u00c7a\u011flar HB. Effect of time interval between surgical resection and radiotherapy on survival of patients with glioblastoma. International Journal of Radiation Oncology, Biology, Physics November 2009, Vol. 75, Issue 3, Supp 1, S229, 2106.<\/p><p>B23. \u00c7a\u011flar, Hale B., Esra K\u00fc\u00e7\u00fckmorkoc, Ay\u015fe Alt\u0131nok, Nadir K\u00fc\u00e7\u00fck, Mine Doyuran, and Hilal Acar. The Effect of Adaptive Planning on Target and Critical Structures During Radiation Treatment for Locally Advanced Lung Cancer. Journal of Thoracic Oncology, vol. 10, no. 9, pp. S449-S449.<\/p><p>B24. Yumuk PF, Besiro\u011flu M, Dane F, Kanitez M, Aktas B, \u00c7a\u011flar C, Y\u0131ld\u0131zzeli B, Dede F, Atasoy B, Turhal NS. Is PET\/CT a better ttol than CT in response evaluation and follow up of stage III non-small cell lung cancer after chemoradiotherapy? Journal of Thoracic Oncologt, vol. 8, pp. S559-S559.<\/p><p>B25. Alt\u0131nok A, Doyuran M, \u00c7a\u011flar M, Cano\u011flu D, K\u00fc\u00e7\u00fckmorko\u00e7 E, Acar H, K\u00fc\u00e7\u00fck N, \u00c7a\u011flar H. Boost volume assessment in breast cancer: preop tumor volume vs clips used in oncoplastic surgery. Radiotherapy and Oncology April 2016 , Volume 119 , S566.<\/p><p>B26. Pa\u00e7ac\u0131 P, Cebe MS, Mabhouti H, Codel G, Serin E, Sanl\u0131 E, Doyuran M et al. \"Dosimetric evaluation of the dose calculation accuracy of different algorithms for two different treatment techniques during whole breast irradiation.\" Physica Medica 32 (2016): 247.<\/p><p>B27. Serin E, Codel G, Mabhouti H, Cebe M, Sanl\u0131 E, Pa\u00e7ac\u0131 P, K\u00fc\u00e7\u00fck N, K\u00fc\u00e7\u00fckmorko\u00e7 E, Doyuran M, Cano\u011flu C, Alt\u0131nok A, Acar H, \u00c7a\u011flar HO. Accuracy of the Small Field Dosimetry Using the Monte Carlo and Sequential Dose Calculation Algorithms of Multiplan Treatment Planning System Within and Beyond Heterogeneous Media for Cyberknife M6 Unit. Physica Medica 32 (2016): 271.<\/p><p>B28. Codel G, Serin E, Cebe MS, Mabhouti H, Pa\u00e7ac\u0131 P, Sanl\u0131 E, Doyuran M, K\u00fc\u00e7\u00fckmorko\u00e7 E, Alt\u0131nok A, Cano\u011flu C, K\u00fc\u00e7\u00fck N, Acar H, \u00c7a\u011flar H. Accuracy of the small field dosimetry using Acuros XB and AAA dose calculation algorithms of eclipse treatment planning system within and beyond heterogeneous media for Trubeam 2.0 unit. Physica Medica: European Journal of Medical Physics, Volume 32, 271.<\/p><p>B29. Mabhouti H, Sanl\u0131 E, Cebe MS, Codel G, Pa\u00e7ac\u0131 P, Serin E, Doyuran M, K\u00fc\u00e7\u00fckmorko\u00e7 E, Alt\u0131nok A, Cano\u011flu D, K\u00fc\u00e7\u00fck N, Acar H, \u00c7a\u011flar H. The dosimetric comparison of Truebeam and Cyberknife treatment planning systems dose calculation accuracy for brain SRS treatment on Randophantom. Physica Medica Volume 32, Supplement 3, September 2016, Pages 273.<\/p><p>C. Uluslararas\u0131 kitap b\u00f6l\u00fcmleri<\/p><p>\u00c7a\u011flar, Hale Ba\u015fak, et al. \"and Branislav Jeremic.\" Decision Tools for Radiation Oncology: Prognosis, Treatment Response and Toxicity (2014): 91.<\/p><p>\u00c7a\u011flar, Hale Ba\u015fak. \"Radiotherapy Options of Brainstem Tumors.\" Posterior Fossa Tumors in Children. Springer International Publishing, 2015. 595-608.<\/p><p>\u00c7a\u011flar, Hale Ba\u015fak. \"Radiation Therapy in Atypical Teratoid\/Rhabdoid Tumors.\" Posterior Fossa Tumors in Children. Springer International Publishing, 2015. 667-672.<\/p><p>\u00c7a\u011flar, Hale Ba\u015fak. Radiation Therapy of Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma: Present Status and Future Directions. DOI: 10.2174\/9781681081946116010026<\/p><p>D. Ulusal dergiler<\/p><p>D1. \u00c7a\u011flar HB, Abac\u0131o\u011flu U. Evre I Seminomda G\u00fcncel Tedavi Yakla\u015f\u0131mlar\u0131. \u00dcroonkoloji B\u00fclteni, 2, 7-11, (2006).<\/p><p>D2. Abac\u0131o\u011flu U, \u00c7a\u011flar HB, \u015eeng\u00f6z M. Trakea T\u00fcm\u00f6rlerinin Tedavisinde Radyoterapi. T\u00fcrkiye Klinikleri J Surg Med Sci, 2(29), 131-132 (2006).<\/p><p>D3. Bat\u0131rel HF, Gemici C, Y\u0131ld\u0131zeli B, La\u00e7in T, Akg\u00fcl AG, Evman S, \u00c7a\u011flar HB, \u0130lhan M, Y\u00fcksel M. Results of Transthoracic Esophagectomy Following Chemoradiation in Locally Advanced Esophageal Cancer. Turkish Journal of Cancer, 38(1): 20-25, 2008<\/p><p>D4. Atasoy BM, Dane F, \u00c7a\u011flar H, Tezcanl\u0131 E, Cingi A, Abac\u0131o\u011flu U, Turhal S, Ye\u011fen C. Rezeke Edilebilir Lokal \u0130leri Evre Rektum Kanserinde Floroprimidin Bazl\u0131 Kemoterapi \u0130le E\u015f Zamanl\u0131 Ameliyat \u00d6ncesi Radyoterapi. T\u00fcrk Onkoloji Dergisi 2008;23(4):163-171.<\/p><p>Atalar B, K\u00fc\u00e7\u00fckmorko\u00e7 E, Doyuran M, G\u00fcng\u00f6r G, Ayd\u0131nG, Yap\u0131c\u0131B, \u00c7a\u011flar H, \u00d6zyarE. Comparisons of static 7 field and dynamic conformal arc techniques for stereotactic lung radiotherapy\/Stereotaktik akciger isinlamalarinda statik 7 alan ve dinamik konformal ark tekniklerinin karsilastirilmasi. Turkish Journal of Oncology 27, no. 3 (2012): 111-119.<\/p><p>\u00c7etin \u0130A, Yumuk PF, Atasoy BM, Dane F, \u00c7a\u011flar HB, \u0130brahimov R. Bat\u0131rel HF, Abac\u0131o\u011flu U. Lokal \u0130leri Evre \u00d6zefagus Kanserinde Kemoradyoterapi Deneyimimiz \/ Chemoradiotherapy Experience in Locally Advanced Esophageal Cancer. Marmara Medical Journal 2012;25:74-7<\/p><p>\u00c7a\u011flar HB. Sa\u011fl\u0131kl\u0131 dokuyu koruyarak lokal kontrol\u00fc art\u0131rmak: Radyoterapide yeni teknikler. Sparing the healthy tissue while increasing the local control: New techniques in radiotherapy. doi:10.5152\/pb.2011.15<\/p><p>E. Ulusal i\u015flemler<\/p><p>E1. \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Atasoy B, \u00c7a\u011flar H, \u00c7etin \u0130, Pamir N, Turkan S. Y\u00fcksek Grade\u2019li Gliomalarda Radyoterapi Sonu\u00e7lar\u0131 ve Prognostik Fakt\u00f6rler. XIII. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s24, S95, Antalya, 1999.<\/p><p>E2. Atasoy B, Abac\u0131o\u011flu U, \u00c7a\u011flar H, \u00c7etin \u0130, \u015eeng\u00f6z M. Beyin Metastazlar\u0131n\u0131n Tedavisinde Palyatif Kraniyal Radyoterapi Sonu\u00e7lar\u0131. IV. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s113, P45, Bursa, 2000.<\/p><p>E3. \u015eeng\u00f6z M, Baltalarl\u0131 B, \u00c7etin \u0130, Abac\u0131o\u011flu U, \u015eenkesen \u00d6, \u0130\u015fbakan Z, Atasoy B, \u00c7a\u011flar H, Turkan S. Definitif Radyoterapi Uygulanan Lokalize Prostat Kanserli Olgularda Biyokimyasal N\u00fckss\u00fcz Sa\u011fkal\u0131m. 6. Ege Onkoloji G\u00fcnleri \u2013 \u00dcrogenital Kanserler Sempozyumu, \u00d6zet Kitap\u00e7\u0131\u011f\u0131, \u0130zmir, 2001.<\/p><p>E4. Abac\u0131o\u011flu U, \u015eeng\u00f6z M, \u00c7a\u011flar H, G\u00fcm\u00fc\u015f M, Atalay G, Turhal S. Rektum ve sigmoid Kanserlerinde Adjuvan Kemoradyoterapi Sonu\u00e7lar\u0131. XIV. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s64, SB-07, \u0130stanbul, 2001.<\/p><p>E5. \u00c7a\u011flar H, \u015eeng\u00f6z M, Abac\u0131o\u011flu U, Kodall\u0131 N. Adjuvan Radyoterapi Uygulanan Meme Kanseri Olgular\u0131nda Geli\u015fen Radyasyon Pn\u00f6monisinin Erken Tedavisi. XIV. Ulusal Kanser Kongresi, Bildiri \u00d6zetleri Kitap\u00e7\u0131\u011f\u0131, s88, SB-15, \u0130stanbul, 2001.<\/p><p>E6. \u015eeng\u00f6z M, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Atasoy B, Turhal S, G\u00fcll\u00fco\u011flu B. Postoperatif Radyoterapi Uygulanan Meme Kanserli Hastalar\u0131m\u0131z\u0131n \u00d6zellikleri ve Tedavi Sonu\u00e7lar\u0131. VI. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Meme Hastal\u0131klar\u0131 Dergisi, Cilt 8(3), s32, P62, \u0130stanbul, 2001.<\/p><p>E7. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Ar\u0131bal E, \u015eeng\u00f6z M, \u00c7etin \u0130, G\u00fcll\u00fco\u011flu B. Memede Kitle Veya Tarama Mamografisi ile Tan\u0131 Konulan Radyoterapi Uygulanm\u0131\u015f Meme Kanserli Hastalar\u0131n Da\u011f\u0131l\u0131m\u0131 ve Sa\u011fkal\u0131m Kar\u015f\u0131la\u015ft\u0131rmas\u0131. VI. Ulusal Meme Hastal\u0131klar\u0131 Kongresi, Meme Hastal\u0131klar\u0131 Dergisi, Cilt 8(3), s32, P-63, \u0130stanbul, 2001.<\/p><p>E8. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Turhal S, \u015eeng\u00f6z M. Evre III K\u00fc\u00e7\u00fck H\u00fccre D\u0131\u015f\u0131 Akci\u011fer Kanseri Hastalar\u0131nda Radyoterapi ile E\u015fzamanl\u0131 Gemsitabinin Radyoduyarl\u0131la\u015ft\u0131r\u0131c\u0131 Olarak Kullan\u0131lmas\u0131. V. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitap\u00e7\u0131\u011f\u0131, s214, ATP-6, Ku\u015fadas\u0131, 2002.<\/p><p>E9. Abac\u0131o\u011flu U, Odaba\u015f \u00d6F, Tezcanl\u0131 E, \u00c7a\u011flar H, Yumuk PF, \u015eeng\u00f6z M, Turhal S. Kolorektal Kanserli Hastalar\u0131n Ya\u015fam Kalitesini De\u011ferlendirmede EORTC Kolorektal Kanser Mod\u00fcl\u00fc QLQ-CR38\u2019in T\u00fcrk\u00e7e \u00c7evirisi ve Pilot-Test \u00c7al\u0131\u015fmas\u0131. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131 s161, P45, Antalya, 2004.<\/p><p>E10. \u00c7a\u011flar H, Abac\u0131o\u011flu U, Tezcanl\u0131 E, Yumuk F, Turhal S, \u015eeng\u00f6z M. Lokal \u0130leri Evre Pankreas Kanserli Hastalarda Radyoterapi ve E\u015f Zamanl\u0131 Gemsitabin Tedavisinin Toksisite ve Sa\u011fkal\u0131m Sonu\u00e7lar\u0131. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s164, P48, Antalya, 2004.<\/p><p>E11. S\u00f6nmez \u00d6, \u00c7a\u011flar H, Demirkaya P, Kaya H, Akkiprikli M, D\u00fc\u015f\u00fcnceli F, Abac\u0131o\u011flu U, G\u00fcll\u00fco\u011flu B, \u015eeng\u00f6z M, \u00d6zer A, Sav A. Meme Kanserinde p53 Geni 3. \u0130ntron B\u00f6lgesindeki 16 BP Duplikasyon Polimorfizm S\u0131kl\u0131\u011f\u0131 ve Prognozla \u0130li\u015fkisi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s366, P250, Antalya, 2004.<\/p><p>E12. \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M. Meme Kanseri Nedeniyle Postoperatif Radyoterapi Uygulanan Hastalarda G\u00f6r\u00fclen Erken D\u00f6nem Yan Etkilerin Hastaya Ve Tedaviye Ba\u011fl\u0131 \u00d6zellikler A\u00e7\u0131s\u0131ndan De\u011ferlendirilmesi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s370, P254, Antalya, 2004.<\/p><p>E13. \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, \u00c7aml\u0131ca H. Meme Kanseri Nedeniyle Postoperatif Radyoterapi Uygulanan Hastalarda G\u00f6r\u00fclen Erken D\u00f6nem Cilt ve Akci\u011fer Toksisiteleri ile Tamoksifen Zamanlamas\u0131n\u0131n De\u011ferlendirilmesi. VI. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s371, P255, Antalya, 2004.<\/p><p>E14. S\u00f6nmez \u00d6, Abac\u0131o\u011flu U, Akkiprik M, Kaya H, Demirkalem P, \u00c7a\u011flar H, G\u00fcll\u00fco\u011flu MB, Sav A, \u00d6zer A. Meme Kanserli T\u00fcrk Kad\u0131nlar\u0131nda p53 \u0130ntron 3-16b Duplikasyon Polimorfizmi. VI. Ulusal Prenatal Tan\u0131 ve T\u0131bbi Genetik Kongresi, Bildiri Kitab\u0131, 64-65, Antalya, 2004.<\/p><p>E15. Solmaz \u00d6, Demirkalem P, \u00c7a\u011flar H, Kaya H, Akkiprik M, D\u00fc\u015f\u00fcnceli F, Abac\u0131o\u011flu U, G\u00fcll\u00fco\u011flu BM, \u015eeng\u00f6z M, Sav A, \u00d6zer A. T\u00fcrk Toplumunda Sa\u011fl\u0131kl\u0131 Bireylerde ve Meme Kanseri Olan Hastalarda p53 Geni Polimorfizmi S\u0131kl\u0131\u011f\u0131: Polimorfizm Varl\u0131\u011f\u0131 Sa\u011fkal\u0131m\u0131 Etkiliyor mu? Ulusal Cerrahi Kongresi \u00d6zet Kitab\u0131, s69, s-120 Antalya, May\u0131s 2004.<\/p><p>E16. Kaya H, Erbarut \u0130, G\u00fcll\u00fco\u011flu B, \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u00d6zkan N, Ar\u0131bal E. Memenin \u0130nvaziv Duktal Karsinomlar\u0131nda p53, ve c-erbB-2 Onkogenlerinin Ekspresyonunun \u00d6strojen-Progesteron Resept\u00f6rleri ve Histopatolojik Parametrelerle \u0130li\u015fkisi. XVII Ulusal Patoloji Sempozyumu Bildiri Kitab\u0131, s208, 1-6 Ekim 2004, Gaziantep.<\/p><p>E17. Akg\u00fcn Z, \u00c7etin \u0130, Kara\u00fc\u00e7 G, \u00c7a\u011flar H, Abac\u0131o\u011flu U, Dane F, Yumuk F, \u015eeng\u00f6z M, Turhal S. Mide Adenokarsinomlar\u0131nda Cerrahi Rezeksiyon Sonras\u0131nda Adjuvan Kemoradyoterapi Sonu\u00e7lar\u0131m\u0131z. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s38, ref 708, Antalya, 2005.<\/p><p>E18. \u00c7etin \u0130, Akg\u00fcn Z, \u00c7a\u011flar H, Tezcanl\u0131 E, Abac\u0131o\u011flu U, \u015eeng\u00f6z M, Yumuk F, Turhal S, T\u00fcrkeri L. Mesane T\u00fcm\u00f6rl\u00fc Hastalar\u0131n Kemoradyoterapi Sonu\u00e7lar\u0131. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s60-61 ref 806, Antalya, 2005.<\/p><p>E19. Zorlu F, Pak Y, Kurtman C, Akman F, \u00c7a\u011flar H, Okumu\u015f N\u00d6, Ko\u00e7 M, Soyuer S, Hayran M. T\u00fcrkiye\u2019de Santral Sinir Sistemi T\u00fcm\u00f6rlerinin \u00c7ok Merkezli Kesitsel \u0130ncelemesi: TOG \u2013 Santral Sinir Sistemi Alt Grubu. XVI. Ulusal Kanser Kongresi, Bildiri \u00d6zet Kitab\u0131, s105, ref 818 Antalya, 2005.<\/p><p>E20. G\u00fcll\u00fco\u011flu BM, Sar\u0131kaya \u00d6, Dede F, Barlas A, Bayrami\u00e7li M, \u00c7a\u011flar H, Yumuk F, Ba\u015faran GA, Kaya H, Aktan A\u00d6. Marmara \u00dcniversitesi T\u0131p Fak\u00fcltesi Genel Cerrahi Uzmanl\u0131k E\u011fitimi \u0130\u00e7erisinde Multidisipliner Meme ve Endokrin Cerrahisi E\u011fitimi; E\u011fitim Kalitesini ve \u00d6\u011frenci Memnuniyetini Art\u0131rabilmek i\u00e7in bir Model. Ulusal T\u0131p E\u011fitimi Kongresi \u00d6zet Kitab\u0131, s78, B12, Adana 2006.<\/p><p>E21. Akg\u00fcn Z, \u00c7a\u011flar H, Abac\u0131o\u011flu U, \u015eeng\u00f6z M. K\u00fcratif Tedavi Uygulanm\u0131\u015f Evre III K\u00fc\u00e7\u00fck H\u00fccreli D\u0131\u015f\u0131 Akci\u011fer Kanseri Hastalar\u0131nda Beyin Metastaz\u0131 Olu\u015fumunu Etkileyen Fakt\u00f6rler. VII. Ulusal Radyasyon Onkolojisi Kongresi, Bildiri \u00d6zet Kitab\u0131, s85, P007, Fethiye, 2006.<\/p><p>E22. Bat\u0131rel HF, Metinta\u015f M, Y\u0131ld\u0131zeli B, La\u00e7in T, \u00c7a\u011flar HB, Bostanc\u0131 K, Akg\u00fcl AG, Evman S, Y\u00fcksel M. Malign Plevral Mezotelyomada Trimodalite Tedavi Sonu\u00e7lar\u0131. Toraks Dergisi 2007;8(2):166, TP 333.<\/p><p>E23. \u00c7aglar HB, Allen A, Othus M, Burke E, Posner M, Tishler R. Ba\u015f boyun IMRT ve Kemoterapisi Sonras\u0131nda Yutma G\u00fc\u00e7l\u00fc\u011f\u00fcn\u00fc Etkileyen Dozimetrik Parametreler. VIII.Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s79, S0021, Antalya, 2008.<\/p><p>E24. Atasoy BM, Dane F, \u00c7a\u011flar H, Cingi A, Abac\u0131o\u011flu U, Turhal S, \u015eeng\u00f6z M, Ye\u011fen C. Rezeke Edilebilir Lokal \u0130leri Evre Rektum Kanserinde Preoperatif Radyoterapiyle E\u015fzamanl\u0131 Floroprimidin Uygulamas\u0131: Oral mi, \u0130ntraven\u00f6z m\u00fc? 8. Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s184, P0184, Antalya, 2008.<\/p><p>E25. Akg\u00fcn Z, Atasoy B, \u00c7a\u011flar H, \u00c7etin \u0130, Dane F, Abac\u0131o\u011flu U. Anal Kanserlerde Definitif Tedavi Sonu\u00e7lar\u0131m\u0131z. 8. Ulusal Radyasyon Onkolojisi Kongresi, Program, Bildiri ve Konu\u015fma \u00d6zetleri Kitab\u0131, s190, P0200, Antalya, 2008.<\/p><p>E26. Sar\u0131kaya \u00d6, Atasoy BM, \u00c7a\u011flar HB, G\u00fcll\u00fco\u011flu B, Dede F, \u00d6ne\u015f T, Yumuk F, Ba\u015faran G, Dane F, Abac\u0131o\u011flu U. Probleme Dayal\u0131 \u00d6\u011frenmede Performans De\u011ferlendirme. V. Ulusal T\u0131p E\u011fitimi Kongresi Bildiri \u00d6zetleri Kitab\u0131, s6, C8, \u0130zmir, 2008.<\/p><p>E27. \u00c7a\u011flar HB, \u0130\u011fdem \u015e, Tezcanl\u0131 E, Al\u00e7o G, Kefeli A\u00dc, Atasoy BM, Dane F, Abac\u0131o\u011flu U. S\u0131n\u0131rl\u0131 Evre K\u00fc\u00e7\u00fck H\u00fccreli Akci\u011fer Kanserinin Multimodalite Tedavi Sonu\u00e7lar\u0131 ve Prognostik Fakt\u00f6r Analizleri. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s4-5, S11, Antalya, 2009.<\/p><p>E28. Ba\u015faran G, Okkan S, \u00c7a\u011flar H, Benekli M, Haydaro\u011flu A, Eralp Y, Abal\u0131 H, Y\u0131ld\u0131z F, Be\u015fe N, G\u00fcrsel B, G\u00fcney N, Derin D. HER-2 Ekspresyonu ve Hormon Resept\u00f6rleri Bilinen T1N0 Meme Kanserli (MK) Hastalar\u0131n Retrospektif Analizi: T\u00fcrk Onkoloji Grubu \u00c7al\u0131\u015fmas\u0131. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s 16, S39, Antalya, 2009.<\/p><p>E29. Akg\u00fcn Z, Kefeli A\u00dc, Atasoy BM, \u00c7a\u011flar HB, Abac\u0131o\u011flu U. Glioblastoma Hastalar\u0131nda Cerrahi ile Radyoterapi Aras\u0131 S\u00fcrenin Sa\u011fkal\u0131ma Etkisi. XVIII. Ulusal Kanser Kongresi, Program ve Bildiri \u00d6zet Kitab\u0131, s134-135, P246, Antalya, 2009.<\/p><p>F. At\u0131flar<\/p><p>F1. G\u00fcm\u00fcs M, Yumuk PF, Atalay G, Aliustao\u011flu M, Macunluo\u011flu B, Dane F, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal S. What is the optimal number of lymph nodes dissected in colorectal cancer surgery? Tumori (91:168-172, 2005) 8 at\u0131f.<\/p><p>GJ Chang GJ, Rodriguez-Bigas MA, Skibber JM et al. Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic Review. J Natl Cancer Inst. 2007;99:433-41.<\/p><p>Koppie TJ, Vickers AJ, Vora K et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy. Can we establish a minimum number of lymph nodes that should be removed? Cancer 2006;107(10):2368-74.<\/p><p>Greco P, Andreola S, Magro G, et al. Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on a resampling of 50 rectal specimens. Virchows Arch 2006;449:647-651.<\/p><p>Govindarajan A, Baxter NN. Lymph Node Evaluation in Early-Stage Colon Cancer. Clinical Colorectal Cancer 2008;7(4):240-246.<\/p><p>Dillman RO, Aaron K, Heinemann KS, et al. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer 2009;115(9):1840-1848.<\/p><p>Trueman P, Lowson K, Bending M, et al. Bowel Cancer Services: Costs and Benefits. Lterature Review. Yorl Health Economics Consortium 2007:1-359.<\/p><p>Norwood MGA, Sutton AJ, West K et al. Lymph node retrieval in colorectal cancer resection specimens: National standards are achievable, and low numbers are associated with reduced survival. Colorectal Disease 2009, epub.<\/p><p>Mart\u00ednez-Ramos D, Escrig-Sos J, Miralles JM, et al. Is there a minimum number of lymph nodes that should be examined after surgical resection of colorectal cancer? Cir Esp. 2008 Mar;83(3):108-17.<\/p><p>F2. Abac\u0131o\u011flu U, Yumuk PF, \u00c7a\u011flar H, \u015eeng\u00f6z M, Turhal NS. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer. BMC Cancer, Vol 5:71, 2005. 1 at\u0131f.<\/p><p>Choi B, Robins HI, Schiller J et al. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer. Cancer Chemother Pharmacol 2008;63:175-179.<\/p><p>F3. \u00c7a\u011flar H, Allen AM. Intensity Modulated Radiotherapy for Head and Neck Cancer. Clinical Advances in Hematology &amp; Oncology. 2007 Jun;5(6):425-31. 5 at\u0131f.<\/p><p>Simo R, Morgan P, Jeannon JP, et al. Integrated media presentation in multidisciplinary head and neck oncology meetings. Eur Arch Otorhinolarngol 2009;266:261-265.<\/p><p>Diaz R, Blakey MD, Murphy PD, et al. Thyroid Storm After Intensity-Modulated Radiation Therapy: A Case Report and Discussion. Oncologist 2009;14:233-239.<\/p><p>Kim M, Ghate A, Phillips MH, et al. A Markov decision process approach to temporal modulation of dose fractions in radiation therapy planning. Phys. Med. Biol 2009;54:4455-4476.<\/p><p>Diaz R, Jaboin JJ, Morales-Paliza M, et al. Hypothyroidism as a Consequence of Intensity-Modulated Radiotherapy with Concurrent Taxane-Based Chemotherapy for Locally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys 2009, epub.<\/p><p>Salama J, Haddad R, Kies M, et al. Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys 2009;75 (3):725-733.<\/p><p>F4. Batirel HF, Metintas M, \u00c7a\u011flar HB, Y\u0131ld\u0131zzeli B, Lacin T, Bostanc\u0131 K, Akgul AG, Evman S, Yuksel M. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2008 May;3(5):499-504. 9 at\u0131f.<\/p><p>Ramalingam SS, Belani CP. Recent Advances in the Treatment of Malignant Pleural Mesothelioma. J Thorac Oncol. 2008 Sep;3(9):1056-64.<\/p><p>McAleer MF, Tsao AS, Liao Z. Radiotherapy in Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):326-37.<\/p><p>Buduhan G, Menon S, Aye R, et al. Trimodality Therapy for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2009 Sep;88(3):870-5.<\/p><p>Trousse DS, Avaro JP, D'Journo XB, et al. Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies. Eur J Cardiothorac Surg. 2009 Oct;36(4):759-63.<\/p><p>Zona A, Bruno C. Health surveillance for subjects with past exposure to asbestos: from international experience and Italian regional practices to a proposed operational model. Ann Ist Super Sanit\u00e0 2009 Vol. 45, No. 2: 147-161.<\/p><p>Ak G, Metintas S, Metintas M, et al. Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma. J Thorac Oncol 2009, epub.<\/p><p>A Hasani, JM Alvarez, JM Wyatt, et al. Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia. J Thorac Oncol 2009;4(9):1010-1016.<\/p><p>Bat\u0131rel HF. Malign Plevral Mezotelyomada Trimodalite Tedavi. T\u00fcrk Toraks Derne\u011fi, Plevra B\u00fclteni, Ocak 2009; 3(1):19-29.<\/p><p>F5. \u00c7a\u011flar HB, Tishler RB, Othus M, Burke E, Li Y; Goguen L, Wirth LJ, Haddad RI, Norris CM, Court LE, Aninno DJ, Posner MR, Allen AM. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys. November 2008;72(4):1110-1118. 7 at\u0131f.<\/p><p>Caudell JJ, Schaner PE, Desmond RA, et al. Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p>Langendijk JA, Bijl HP. Late Radiation-Induced Side Effects. Functional Preservation and Quality of Life in Head and Neck Radiotherapy, ed: P. M. Harari, N. P. Connor and C. Grau, Springerlink, 2009.<\/p><p>N Platteaux, P Dirix, E Dejaeger, et al. Dysphagia in Head and Neck Cancer Patients Treated with Chemoradiotherapy. Dysphagia 2009, epub.<\/p><p>Caudell JJ, Burnett III OL, Schaner PE, et al. Comparison of Methods to Reduce Dose to Swallowing-Related Structures in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p>Rancati T, Fiorino C, Sanguineti G. NTCP Modeling of Subacute\/Late Laryngeal Edema Scored by Fiberoptic Examination. Int J Radiat Oncol Biol Phys. 2009;75(3):915-23.<\/p><p>Popovtzer A, Cao Y, Feng FY, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose\u2013effect relationships: MRI-based study. Radiother Oncol 2009, epub.<\/p><p>Yang ES, Murphy BM, Chung CH, et al. Evolution of clinical trials in head and neck cancer. Crit Rev Oncol Hematol. 2009 Jul;71(1):29-42.<\/p><p>F6. Demiral AN, Alicikus ZA, Ugur VI, Karadogan I, Yoney A, Andrieu MN, Yalman D, Pak Y, Aksu G, Ozyigit G, Ozkan L, Kilciksiz S, Koca S, Calo\u011flu M, Yavuz AA, \u00c7a\u011flar HB, Beyzadeo\u011flu M, Igdem S, Serin M, Kaplan B, et al. Patterns of Care for Lung Cancer in Radiation Oncology Departments of Turkey. Int J Radiat Oncol Biol Phys. 2008;72(5):1530-1537. 2 at\u0131f.<\/p><p>Kepka L, Casas F, Perin B, et al. Radiochemotherapy for Lung Cancer in Developing Countries. Clinical Oncology 2009;21:536-542.<\/p><p>Tomita N, Kodaira T, Hida T, et al. The Impact of Radiation Dose and Fractionation on Outcomes for Limited-Stage Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2009, epub.<\/p><p><strong>Bilimsel projeler<\/strong><\/p><p>1. p53 Polimorphisms and Haplotypes in Breast Cancer, Breast Cancer Research Group Study (MEKAG), Co-Investigator<\/p><p>2. A Double Blind, Placebo Controlled, Parallel Group, Multicenter, Randomised Phase III Survival Study Comparing ZD1839 (IRESSATM) (250 mg Tablet) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients with Advanced NSCLC Who Have Received One or Two Prior Chemotherapy Regimens and are Refractory or Intolerant to Their Most Recent Regimen, Co-Investigator<\/p><p>3. No Radiotherapy Versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases From Solid Tumour After Surgical Resection or Radiosurgery, A Randomized Phase III Trial, EORTC Protocol 22952-26001, International, Multicentric, Co-Investigator.<\/p><p>4. -EULINT1. International Prophylactic Cranial Irradiation Trial. A Multicenter Randomized Trial of High Versus Standard Doses of Prophylactic Cranial Irradiation in Limited Small Cell Lung Cancer Complete Responders, EORTC Protocol 22003-08004, International, Multicentric study, Co-Investigator.<\/p><p>5. AMAROS After Mapping of the Axilla: Radiotherapy or Surgery, EORTC protocol 10981-22023, International, Multicentric study, Co-Investigator.<\/p><p>6. SUPREMO A Phase III Randomized Trial to Assess the Role of Adjuvant Chest Wall Irradiation in \u201cIntermediate Risk\u201d Operable Breast Cancer Following Mastectomy, EORTC Protocol 22051-10052, International, Multicentric study, Co-Investigator.<\/p><p>7. Adjuvant Postoperative High-dose Radiotherapy for Atypical and Malignant Meningioma: A Phase-II and Observation Study. EORTC protocol 22042-26042 International, Multicentric study, Co-Investigator.<\/p><p>8. Meme Kanseri Tan\u0131s\u0131 ile Takip Edilen Hastalarda Kemik Metastaz\u0131n\u0131n G\u00f6r\u00fclme S\u0131kl\u0131\u011f\u0131n\u0131, Tan\u0131 Y\u00f6ntemlerini ve Tedavi Yakla\u015f\u0131mlar\u0131n\u0131 De\u011ferlendiren G\u00f6zlem \u00c7al\u0131\u015fmas\u0131, ZO-SAFE. (The frequency, diagnostic tools used and treatment modalities of bone metastatic breast cancer: an observation study ZO-SAFE). Protokol no: CZOL446ETR02, National, Multicentric study, Co-Investigator.<\/p><p>9. Hormon Resept\u00f6r\u00fc Pozitif Opere Postmenopozal Meme Kanserli Hastalar\u0131n Erken Adjuvan Tedavisinde Aromataz \u0130nhibit\u00f6r\u00fc Kullan\u0131m\u0131n\u0131n G\u00fcvenlili\u011fi ve N\u00fcks Paterni \u00dczerine Etkileri, ERADA. (Aromatase inhibitors in the adjuvant treatment of hormone receptor positive breast cancer: Implications on safety on recurrence patterns, ERADA). Protokol no: CFEM345DTR002. National, Multicentric study, Primary Investigator.<\/p><p>10. Akci\u011fer Kanseri Nedeniyle E\u015f Zamanl\u0131 Kemoradyoterapi + Oral Glutamin Uygulanan Hastalarda Ya\u015fam Kalitesi De\u011ferlendirmesi. (Concuurent chemoradiation + oral glutamine in locally advanced lung cancer: a quality of life study). Primary Investigator.<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-528a4a9 elementor-widget elementor-widget-triumf_lightbox\" data-id=\"528a4a9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-528a4a9-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"528a4a9\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Assoc. Prof. Eda Tanr\u0131kulu \u015eim\u015fek<\/h2><p><strong>Specialty<\/strong><\/p><p>Oncology Center (Cancer Center)<br \/>Chemotherapy<br \/>Breast Cancer<br \/>Urological Cancers<br \/>Lung Cancer<br \/>Colon and Rectal Cancers<br \/>Gastric Cancer<br \/>Pancreatic Cancer<br \/>Esophageal Cancer<br \/>Gynecological Cancers<br \/>Malignant Melanoma<br \/>Soft Tissue Sarcomas and Bone Tumors<br \/>Personalized Treatments Tailored to Each Person<br \/>Immunotherapy and Targeted Treatments<\/p><p><strong>Education<\/strong><\/p><p>2005 - Ankara University of Medicine, Doctor of Medicine, Ankara<br \/>2012 - Istanbul University, Cerrahpa\u015fa Faculty of Medicine, Specialist in Internal Medicine, Istanbul<br \/>2017 - Marmara University, Faculty of Medicine, Specialist in Medical Oncology, Istanbul<\/p><p><strong>Institutions Worked at<\/strong><\/p><p>Istanbul Cerrahpa\u015fa University of Medicine<br \/>Marmara University of Medicine<br \/>\u015eanl\u0131urfa Mehmet Akif \u0130nan Education and Research Hospital<br \/>Haydarpa\u015fa Numune Education and Research Hospital<br \/>Health Center Anadolu<\/p><p><strong>Awards<\/strong><\/p><p>Thesis Award in Hematology of the Turkish Hematology Association, 2013<\/p><p>Institutional Membership<\/p><p>Turkish Society of Medical Oncology (TTOD)<\/p><p>European Society of Medical Oncology (ESMO)<\/p><p>American Society of Medical Oncology (ASCO)<\/p><p><strong>Course Attendance<\/strong><\/p><p>Turkish-Chinese Cooperation Project, Colorectal Cancer Exchange Program, Shanghai, China, 2014<br \/>Radcliffe Department of Medicine, University of Oxford, Metastatic Colorectal Cancer Preceptorship, Oxford, England, 2015<br \/>CHRISTIE Preceptorship in Lung Cancer - ESMO, Manchester, England, 2016<br \/>European Experience Exchange in Melanoma: Focus on Therapy, Essen, Germany (Online), 2020<\/p><p><strong>Scientific Publications<\/strong><\/p><p><strong>Yay\u0131nlar<\/strong><\/p><p>1- Simsek ET, Coban E, Atag E, Gungor S, Sari M, Gurleyik G. The Role of FDG PET\/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer. J Coll Physicians Surg Pak. 2021 Jul;30(7):792-797.<\/p><p>2- Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. J Clin Pathol. 2016 Sep;69(9):810-6.<\/p><p>3- Tanrikulu Simsek E, Dane F. Nutrition in Cancer Patients Who Have Problems in Oral Taking. T\u00fcrkiye Klinikleri T\u0131bbi Onkoloji Kanser ve Beslenme \u00d6zel say\u0131s\u0131. Turkiye Klinikleri J Med Oncol-Special Topics. 2016;9(3):58-64.<\/p><p>4- Tanrikulu Simsek E, Dane F. Primary Central Nervous System Lymphomas: Diagnosis, Staging and Systemic Treatment. Eri\u015fkin Santral Sinir Sistemi T\u00fcm\u00f6rleri \u00d6zel say\u0131s\u0131. Turkiye Klinikleri J Med Oncol-Special Topics. 2019. p.78-83.<\/p><p>5- Tanr\u0131kulu \u015eim\u015fek E, Be\u015firoglu M, Akta\u015f B, Koca S, Halil S, Alan \u00d6, Hasanov R, Akg\u00fcl Babacan N, \u00d6zt\u00fcrk MA, Kaya S, Ozdogan OC, Dane F, Yumuk PF. Can we Restart Vemurafenib after Severe Hepatotoxicity? A Case Report. J J Gastro Hepato. 2015, 2(4): 025.<\/p><p>6- Simsek ET, Coban E, Atag E, Gungor S, Aker F, Sari M. The Effect of FDG-PET\/CT on Clinical Prognostic Staging of Breast Cancer Patients Planning Neoadjuvant Treatment. J Coll Physicians Surg Pak. 2021<\/p><p>7- Tanr\u0131kulu \u015eim\u015fek E, Bayram B, Y\u0131ld\u0131r\u0131m A, E\u015fkazan AE. Is it possible to predict the pCR with CBC? A commentary on \"correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer\" by Meng et al. Transl Oncol. 2022 Jun;20:101403. doi: 10.1016\/j.tranon.2022.101403. Epub 2022 Mar 23.<\/p><p>8- Alan O, Akin Telli T, Ercelep O, Tanrikulu Simsek E, Basoglu Tuylu T, Mutis A, Hasanov R, Kaya S, Akg\u00fcl Babacan N, Dane F, Yumuk PF. Chordoma: a case series and review of the literature. J Med Case Rep. 2018 Aug 27;12(1):239.<\/p><p>9- Alan O, Telli TA, Ercelep O, Hasanov R, Simsek ET, Mutis A, Ones T, Kaya H, Yumuk PF. A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy. Curr Probl Cancer. 2019 Aug;43(4):308-311<\/p><p>10- Kaya S, Aktas B, Tanrikulu Sim\u015fek E, Akif Ozturk M, Dede F, Kaya H, Ugurlu U, Ozgen Z, Koca S, Halil S, Hasanov R, Alan O, Akgul Babacan N, Ercelep O, Dane F, Gumus M, Yumuk F. Changes in 18F-FDG-PET\/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer. J BUON. 2017 Sep-Oct;22(5):1191-1198.<\/p><p>11- Gurleyik G, Aksu SA, Aker F, Tekyol KK, Tanrikulu E, Gurleyik E. Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy. Ann Surg Treat Res. 2021 Jun;100(6):305-312.<\/p><p>12- Kaytaz Tekyol K, Gurleyik G, Akta\u015f A, Aker F, Tanrikulu E, Tekyol D. Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes. Cureus. 2021 Apr 30;13(4):e14774. doi: 10.7759\/cureus.14774. PMID: 34094739; PMCID: PMC8164848.<\/p><p>13- Demirelli B, Babacan NA, Ercelep \u00d6, \u00d6zt\u00fcrk MA, Kaya S, Tanr\u0131kulu E, Khalil S, Hasanov R, Alan \u00d6, Telli TA, Koca S, Ar\u0131bal ME, Kuzan B, Dane F, Yumuk PF. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Nutr Cancer. 2021;73(2):230-238.<\/p><p>14- Demircan NC, Dane F, Ozturk MA, Babacan NA, Besiroglu M, Kaya S, Ercelep O, Tanrikulu E, Halil S, Koca S, Alan O, Hasanov R, Yumuk PF. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy. J BUON. 2019 Jul-Aug;24(4):1494-1500.<\/p><p>15- Dulundu E, Attaallah W, Tilki M, Yegen C, Coskun S, Coskun M, Erdim A, Tanrikulu E, Yardimci S, Gunal O. Simultaneous resection for colorectal cancer with synchronous liver metastases is a safe procedure: Outcomes at a single center in Turkey. Biosci Trends. 2017 May 23;11(2):235-242.<\/p><p>16- Aydin D, Sendur MA, Kefeli U, Umut Unal O, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Bala Ustaalioglu B, Sener Dede D, Esbag O, Inal A, Bilir C, Bilici A, Harputlu H, Berk V, Sevinc A, Yildirim Ozdemir N, Yildirim E, Sonkaya A, Ali Ustaoglu M, Gumus M. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO). J BUON. 2016 Sept-Oct;21(5):1242-1249.<\/p><p>17- Demirci NS, Aksoy S, \u00d6zdemir NY, Erdem GU, Ozcelik M, Tanrikulu E, Eren T, Bozkaya Y, Sahin S, Ba\u015fol F, Aslan SA, Zengin N, G\u00fcll\u00fc \u0130. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent\/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study. Curr Med Res Opin. 2017 Mar;33(3):401-407.<\/p><p>18- Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanr\u0131verdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clin Colorectal Cancer. 2017 Sep;16(3):220-227.<\/p><p>19- Ar\u0131 MC, B\u00fcy\u00fckta\u015f D, E\u015fkazan AE, Ong\u00f6ren Ayd\u0131n S, Tanr\u0131kulu E, Ba\u015flar Z, Buyru AN, Ferhano\u011flu B, Ayd\u0131n Y, T\u00fcz\u00fcner N, Soysal T. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2012 Sep;29(3):242-7.<\/p><p>20- Ugurlu S, Caglar E, Yesim TE, Tanrikulu E, Can G, Kadioglu P. Evaluation of thyroid nodules in Turkish population. Intern Med. 2008;47(4):205-9.<\/p><p>21- Ercelep O, Alan O, Telli TA, Tuylu TB, Ar\u0131kan R, Demircan NC, Simsek ET, Babacan NA, Kaya S, Dane F, Bozkurtlar E, Ones T, Lacin T, Yumuk PF. Differences in PET\/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori. 2021 Jun;107(3):231-237.<\/p><p>22- Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC, Simsek E, Hamuryudan V, Kucukoglu S, Yazici H. The estimated pulmonary artery pressure can be elevated in Beh\u00e7et's syndrome. Respir Med. 2011 Nov;105(11):1739-47.<\/p><p>23- Ercelep \u00d6, Ak\u0131n Telli T, Alan \u00d6, Hasanov R, Tanr\u0131kulu \u015eim\u015fek E, Akg\u00fcl Babacan N, Kaya S, Kaya H, Dane F, Yumuk PF. Smokers having activating egfr mutant non-small cell lung cancer might Benefit from EGFR-TKI Treatment \u2013 Single-Center Experience. Turk J Oncol 2020;35(3):334\u20139.<\/p><p>24- Bavuno\u011flu I, Balta M, Tanr\u0131kulu E, T\u00fcrkmen Z, \u0130kizceli \u0130. Unexpected Diagnosis in the Metropolis: Organophosphate Poisoning. JAEMCR 2012; 3(2): 52-5.<\/p><p>25- Oven B, Celik S, Okten IN, Tanr\u0131kulu E, Aliyev A, Seker M. Approachment to the Brain Metastasis without Extracranial Metastasis of the HER2 Positive Metastatic Breast Cancer. Volume 3(6): 2-6. 2020.<\/p><p>26- Alan \u00d6, Ercelep \u00d6, Ak\u0131n Telli T, Tanr\u0131kulu \u015eim\u015fek E, Hasanov R, Ba\u015fo\u011flu T, \u00d6zt\u00fcrk MA, Kaya S, Akg\u00fcl Babacan N\u0130 La\u00e7in T, Bozkurtlar E, Dane F, Yumuk PF. Opere Erken Evre Akci\u011fer Kanseri Hastalar\u0131nda Prognostik Fakt\u00f6rler Retrospektif Tek Merkez Sonu\u00e7lar\u0131. Nam\u0131k Kemal T\u0131p Dergisi 2020; 8(3): 376 - 382.<\/p><p>27- Gungor S, Gunaydin UM, Yakar HI, Simsek ET, Akbiyik AG, Keskin H. Total Lesion Glycolysis Obtained by FDG PET\/CT in Diagnosing Solitary Pulmonary Nodules. J Coll Physicians Surg Pak. 2023 Jan;33(1):27-31. doi: 10.29271\/jcpsp.2023.01.27.PMID: 36597231<\/p><p>28- Sari M, Atag E, Demir T, Simsek ET, Coban E, Cikrikcioglu M. Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients. J Coll Physicians Surg Pak. 2022 Feb;32(2):186-192. doi: 10.29271\/jcpsp.2022.02.186.PMID: 35108789<\/p><p>29- Caliskan Yildirim E, Atag E, Coban E, Umit Unal O, Celebi A, Keser M, Uzun M, Keskinkilic M, Tanrikulu Simsek E, Sari M, Yavuzsen T. The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4\/6 inhibitor and endocrine therapy: A multicentric retrospective study. Breast. 2023 Aug;70:56-62. doi: 10.1016\/j.breast.2023.06.006. Epub 2023 Jun 14.<\/p><p>30- Aker FV, Ekren E, Dogan M, Gurleyik G, Tanrikulu E, Oven BB. Clinicopathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma-NOS: Worse or Better? J Coll Physicians Surg Pak. 2022 Sep;32(9):1196-1201. doi: 10.29271\/jcpsp.2022.09.1196.PMID: 36089720<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-84b07f6 elementor-widget elementor-widget-triumf_lightbox\" data-id=\"84b07f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-84b07f6-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"84b07f6\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. B\u00fclent Karag\u00f6z<\/h2><p><strong>Specialties<\/strong><\/p><p>Tumor Biology.<br \/>Tumor Immunology.<br \/>Cancer Immunotherapy.<br \/>Goal-Oriented Treatments<\/p><p><strong>Education<\/strong><\/p><p>G\u00fclhane Military Medical Academy Military Medical Faculty, 1986-1992.<br \/>GATA Haydarpasa Training Hospital, Internal Medicine Specialist training, 1995-1999.<br \/>GATA Haydarpasa Training Hospital, Medical Oncology Minor Specialist training, 2003-2006.<\/p><p><strong>Institutions where he worked<\/strong><\/p><p>Born in 1968. He completed primary and high school in Istanbul. In 1992, he graduated from G\u00fclhane Military Medical Academy. Between 1993-1995, he worked in the Turkish Peacekeeping Forces Command in Cyprus. He completed his specialization studies in Internal Medicine between 1995-1999. Between 1999-2003, he worked as a specialist in internal medicine at \u00c7orlu Military Hospital. In 2001, he served at NATO's KFOR Command in Kosovo. Between 2003 and 2006, he completed a minor specialization in medical oncology. In 2004, he completed the Applied Flow Cytometry course at Istanbul University (DETAE), in 2005 the Basic Epidemiology course at GATA, and in 2009 and 2017, he completed the Ethical Approach in Clinical Research courses organized by the Ministry of Health, General Directorate of Pharmacy and Pharmaceutical Products. In 2007, he was appointed assistant professor. In 2011, he received the title of associate professor. Between 2012-2017, he served as the Head of the Medical Oncology Section of the Department of Internal Medicine at GATA Haydarpa\u015fa Training Hospital. He became a full professor in 2017 at Okan University, Istanbul. Between 2017-2019, he worked as the Head of the Department of Internal Medicine at Okan University, Istanbul Faculty of Medicine. He also served as the Head of the Departments of Internal Medicine and Medical Oncology and the Chairman of the Medical Ethics Committee. Dr. B\u00fclent Karag\u00f6z is married and has one child.<\/p><p><strong>Institutional Affiliations<\/strong><\/p><p>Turkish Association of Medical Oncology<\/p><p>European Society of Head and Neck Medicine<\/p><p><strong>Course Attendance<\/strong><\/p><p>TUMOR Biology Course, Medical Oncology Association, 2003.<\/p><p>Applied Flow Cytometry Training, Istanbul University (DETAE), 2004.<\/p><p>Basic Epidemiology (Research Methods and Analysis Techniques in Health) Course, GATA Command, 2005.<\/p><p>Ethical Approach in Clinical Research Course, Ministry of Health General Directorate of Pharmaceuticals and Pharmacy, 2009 and 2017 (twice).<\/p><p><strong>Scientific publications<\/strong><\/p><p>1. Kandemir, E. G., A. Mayadagli, B. Karag\u00f6z, O. Bilgi, O. Turken ve M.Yaylac\u0131, \u201cPrognostic Significance of Thrombocytosis in Node-negative Colon Cancer,\u201d J Int Med Res, 33 (2), 228-235 (2005).<br \/>2. Karag\u00f6z, B., S. S\u00fcleymano\u011flu, G. Uzun, O. Bilgi, S. Ayd\u0131n\u00f6z, A. Haholu, O. T\u00fcrken, Y. \u00d6nem ve E. G. Kandemir, \u201cHyperbaric Oxygen Therapy Does Not Potentiate Doxorubicin-induced Cardiotoxicity in Rats,\u201d Basic Clin Pharmacol Toxicol, 102 (3), 287-292 (2008). <br \/>3. Bilgi, O., B. Karag\u00f6z, O. Turken, E. G. Kandemir, A. Ozturk, M. Gumus ve M. Yaylac\u0131, \u201cPeripheral Blood Gamma-Delta T Cells in Advanced-Stage Cancer Patients,\u201d Adv Ther, 25 (3), 218-224 (2008). <br \/>4. Erik\u00e7i, A. A., A. \u00d6zt\u00fcrk, B. Karag\u00f6z, O. Bilgi, O. T\u00fcrken, C. Top ve E. G. Kandemir, \u201cResults of Combination Therapy With Amifostine, Pentoxifylline, Ciprofloxacin And Dexamethasone in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia,\u201d Hematology, 13 (5), 289-292 (2008).<br \/>5. Aydinoz, S., G. Uzun, H. Cermik, E. M. Atasoyu, \u015e. Y\u0131ld\u0131z, B. Karagoz ve R. Evrenkaya, \u201cEffect of Different Doses of Hyperbaric Oxygen on Cisplatin-Induced Nephrotoxicity,\u201d Ren Fail, 29 (3), 1-7 (2007).<br \/>6. Erik\u00e7i, A. A., B. Karag\u00f6z, A. \u00d6zt\u00fcrk, S. \u00c7a\u011flayan, G. \u00d6z\u0131\u015f\u0131k, i. Kaygusuz ve M. \u00d6zata, \u201cThe Effect of Subclinical Hypothyroidism on Platelet Parameters,\u201d Hematology, 14 (2), 115-117 (2009).<br \/>7. Karag\u00f6z, B., O. Bilgi, M. G\u00fcm\u00fcs, A. A. Erik\u00e7i, \u00d6. Sayan, O. T\u00fcrken, E. G. Kandemir, A. Ozt\u00fcrk ve M. Yaylac\u0131, \u201cCD8+CD28- Cells and CD4+CD25+ Regulatory T cells in The Peripheral Blood of Advanced Stage Lung Cancer Patients,\u201d Med Oncol, 27 (1), 29-33 (2010).<br \/>8. Erik\u00e7i, A. A., B. Karag\u00f6z, M. \u00d6zyurt, A. Ozturk, S. K\u0131l\u0131\u00e7 ve O. Bilgi, \u201cHLA-G Expression in B Chronic Lymphocytic Leukemia: A New Prognostic Marker?\u201d Hematology, 14 (2), 101-105 (2009).<br \/>9. Karag\u00f6z, B., O. Bilgi, E. G. Kandemir, \u00d6. Sayan, A. A. Erik\u00e7i, A. \u00d6zg\u00fcn, B. Y\u0131lmaz ve A. \u00d6zt\u00fcrk, \u201cDecreased NKG2D Expression on Natural Killer Cells in Gastric Cancer Patients\u201d, UHOD, 19 (1), 42-47 (2009).<br \/>10. Karag\u00f6z, B., O. Bilgi, A. Alacac\u0131o\u011flu, A. \u00d6zg\u00fcn, \u00d6 Sayan, A. A. Erik\u00e7i ve E. G. Kandemir, \u201cMean Platelet Volume Increase after Tamox\u0131fen, but not after Anastrazole in Adjuvant Therapy of Breast Cancer,\u201d Med Oncol, 27 (2),199-202 (2010).<br \/>11. Karag\u00f6z, B., O. Bilgi, E. G. Kandemir, A. A. Erik\u00e7i, \u00d6. Sayan, \u00d6. Alpaslan, B. Y\u0131lmaz, O. T\u00fcrken, A. Alacac\u0131o\u011flu, A. \u00d6zt\u00fcrk, \u201cCD4+CRTH2+ Cells in Advanced Stage Non Small Cell Lung Cancer,\u201d Central European Journal of Medicine, 5: 431 (2010).<br \/>12. Karag\u00f6z, B., \u0130. S\u00fcc\u00fcll\u00fc, \u00d6. Sayan, O. Bilgi, T. Tuncel, A. \u0130. Filiz, E. Y\u00fccel, A. \u00d6zg\u00fcn, A. A. Erik\u00e7i, A. Alacac\u0131o\u011flu ve E. G. Kandemir, \u201cPlatelet indices in patients with colorectal cancer\u201d, Central European Journal of Medicine, 5: 365 (2010).<br \/>13. \u00d6zg\u00fcn, A., B. Karag\u00f6z, O. Bilgi, E. G. Kandemir ve O. T\u00fcrken, \u201cThe Prognostic Significance of Comorbidity and Relation of Comorbidity with the Other Prognostic Factors in Patients with Non Small Cell Lung Cancer\u201d, UHOD, 19 (2), 63-68 (2009).<br \/>14. Cetinkaya H, Karagoz B, Bilgi O, Ozgun A, Tuncel T, Emirzeoglu L, Top C, Kandemir EG. Nesfatin-1 in advanced lung cancer patients with weight loss. Regulatory Peptides 2013;181:1-3. <br \/>15. Ozgun A, Karagoz B, Bilgi O, Tuncel T, Baloglu H, Kandemir E.G. MicroRNA-21 as an Indicator of Aggresive Phenotype in Breast Cancer. Onkologie 2013; 36: 115-118.<br \/>16. Tuncel, T., B. Karagoz, A. Haholu, A. Ozgun, L. Emirzeoglu, O. Bilgi ve E.G. Kandemir, \u201cImmunoregulatory Function of HLA-G in Gastric Cancer.\u201d Asian Pac J Cancer Prev. 2013;14(12):7681-4. <br \/>17. Ozgun A., B. Karagoz, T. Tuncel, L. Emirzeoglu, S. Celik ve O. Bilgi, \u201cClinicopathological features and survival of young Turkish patients with testicular germ cell tumors.\u201d Asian Pac J Cancer Prev. 2013;14(11):6889-92. <br \/>18. Haholu A., U. Berber, B. Karag\u00f6z, T. Tuncel, O. Bilgi ve D. Demirel, \u201cIs there any association of glutathione S-transferase T1 (GSTT1) and glutathione S-transferase M1 (GSTM1) gene polymorphism with gastric cancers?\u201d Pol J Pathol. 2013;64(4):247-52.<br \/>19. Karagoz B., A. Haholu, A. Ozgun, O. Bilgi, T. Tuncel, L. Emirzeoglu, S. Celik ve D. Demirel. \u201cHLA-G in Testicular Germ Cell Tumors.\u201d Oncol Res Treat. 2014;37: 245\u2013248<br \/>20. Bilgi O., B. Karagoz, O. Turken, M. G\u00fcltepe, A. Ozgun, T. Tuncel, L. Emirzeoglu, S. Celik, T. M\u00fcft\u00fco\u011flu ve EG. Kandemir.. \u201cCD4+CD25high, CD8+CD28\u2013 cells and thyroid autoantibodies in breast cancer patients.\u201d Central Eur J Immun 2014; 39(3): 338-344.<br \/>21. Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O ve Karagoz B. \u201cMean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.\u201d Asian Pac J Cancer Prev. 15(15):6421-3 (2014)<br \/>22. Adayener, C., \u0130. Akyol, B. Sen, F. Ates, A. Haholu, H. Soydan ve B. Karag\u00f6z, \u201cSertoli Cell Tumor of The Testis: A Case with Late Metastasis,\u201d Int Urol Nephrol, 40 (4), 1005-1008 (2008).<br \/>23. Karag\u00f6z, B., O. Bilgi, \u0130. Akyol, A. Ozgun, O. Turken ve E. G. Kandemir, \u201cCerebrovascular Accident after Chemotherapy for Testicular Cancer,\u201d Mil Med, 174 (3), 320-321 (2009).<br \/>24. Karag\u00f6z, B., A. Ayata, O. Bilgi, G. Uzun, M. \u00dcnal, E. G. Kandemir, A. \u00d6zg\u00fcn, O. T\u00fcrken, \u201cHemicentral Retinal Artery Occlusion in a Breast Cancer Patient Using Anastrazole,\u201d Onkologie, 32 (7), 421-423 (2009).<br \/>25. Turken, O., C. Basekim, A. Haholu, B. Karag\u00f6z, O. Bilgi, A. Ozgun, Y. Kucukardal\u0131, Y. Narin, Y. Yazgan ve E. G. Kandemir, \u201cHyperammonemic Encephalopathy in A Patient with Primary Hepatic Neuroendocrine Carcinoma,\u201d Med Oncol. 26 (3), 309-313 (2009).<br \/>26. Erik\u00e7i, A. A., \u00d6. Sayan, B. Karag\u00f6z, Z. B\u00fcy\u00fckodac\u0131, ve M. Velio\u011flu, \u201cIntracerebral Plasmacytoma as an Initial Presentation of Multiple Myeloma\u201d, Central European Journal of Medicine, DOI:10.2478\/s11536-009-0104-8 [Elektronik bas\u0131m] (2009). <br \/>27. Karag\u00f6z, B., O. Bilgi, A. \u00d6zg\u00fcn, A. Alacac\u0131o\u011flu, B. Y\u0131lmaz ve E. G. Kandemir, \u201cAutoimmunity and Thyroid Dysfunction During Sunitinib Treatment in Metastatic Renal Cell Carcinoma\u201d, Endocrinologist,19 (5), 224-225 (2009).<br \/>28. Bilgi, O., B. Karag\u00f6z, H. \u00c7ermik, O. T\u00fcrken ve E. G. Kandemir, \"A Case of Neck Metastasis in Early Stage of Gastric Carcinoma\", UHOD, 20 (2), 119-121 (2010).<br \/>29. Filiz, A. \u0130., \u0130. S\u00fcc\u00fcll\u00fc, Y. Kurt, O. Okul, Z.K\u00fc\u00e7\u00fckodac\u0131, ve B. Karag\u00f6z, \u201cSeminoma presented with acute abdomen due to ileum perforation\u201d, Central European Journal of Medicine, DOI: 10.2478\/s11536-009-0128-0 (2009).<br \/>30. \u00c7al\u0131\u015fkan T, A. Ozgun, E. Demirer, A. Haholu, B. Karag\u00f6z ve \u00c7ift\u00e7i F. Agressive and HIV-negative HHV8-unrelated Primary Effusion-like Lymphoma with T-cell phenotype: A Rare Case Report. Acta Medica Mediterranea, 30, 127-130 (2014) <br \/>31. Ozgun A, Tuncel T, Emirzeoglu L, Celik S, Bilgi O, Haholu A, Urhan M, Karagoz B. Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and were treated simultaneously: A rare case report and review of the literature. Oncology Letters 2014.<br \/>32. Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Broca\u2019s Aphasia due to cisplatin-based chemoterapy: Case report and review of the literature. Oncology Letters, 2014.<br \/>33. Akyol AE, Karag\u00f6z B, Bilgi O. Regulatory T cells in patients with Idiopatic Thrombocytopenic Purpura. Turk J Hematol 2016; 33: 153-155<br \/>34. Turken, O., B. Karag\u00f6z, O. Bilgi, B. Do\u011fan, E. G. Kandemir ve E. Kunter, \u201cOral Etoposide-\u0130induced Leucocytoclastic Vasculitis in A Patient with Lung Carcinoma,\u201d J Eur Acad Dermatol Venereol, 21 (9), 1297-1298 (2007).<br \/>35. Atasoyu, E. M., O. Bigi, R. C. Kinalp, B. Karag\u00f6z, A. Haholu, S. \u00dcnver ve T. R. Evrenkaya, \u201cCutaneous Kaposi\u2019s Sarcoma Fallowing Immunosuppressive Therapy for Membranoproliferative Glomerulonephritis\u201d, Clinical Nephrology, 72 (5), 420-421 (2009).<br \/>36. Bilgi, O., B. Karag\u00f6z, A. Alacac\u0131o\u011flu, A. \u00d6zg\u00fcn, T. Tun\u00e7el ve E. G. Kandemir, \u201cIrinotecan and cisplatin vs cyclophospamide, doxorubicin, and vincristine as second line treatment after platinum and etoposide in small cell lung cancer\u201d, J BUON, 15 (2), 395 (2010).<br \/>37. Ozgun A, Tuncel T, Emirzeoglu L, Bilgi O, Karagoz B. Epidemiological characteristics of patients who died of cancer in the Haydarpasa Training Hospital, Istanbul. Croatian Medical Journal 2012;53(6):645.<br \/>38. Karagoz B. ve Bilgi O, Systemic Treatment in Ductal Carcinoma in situ. The Journal of Breast Health 2013; 9: 44-7.<br \/>39. Erik\u00e7i, A. A., A. \u00d6zt\u00fcrk, \u00d6. Sayan, O. Bilgi ve B. Karag\u00f6z, \u201cAcute lymphoblastic leukemia presented with priapism\u201d, Balkan Military Medical Review, 11, 146-147 (2008).<br \/>40. Bilgi O, Karagoz B, Alacacioglu A, Tuncel T, Ozgun A, Emirzeoglu L, Kandemir EG. The effect of Cisplatin-Etoposide Chemotherapy on platelet parameters in lung cancer patients. Disease and Molecular Medicine 2013; 1(2): 35-38.<br \/>41. Karagoz B. ve O. Bilgi, Individualized Systemic Treatment of Lung Cancer. Disease and Molecular Medicine 2013; 1(1): 15-18.<br \/>42. Karag\u00f6z B, Bilgi O, \u00d6zg\u00fcn A, Emirzeo\u011flu L, \u00c7elik S ve \u00d6zet A. \u2018\u2019Long term survival with the combination of interferon and chemotherapy in metastatic melanoma.\u2019\u2019 J Egypt Natl Canc Inst. 27(3): 2015: 61-3. <br \/>43. Karag\u00f6z B, \u00d6zg\u00fcn A, Emirzeo\u011flu L, Tun\u00e7el T, \u00c7elik S, Bilgi O ve Kara K. \u201c Long-term survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer\u201d J Breast Health 2015; 11: 48-51.<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2dc27eb elementor-widget elementor-widget-triumf_lightbox\" data-id=\"2dc27eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-2dc27eb-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"2dc27eb\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. Necdet \u00dcskent<\/h2><p><strong>Specialty<\/strong><\/p><p>Breast Cancer<br \/>Gastrointestinal Cancers<br \/>Lung Cancers<br \/>Lymphomas<br \/>Myeloma<br \/>Medical Oncology<br \/>Hematology<\/p><p><strong>Education<\/strong><\/p><p>Ankara University Faculty of Medicine<br \/>Ankara Gulhane Military Medical Academy and Faculty of Medicine (GATA)<br \/>Istanbul Gulhane Military Medical Academy and Faculty of Medicine (GATA)<br \/>Kadir Has University Faculty of Medicine<br \/>Florence Nightingale Metropolitan Hospital<br \/>Wadley Cancer Center, Division of Oncology, Dallas, USA<br \/>London Westminster University and Charing Cross Medical School, UK (training in spinal cord transplantation)<br \/>Kantonspittal Basel, Switzerland (training in stem cell transplantation)<br \/>Royal Free Hospital, UK (locoregional chemotherapy)<\/p><p><strong>Institutions for which he works<\/strong><\/p><p>Westminster Hospital<br \/>Charing Cross, Hammersmith<br \/>Royal Free Hospital<br \/>University College Hospital<br \/>Cantonal Hospital Basel<br \/>Clinic of Medical Oncology and Hematology GATA Istanbul<br \/>Kadir Has University (University of Science) Department of Internal Medicine<br \/>Florence Nightingale Hospital<br \/>Anadolu Medical Center<\/p><p><strong>Institutional Membership<\/strong><\/p><p>Turkish Society of Medical Oncology<br \/>Turkish Society of Hematology<br \/>Lung Cancer Society<br \/>Immuno-Oncology Society<br \/>Neuro-Oncology Society<br \/>Breast Cancer Society<br \/>Istanbul Gastrointestinal Cancer Group<br \/>Istanbul Lymphoma Group<br \/>Istanbul Myeloma Group<br \/>European Society of Medical Oncology<br \/>American Society of Clinical Oncology<\/p><p><strong>Scientific Publications<\/strong><\/p><p>1991<\/p><p>N. \u00dcskent, M. Danac\u0131, M. \u00d6zel, \u0130. \u00d6ztek, Z. Alt\u0131nok, B. S. Cebeci, M. Alt\u0131n, S. Y\u00fcr\u00fctken, N. Do\u011fan, F. Karsl\u0131: R\u0103spuns complet la interferonul alfa 2b \u00een sarcomul Kaposi clasic (f\u0103r\u0103 leg\u0103tur\u0103 cu SIDA) \u0219i o toxicitate neobi\u0219nuit\u0103 a interferonului. Kanser. Turk J Cancer. 1991; 21(2): 83-88.<br \/>N. \u00dcskent, M. Danac\u0131, M. \u00d6zel: Orizonturi noi \u00een tratamentul cancerului. Utilizarea clinic\u0103 a factorilor de stimulare a coloniilor endogene (CSF). T\u00fcrk Onkoloji Dergisi. 1991; 6 (3-4): 1205-1210.<br \/>M. Danac\u0131, N. \u00dcskent, K. Do\u011fru\u00f6z, \u0130. \u00d6ztek, Z. Alt\u0131nok, M. \u00d6zel: Un caz rar \u00eent\u00e2lnit: purpura toxic\u0103 asociat\u0103 cu utilizarea topic\u0103 a etofenamatului. Sendrom. 1991; 3: 19-22.<\/p><p>1992<\/p><p>N. \u00dcskent, M. Danac\u0131, M. \u00d6zel, H. Tor, G. \u00d6zt\u00fcrk, \u0130. \u00d6ztek, F. Karsl\u0131, T. \u00c7elenk, Y. Z. Yerg\u00f6k: Metastaza cancerului ovarian la tiroid\u0103 \u0219i ganglionii limfatici cervicali. Turk J Cancer. 1992; 22(1): 39-43. Rezultatele ob\u021binute cu combina\u021bia 5-FU, Etposid \u0219i doze mari de leucovorin\u0103 (FEL). GATA B\u00fclteni. 34: 563-568, 1992.<br \/>\u00dcskent N. Danac\u0131 M. Haksever H. Cancer colorectal \u00een stadiu avansat.<br \/>N. \u00dcskent, M. Danac\u0131, M. \u00d6zel, M. Yaylac\u0131, H. Tor: Tratamentul anemiei aplastice severe cu ciclosporin\u0103-A \u0219i metilprednisolon \u00een doze mari. Marmara Medical Journal. 1992; 5(1): 27-30.<br \/>M. Danac\u0131, L. Dumanhan, M. \u00d6zel, H. Tor, N. \u00dcskent: Efectul gemfibrozilului asupra hiperlipidemiei diabetice. GATA B\u00fclteni. 1992; 34: 285-295.<br \/>H. Tor, M. Yaylac\u0131, N. \u00dcskent, A. Acaro\u011flu, M. Danac\u0131, M. \u00d6zel: Evaluarea nefropatiei diabetice \u0219i valoarea beta 2 microglobulinei \u00een diagnosticarea precoce. GATA B\u00fclteni. 1992; 34: 691-704.<br \/>N. \u00dcskent, Z. Mete, M. Danac\u0131, M. \u00d6zel, H. Tor, \u0130. G\u00f6\u00e7men, N. Haksever: Rezultatele ob\u021binute din aplica\u021biile de imunoglobulin\u0103 G intravenoas\u0103 \u00een doze mari \u00een purpura trombocitopenic\u0103 idiopatic\u0103 acut\u0103 \u0219i cronic\u0103. GATA B\u00fclteni. 1992; 34: 859-865.<\/p><p>1993<\/p><p>S. H\u00fclag\u00fc, \u0130. Din\u00e7, M. Alt\u0131n, M. Danac\u0131, M. \u00d6zel, Z. \u00c7ank\u0131r, G. \u00d6zt\u00fcrk, M. Yaylac\u0131, N. \u00dcskent, S. Y\u00fcr\u00fctken: Evaluarea efectelor octreotidei asupra hemodinamicii portale folosind ultrasonografia Doppler pulsat\u0103 la pacien\u021bii cu boli cronice ale ficatului. Marmara Medical Journal. 1993; 6(4): 131-136.<br \/>\u00d6zt\u00fcrk A. \u00dcskent N. Valoarea nivelului de protein\u0103 C seric\u0103 \u00een infarctul miocardic. Marmara Medical Journal. 6: 3, 88-90, 1993.<\/p><p>1994<\/p><p>M. Danac\u0131, S. G\u00fcl, M. \u00d6zel, M. Yaylac\u0131, N. \u00dcskent, S. Y\u00fcr\u00fctken: Evaluarea problemei repet\u0103rii re\u021betelor \u00een spitalele militare. GATA B\u00fclteni. 1994; 36: 329-35.<br \/>Yaylac\u0131 M. \u00d6zt\u00fcrk A. \u00dcskent N. Boala Graft-Versus-Host. Haseki T\u0131p B\u00fclteni. 33: 237-241, 1994.<br \/>Yaylac\u0131 M. \u00d6zt\u00fcrk A. \u00dcskent N. Factorul de stimulare a coloniilor granulocit-macrofag (GM-CSF). Interac\u021biunea cu alte citokine \u0219i domeniile de utilizare clinic\u0103. T\u00fcrkiye Klinikleri T\u0131p Bilimleri Dergisi. 14: 373-377, 1994.<\/p><p>1995<\/p><p>M.Danac\u0131, M.\u00d6zel, M.Yaylac\u0131, H.Balo\u011flu, N.\u00dcskent: Demonstrerea rela\u021biei dintre boala Hodgkin \u0219i limfoamele non-Hodgkin cu virusul Epstein-Barr. GATA B\u00fclteni. 1995; 37: 489-96.<br \/>\u00d6zt\u00fcrk A. Uskent N. Rezisten\u021ba la Protein\u0103 Activat\u0103 \u2013C \u00een malignitate. Acta hematologica, 1995.<\/p><p>1996<\/p><p>Oztek I, Balo\u011flu H, Uskent N, Kartalo\u011flu Z, U\u00e7makli E, Aydilek R, Dorkip O,Yaylaci M, Ozel M. \"Alter\u0103ri citologice induse de chimioterapie \u0219i radioterapie \u00een sput\u0103 la pacien\u021bii cu carcinom pulmonar inoperabil. Rol \u00een urm\u0103rire.\" Acta Cytol. 1996 Nov-Dec;40(6):1265-71.<br \/>O, Kozluca, Olcay E, S\u00fcr\u00fcc\u00fc S, G\u00fcran Z, Kulaksiz T, Uskent N. 1996. \"Prevenirea cardiotoxicit\u0103\u021bii induse de doxorubicin\u0103 prin catechin\u0103.\" Cancer Lett 99 (1): 1-6.<br \/>M, Danaci, G\u00fcl S, Yazgan Y, H\u00fclag\u00fc S, Uskent N. 1996. \"Sindromul Budd-Chiari ca o complica\u021bie a sindromului Beh\u00e7et. Un raport de caz.\" Angiology 47 (1): 93-5.<\/p><p>1997<\/p><p>H, Yazici, Seng\u00fcn Z, Aktan M, Aktuglu G, Uskent N, Dalay N. 1997. \"Utilizarea clinic\u0103 a testului cu sond\u0103 bcr\/abl \u00een evaluarea pacien\u021bilor cu leucemie mieloid\u0103 cronic\u0103.\" Journal of Experimental &amp; Clinical Cancer Research: 16 (1): 105-9.<br \/>Alta\u015f A. \u00d6zt\u00fcrk A. \u00dcskent N. Valoarea IL-6 seric \u00een limfoamele non-Hodgkin. GATA B\u00fclteni 39: 15-19, 1997.<br \/>Cebeci B. \u0130ng\u00f6zbay Y. \u00d6zt\u00fcrk A. \u00dcskent N. Rezisten\u021ba la Protein\u0103 Activat\u0103 C \u00een infarctul miocardic. Marmara Medical Journal. 10: 84-86, 1997.<br \/>\u00d6zt\u00fcrk A. Sezer M. \u00dcskent N. Rezultatele imunosupresiei intense cu globulin\u0103 anti-timoctic\u0103 \u0219i ciclosporin\u0103 A \u00een anemia aplastic\u0103 sever\u0103. Marmara Medical Journal. 10: 101-103, 1997.<br \/>\u00d6zt\u00fcrk A. Kandemir G. \u00dcskent N. Regimul ABDIC \u00een boala Hodgkin recidivant\u0103\/refractory. Marmara Medical Journal. 10: 135-137, 1997.<br \/>\u00d6zt\u00fcrk A. Kandemir G. \u00dcskent N. Rezisten\u021ba Activ\u0103 la Protein\u0103 C \u0219i echilibrul hemostatic \u00een malignitate. T\u00fcrk Onkoloji Dergisi. 12: 1, 24-26, 1997.<br \/>\u00d6zt\u00fcrk A. \u00dcskent N. Rezultatele ob\u021binute cu protocolul CVPD \u00een leucemia limfoblastic\u0103 acut\u0103. GATA B\u00fclteni. 39: 159-162, 1997.<br \/>\u00d6zt\u00fcrk A. Sezer M. \u00dcskent N. Valoarea nivelului de interleukin\u0103-6 seric\u0103 \u00een mielomul multiplu. T\u00fcrk Onkoloji Dergisi. 12: 1, 21-23, 1997.<br \/>\u00d6zt\u00fcrk A. Kandemir G. Yaylac\u0131 M. \u00dcskent N. Chimioterapie cu doz\u0103 mare cu suport de celule stem periferice autologe congelate. Dezvoltare clinic\u0103. 10: 173-176, 1997.<br \/>\u00d6zt\u00fcrk A. G\u00fcnay A. Budak T. Ako\u011flu T. \u00dcskent N. Rezisten\u021ba Activ\u0103 la Protein\u0103 C \u00een leucemia mieloid\u0103 cronic\u0103. Dezvoltare clinic\u0103. 10: 147-149, 1997.<\/p><p>1998<\/p><p>T, Budak-Alpdogan, Demir\u00e7ay, Alpdogan O, Direskeneli H, Ergun T, Ozt\u00fcrk A, et al. \"Hiperreactivitatea cutanat\u0103 a pacien\u021bilor cu Beh\u00e7et (reac\u021bia pathergy) este, de asemenea, pozitiv\u0103 la pacien\u021bii cu leucemie mieloid\u0103 cronic\u0103 trata\u021bi cu interferon alfa, indic\u00e2nd func\u021bii alterate similare ale neutrofilelor \u00een ambele afec\u021biuni.\" British Journal of Rheumatology 1998; 37 (11): 1148-51.<br \/>A, Ozt\u00fcrk, G\u00fcnay A, Uskent N. 1998. \"Eficacitatea terapeutic\u0103 a interferonului alfa recombinant \u00een policitemia vera.\" Acta Haematologica 99 (2): 89-91. doi:40817.<\/p><p>1999<\/p><p>Kandemir EG, Yaylaci M, Ozturk A, Uskent N. Dermatita de recall indus\u0103 de docetaxel. THOD 1999; 9(2):111\u20133.<br \/>Kandemir G. Yaylac\u0131 M. \u00dcskent N. Combina\u021bia vinorelbin-mitomicin\u0103-C \u00een cancerul mamar metastatic anterior netratat. T\u00fcrk Onkoloji Dergisi 13: 120-123, 1999.<br \/>\u00d6zt\u00fcrk A. Sezer M. \u00dcskent N. Efectele inhibitorilor HMG CoA reductaz\u0103 asupra agreg\u0103rii plachetare. Clinica \u0218tiin\u021belor. 5:2, 161-164, 1999.<\/p><p>2000<\/p><p>Karado\u011fan, B. Artmen, M. Bay\u0131k, \u015e. Kansoy, E. Oval\u0131, A. U. Ural, O. \u0130lhan: Studiu na\u021bional al complica\u021biilor aferesei cu celule stem periferice (PBSC) \u00een Turcia 1998. Bone Marrow Transplantation 25: p-906, 2000.<br \/>N. \u00dcskent, A. \u00d6zt\u00fcrk, \u00d6. Arslan, S. B. Omay, A. \u00dcnal, S. Anak, S. Paydap, S. Kalayo\u011flu, F. Arpac\u0131, S. Cadurgan, E. Oval\u0131, S. Kensoy, M. Bay\u0131k, A. U. Ural, Z. G\u00fclba\u015f, O. \u0130lhan: Colectarea de celule stem periferice autologe. Activitatea din 1998 a Turciei. Bone Marrow Transplantation 25: 911, 2000.<br \/>Yaylac\u0131 M. T\u00fcrken O. \u00dcskent N. Demonstrarea experimental\u0103 a efectului citoprotector al amifostinului \u00een reducerea cardiotoxicit\u0103\u021bii induse de doxorubicin\u0103. T\u00fcrk Onkoloji Dergisi. 15(14), 2000.<br \/>G\u00fcnay A, \u00d6zt\u00fcrk A, Budak T, \u00d6zbek U, \u00dcskent N. Rezisten\u021ba la protein\u0103 activat\u0103 C \u00een policitemia vera Turk J Haematol 2000 18(3):157-164.<br \/>O, Ilhan, Uskent N, Arslan O, Arat M, Ozkalemka\u015f F, Ozt\u00fcrk G, et al. 2000. \"Studiu na\u021bional al practicii de hemaferesis \u00een Turcia.\" Transfusion Science 22 (3): 195-201. 2000.<br \/>N, K\u00f6ksal, M\u00fcft\u00fco\u011flu T, G\u00fcnerhan Y, Uskent N. \"Remisie complet\u0103 a metastazelor hepatice ale melanomului malign anorectal cu chimioterapie regional\u0103: un raport de caz.\" Hepato-gastroenterology. 2000; 47 (33): 612-4.<\/p><p>2001<\/p><p>O. T\u00fcrken, B. Orhan, A. \u00d6zt\u00fcrk, D. Etiz, M. Yaylac\u0131, N. \u00dcskent; Pacien\u021bii cu sindrom myelodysplastic beneficiaz\u0103 de terapie cu amifostin\u0103, pentoxifilin\u0103 \u0219i ciprofloxacin\u0103 cu dexametazon\u0103. Blood 98, 24bb, 2001<br \/>O. T\u00fcrken, A. \u00d6zt\u00fcrk, B. Orhan, G. Kandemir, M. Yaylac\u0131, N. \u00dcskent; Un raport de caz: Leucemie\/limfom cu celule mari granuloase. Blood 98, 207b, 2001<br \/>O. T\u00fcrken, B. Orhan, A. \u00d6zt\u00fcrk, D. Etiz, M. Yaylac\u0131, N. \u00dcskent; Pacien\u021bii cu sindrom myelodysplastic beneficiaz\u0103 de terapie cu amifostin\u0103, pentoxifilin\u0103 \u0219i ciprofloxacin\u0103 cu dexametazon\u0103. Blood 98, 24bb, 2001<br \/>Yaylac\u0131 M, Orhan B, Etiz D, \u00d6zt\u00fcrk A, \u00c7ermik H, T\u00fcrken O, \u00dcskent N. Angiosarcom primar al s\u00e2nului. Journal of Balkan Union of Oncology. 6: 203-205, 2001.<br \/>\u00dcskent N, Orhan B. Limfoame malteze. Revista de Hematologie-Oncologie Actual\u0103. 3: 37-42, 2001.<br \/>Orhan T, \u00d6zt\u00fcrk A, Yaylac\u0131 M, Orhan B, \u00dcskent N. Chimio-terapie \u00eenalt\u0103 doz\u0103 cu transplant de celule stem periferice autologe necryoprezervate \u00een carcinoma testicular refractar\/recurent, rezultate dintr-un singur centru. Turkish Journal of Cancer. 31: 72-77, 2001.<br \/>Dincba\u015f FO, Koca S, Alt\u0131nel A, Hanc\u0131lar T, \u00c7avu\u015fo\u011flu M, Turhal S, \u00dcskent N, \u00d6zg\u00fcro\u011flu M, Okkans S. Radioterapie hipofractat\u0103 accelerat\u0103 continuu (CHART) plus chimioterapie (CT) cu vinorelbin\u0103 (VB) \u0219i cisplatin\u0103 (CDDP) \u00een NSCLC avansat local (studiul TOG-011). European Journal of Cancer 2001 37(6): S53<br \/>Sezer M, \u00d6zt\u00fcrk A, Ivan A, \u00d6zkan M, \u00dcskent N. Schimb\u0103rile hemostatice \u00een tuberculoza pulmonar\u0103 activ\u0103. Turk J Haematol; 18: 2, 95-100, 2001<br \/>Etiz D, \u00dcskent. Plasmocitom pulmonar extramedular post-radiere cu efuziune pleural\u0103. Journal of Balkan Union of Oncology 6: 103-106, 2001<br \/>G\u00fcnay A, \u00d6zt\u00fcrk A, Budak T, \u00dcskent N. Rezisten\u021ba proteinei C activate \u00een policitemia vera. Turkish Journal of Haematology. 18: 157-164, 2001<\/p><p>2002<\/p><p>\u00d6zt\u00fcrk A, Orhan B, T\u00fcrken O, Etiz D, Yaylac\u0131 M, \u00dcskent N. Leucemie mieloblastic\u0103 acut\u0103 care a ob\u021binut remisie complet\u0103 doar cu amifostin\u0103. Leukemia and Lymphoma 2002; 43(2): 451-453.<br \/>T\u00fcrken O, Etiz D, Orhan B, \u00c7ermik H, Yaylac\u0131 M, \u00d6zt\u00fcrk A, \u00dcskent N. Metastaz\u0103 muscular\u0103 ca manifestare ini\u021bial\u0103 a carcinomului epidermoid al pl\u0103m\u00e2nului. Clinical Oncology (Royal College of Radiologists (Marea Britanie)) 2002; 14: 129-131.<br \/>T\u00fcrken O, G\u00fcney Y, Kandemir EG, Yaylac\u0131 M, \u00d6zt\u00fcrk A, Orhan B, \u00dcskent N. Importan\u021ba prognostic\u0103 a expresiei c-erb-2 (Her-2\/neu) \u00een cancerul de s\u00e2n \u00een stadiu incipient \u0219i rela\u021bia cu al\u021bi factori prognostici. T\u00fcrk Onkoloji Dergisi 17: 166-170, 2002.<br \/>T\u00fcrken O, Sanal A, Y\u0131ld\u0131r\u0131m \u015e, \u00dcskent N. Investigarea valorii prognostice a seleniu \u00een cancerul de s\u00e2n. T\u00fcrk Onkoloji Dergisi. 2002 17(3): 109-112<br \/>T\u00fcrken O, De\u011ferlio\u011flu A, \u00dcskent N. Rolul nivelului receptorului de transferrin\u0103 \u00een diagnosticul anemiei prin deficit de fier \u0219i diferen\u021bierea de anemia asociat\u0103 bolilor cronice. T\u00fcrk Hematoloji-Onkoloji dergisi. 121-5, 2002<br \/>T\u00fcrken O, \u00dcskent N. Importan\u021ba prognostic\u0103 a expresiei c-Erb-B2 \u00een cancerul de s\u00e2n \u00een stadiu incipient. T\u00fcrk onkoloji dergisi. 17: 166-170, 2002<\/p><p>2003<\/p><p>\u00dcskent N, Demirta\u015f S, T\u00fcrken O. Supravie\u021buirea dup\u0103 metastaza cerebral\u0103 precoce a cancerului colorectal. Turkish Journal of Cancer 33(3): 154-157, 2003<br \/>\u00dcskent N. Istoricul natural al cancerului de s\u00e2n, dezvoltarea, factorii de risc, distribu\u021bia \u0219i epidemiologia \u00een lume. \u00cen Breast Cancer, edi\u021bia 1. 2003: 1-14<\/p><p>2010<\/p><p>\u00dcskent N. Principiile generale ale vaccinurilor \u00eempotriva cancerului, studii preclinice \u0219i de faz\u0103 ini\u021bial\u0103. T\u00fcrkiye Klinkleri 2010: 3(2): 5-10<\/p><p>2011<\/p><p>Uskent N, Cokmez A, Atahan MK, Aksaz E, Guler N, Muslumanoglu M, Ozmen V. Un studiu electronic non-interven\u021bional de farmacovigilen\u021b\u0103 asupra pacien\u021bilor cu cancer mamar \u00een stadiu incipient care primesc tratament adjuvant cu anastrozol (Arimidex\u00ae). Turkish Journal of Oncology; 2011, 26:55-60.<br \/>Ramadan S, Yap\u0131c\u0131er \u00d6, Kihtir S, Erdemir A, Do\u011fan TH, \u00dcskent N, Onat H, \u00c7akmak\u00e7\u0131 M. Corelarea amplific\u0103rii genei HER 2\/neu cu imunohistochimia \u0219i alte factori prognostici \u00een carcinomul mamar. Turkish Journal of Pathology 2011 Sept;27(3):196-203.<br \/>Uskent N, Sezer M, Belen G. Pancreatit\u0103 acut\u0103 sever\u0103 indus\u0103 de tamoxifen dup\u0103 o terapie pe termen scurt: un raport de caz. Turkish Journal of Oncology; 26(1):26-28, 2011.<\/p><p>2016<\/p><p>Remisiune complet\u0103 a limfomului Burkitt dup\u0103 excizie chirurgical\u0103: un raport de caz. Indian Journal of Hematology and Blood Transfusion 01\/2016; 32(Suppl 1). DOI:10.1007\/s12288-016-0650-6<br \/>Uskent N, Baloglu B, \u00c7akmakc\u0131 M, Saglam S, Koksal U. Metastaze ale cancerului mamar la stomac \u0219i colon care imit\u0103 cancerul gastro-intestinal primar. Advances in Modern Oncology Research 2016;2(4):204-210.<br \/>Aykan F, Onat H, \u00dcskent N. Compararea virtual\u0103 a metodelor de reducere a dimensiunii tumorale bazate pe dimensiune \u0219i efectul heterogenit\u0103\u021bii tumorale. Ghent, Belgia, Cell Symposia Hallmarks of Cancer, 2016.<\/p><p>2017<\/p><p>Uskent N, Molinal N. Testele citolitice cu seruri de pacien\u021bi hiperimuni sunt un instrument prognostic bun \u00een imunoterapia racotumomab \u00een cancerul pulmonar non-mic celular avansat. Advances in Modern Oncology Research 2017;3(5):223-231.<br \/>S. Kilickap et al., \"Eficacitatea Crizotinib \u00een pacien\u021bii cu cancer pulmonar non-mic celular avansat pozitiv ALK: O experien\u021b\u0103 din via\u021ba real\u0103 din Turcia,\" JOURNAL OF THORACIC ONCOLOGY, vol. 13, 2018.<\/p><p>2019<\/p><p>Karadurmus N, Paydas S, Uskent N. Eficien\u021ba Bendamustinei \u00een cazurile de limfom recidivant sau refractor. Un studiu al grupului turc de oncologie. Archives of Medical Science. DOI: https:\/\/doi.org\/10.5114\/aoms.2019.8300<br \/>N. Uskent, S. Ayla, N. Molinas. Semnifica\u021bia prognostic\u0103 a expresiei gangliosidului NeuGcGm3 \u00een \u021besutul tumoral \u0219i valoarea predictiv\u0103 a monitoriz\u0103rii num\u0103rului de celule tumorale circulante \u00een pacien\u021bii care primesc imunoterapia racotumomab. Annals of Oncology, Volumul 30, Num\u0103rul suplimentar 5, Octombrie 2019, 1266P, mdz253.09.<\/p><p>2020<\/p><p>Demir A, Mandel NM, Payda\u015f S, Demir G, \u00dcskent N. Eficien\u021ba Palbociclibului \u0219i a tratamentului endocrin \u00een cancerul mamar avansat cu receptor hormonal pozitiv\/HER2-negativ: studiu retrospectiv multicentric. Balkan Medical Journal 37(2):104-107, 2020.<br \/>Uskent N, Ayla S, Mandel NM. Semnifica\u021bia prognostic\u0103 a gangliosidului NeuGm3 \u00een \u021besutul tumorii la pacien\u021bii care primesc imunoterapia racotumomab. Journal of Oncology Hindawi, Volumul 2020, Articol ID 1360431, doi.org\/10.1155\/20\/1360431.<\/p><p>2021<\/p><p>G\u00fcrb\u00fcz M, Akku\u015f E, Sakin A, \u00dcskent N et al. Trastuzumab \u00b1 Capecitabine \u00eentre\u021binere dup\u0103 tratamentul de prim\u0103 linie al cancerului gastric avansat HER2-pozitiv: date observa\u021bionale retrospective din via\u021ba real\u0103 ale grupului turc de oncologie, februarie 2021. Journal of Gastrointestinal Cancer. DOI: 10.1007\/s12029-021. Februarie 2021.<\/p><p>2022<\/p><p>2022 Atezolizumab combinat cu chimioterapie \u00een tratamentul de prim\u0103 linie al cancerului pulmonar cu celule mici \u00een stadiu avansat: date din via\u021ba real\u0103 ale grupului turc de oncologie. Journal of Cancer Research and Clinical Oncology. Iunie 2022. DOI: 10.1007\/s00432-022-04087-x<br \/>Date din via\u021ba real\u0103 privind eficacitatea \u0219i siguran\u021ba tratamentului de prim\u0103 linie cu alectinib \u00een pacien\u021bii cu cancer pulmonar non-mic celular avansat, pozitiv ALK: un studiu al grupului turc de oncologie. Future Oncology. Vol. 18:23, 2022.<\/p><p><strong>Book chapters<\/strong><\/p><p>Tecimer C, \u00dcskent N. Tumori asociate cu SIDA. Ayd\u0131ner A, Topuz E. (Ed.) Manual de oncologie, Turgut Yay\u0131nc\u0131l\u0131k A.\u015e. Istanbul, 2006: 520-30<br \/>\u00dcskent N. Tecimer C. Leucemii acute. Manual de oncologie. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e. 2006: 531-49<br \/>\u00dcskent N. Tecimer C. Leucemia mieloid\u0103 cronic\u0103. Manual de oncologie, Turgut Yay\u0131nc\u0131l\u0131k, 2006: 550-57<br \/>\u00dcskent N. Tecimer C. Leucemia limfoid\u0103 cronic\u0103. Manual de oncologie, Turgut Yay\u0131nc\u0131l\u0131k, 2006: 558-68<br \/>\u00dcskent N. Tecimer C. Limfomul Hodgkin. Ayd\u0131ner A, Topuz E. (Ed.) Manual de oncologie, Turgut Yay\u0131nc\u0131l\u0131k, Istanbul, 2006: 569-586<br \/>\u00dcskent N. Tecimer C. K\u0131nay M. Limfoame non-Hodgkin. Ayd\u0131ner A, Topuz E. (Ed.) Manual de oncologie, Turgut Yay\u0131nc\u0131l\u0131k, Istanbul, 2006: 587-614<br \/>\u00dcskent N. Tecimer C. Boli mieloproliferative. Ayd\u0131ner A, Topuz E. (Ed.) Manual de oncologie. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e. Istanbul, 2006: 637-45<br \/>\u00dcskent N. Transfuziile de s\u00e2nge \u0219i componentele sanguine la pacien\u021bii cu cancer. Onat H, Mandel NM (Ed.), \u00cen: Abordarea pacien\u021bilor cu cancer, diagnostic, tratament \u0219i probleme de urm\u0103rire. Edi\u021bie revizuit\u0103, 2-a edi\u021bie, Nobel T\u0131p Kitabevleri, Istanbul 2012, 147-155<br \/>\u00dcskent N. Istoricul natural al cancerului de s\u00e2n, dezvoltare, factori de risc, distribu\u021bie \u0219i epidemiologie la nivel mondial. \u00cen: Cancerul de s\u00e2n 1-a edi\u021bie, Istanbul 2003: 1-14<br \/>\u00dcskent N. Prevenirea cancerului de s\u00e2n \u0219i studiile de profilaxie la persoanele cu risc ridicat. \u00cen: Boli ale s\u00e2nului. Editor \u00dcnal G, \u00dcnal H. Istanbul, Nobel T\u0131p Kitabevi 2001<br \/>\u00dcskent N. Prevenirea cancerului \u0219i screeningul cancerului. \u00cen: Manual de medicin\u0103 intern\u0103. Editor Erol \u00c7. Nobel Yay\u0131nevi, 2011: 7-15<\/p><p>Lucr\u0103ri de congres<\/p><p>1990<br \/>N. \u00dcskent, M. Danac\u0131, Z. Alt\u0131nok, B. S. Cebeci, M. \u00d6zel: R\u0103spunsul sarcomului Kaposi nes asociat cu SIDA la interferonul alfa 2b. 5. Congres Na\u021bional de Antibiotice \u0219i Chimoterapie, 1-4 mai 1990, Antalya.<\/p><p>1991<br \/>N. \u00dcskent, M. Danac\u0131, M. Yaylac\u0131, M. \u00d6zel, H. Tor: Tratamentul anemiei aplastice severe cu ciclosporin\u0103 A. 22. Congres Na\u021bional de Hematologie, 21-25 octombrie 1991, Istanbul.<br \/>M. Danac\u0131, L. Dumanhan, M. \u00d6zel, N. \u00dcskent: Efectul gemfibrozilului asupra hiperlipidemiei diabetice. Congresul Na\u021bional de Diabet 1991, 27-29 mai 1991, Istanbul.<br \/>\u00dcskent N. Yaylac\u0131 M, Danac\u0131 M. Remisiuni hematologice \u0219i citogenice induse de interferonul alfa-recombinat 2b \u00een LMC. Congresul Interna\u021bional de Medicin\u0103 Militar\u0103, Istanbul, 18-25 septembrie 1993.<\/p><p>1994<br \/>N. \u00dcskent, M. Yaylac\u0131, A. \u00d6zt\u00fcrk, O. T\u00fcrken: Tratamentul anemiei induse de chimioterapie cu eritropoietin\u0103 uman\u0103 recombinat\u0103. Analele Oncologiei, Lisabona, 1994.<br \/>\u00dcskent N, Yaylac\u0131 M, A. \u00d6zt\u00fcrk, O. T\u00fcrken, M. Danac\u0131: Rezultatul administr\u0103rii intravenoase de imunoglobulin\u0103 G \u00een doze mari \u00een purpura trombocitopenic\u0103 idiopatic\u0103 acut\u0103 \u0219i cronic\u0103. NATO Conferin\u021ba Militar\u0103 \u0219i Civil\u0103 3-a despre S\u00e2nge, Istanbul, 1994.<br \/>N. \u00dcskent, M. Yaylac\u0131, A. \u00d6zt\u00fcrk: Tratamentul trombocitopeniei severe induse de chimioterapie cu plachete ob\u021binute prin trombocitofereza prin flux continuu. NATO Conferin\u021ba Militar\u0103 \u0219i Civil\u0103 3-a despre S\u00e2nge, Istanbul, 1994.<br \/>N. \u00dcskent, E. Ek\u015fio\u011flu Demiralp, S. \u015e. \u00d6zg\u00fcn, T. Budak, O. Alpdo\u011fan, A. \u00d6zt\u00fcrk, T. F. Tu\u011flular, M. Aktan, M. Bay\u0131k, T. Ako\u011flu: Expresia moleculei CD 49d pe limfocitele CLL. British Journal of Haematology, 87, supliment 1, 1994.<br \/>N. \u00dcskent, M. Yaylac\u0131, A. \u00d6zt\u00fcrk, F. Karsl\u0131: Interferonul alfa 2a intraarterial prin artera hepatic\u0103 induce un r\u0103spuns pe termen lung \u00een carcinoma renal cu metastaze hepatice. 5-a Conferin\u021b\u0103 Interna\u021bional\u0103 pe Chimioterapia Anti-Cancer, Paris 1994.<br \/>M. Yaylac\u0131, A. \u00d6zt\u00fcrk, N. \u00dcskent: Un studiu comparativ al protocoalelor antiemetice. Cre\u0219terea \u0219i Terapia Cancerului. Budapesta, 1994.<br \/>M. \u00d6zel, N. \u00dcskent: Demonstrarea asocierii virusului EBV cu limfomul Hodgkin. 19-a Conferin\u021b\u0103 ESMO, 18-22 noiembrie 1994, Lisabona, Portugalia.<br \/>Y. K\u00fc\u00e7\u00fckardal\u0131, N. Haksever, S. G\u00fcl, A. \u00d6zt\u00fcrk, H. Tor, N. \u00dcskent: Activitatea fosfatazei alcaline a leucocitelor la pacien\u021bii diabetici. NATO Conferin\u021ba Militar\u0103 \u0219i Civil\u0103 3-a despre S\u00e2nge, Istanbul, 1994.<br \/>M. Yaylac\u0131, \u00d6zt\u00fcrk A, T\u00fcrken O, \u00dcskent N: Eficacitatea terapeutic\u0103 a G-CSF \u00een mielosupresia indus\u0103 de chimioterapie. NATO Conferin\u021ba Militar\u0103 \u0219i Civil\u0103 3-a despre S\u00e2nge, Istanbul, 1994.<\/p><p>1995<br \/>\u00d6zt\u00fcrk, N. \u00dcskent, M. Yaylac\u0131: Trombocitopenie sever\u0103 complic\u00e2nd infec\u021bia EBV. 13-a \u00cent\u00e2lnire a Societ\u0103\u021bii Interna\u021bionale de Hematologie. Istanbul, 1995.<br \/>A. \u00d6zt\u00fcrk, N. \u00dcskent, M. Yaylac\u0131: Rezisten\u021ba la proteina C activat\u0103 \u00een malignitate. 13-a \u00cent\u00e2lnire a Societ\u0103\u021bii Interna\u021bionale de Hematologie. Istanbul, 1995.<br \/>M. \u00d6zel, N. \u00dcskent, M. Danac\u0131, M. Yaylac\u0131, H. Balo\u011flu: Demonstrarea rela\u021biei virusului Epstein-Barr (EBV) cu boala Hodgkin \u0219i limfoamele non-Hodgkin. XI-a Congres Na\u021bional de Cancer, 28 mai - 2 iunie 1995, Antalya.<\/p><p>1996<br \/>A. \u00d6zt\u00fcrk, G. Kandemir, M. Sezer, M. Yaylac\u0131, N. \u00dcskent: Leucemia mastocitar\u0103. 1-a Conferin\u021b\u0103 a Comitetului Medical Militar Balcanic, Istanbul, 1996.<br \/>A. \u00d6zt\u00fcrk, G. Kandemir, M. Sezer, M. Yaylac\u0131, N. \u00dcskent: Hemosideroza pulmonar\u0103. 1-a Conferin\u021b\u0103 a Comitetului Medical Militar Balcanic, Istanbul, 1996.<br \/>A. \u00d6zt\u00fcrk, G. Kandemir, M. Yaylac\u0131, N. \u00dcskent: Chimioterapia CHOEP \u00een limfoamele non-Hodgkin de grad intermediar \u0219i \u00eenalt. Analele Oncologiei, Lugano, 1996 {6-ICMLJune5-81996\/12_posters-576}.<br \/>T. R. Evrenkaya, M. Akg\u00fcn, A. \u00d6zt\u00fcrk, M. Y. T\u00fclbek, N. \u00dcskent: Efectele administr\u0103rii intravenoase de aminoacizi esen\u021biali asupra sistemului imunitar al pacien\u021bilor cu hemodializ\u0103 cronic\u0103. Asocia\u021bia European\u0103 de Rinichi, Asocia\u021bia European\u0103 de Dializ\u0103 \u0219i Transplant. Amsterdam, 1996.<br \/>A. \u00d6zt\u00fcrk, M. Sezer, E. G. Kandemir, M. Yaylac\u0131, N. \u00dcskent: Un studiu comparativ al tropisetronului versus granisetronul \u00een controlul hiperemesis indus de cisplatin\u0103. 10-a Conferin\u021b\u0103 Mediteranean\u0103 de Chimioterapie. Antalya, 1996.<br \/>A. \u00d6zt\u00fcrk, A. G\u00fcnay, M. Sezer, G. Kandemir, M. Yaylac\u0131, N. \u00dcskent: Trombose arteriale cauzate de L-asparaginaz\u0103 \u00een ALL. 10-a Conferin\u021b\u0103 Mediteranean\u0103 de Chimioterapie. Antalya, 1996.<br \/>A. \u00d6zt\u00fcrk, M. Sezer, E. Kandemir, M. Yaylac\u0131, N. \u00dcskent: E\u0219ecul medular indus de antibiotice \u00een timpul fazei de remisie complet\u0103 \u00een ALL. 10-a Conferin\u021b\u0103 Mediteranean\u0103 de Chimioterapie. Antalya, 1996.<br \/>A. \u00d6zt\u00fcrk, M. Sezer, E. Kandemir, M. Yaylac\u0131, N. \u00dcskent: Rezultatele regimului BEP \u00een tratamentul cancerului testicular non-seminomatos. 10-a Conferin\u021b\u0103 Mediteranean\u0103 de Chimioterapie. Antalya, 1996.<\/p><p>2012<\/p><p>\u00dcskent N. Progrese \u00een Malignit\u0103\u021bile Hematologice. A doua Conferin\u021b\u0103 ISC pe Terapii Inovatoare, Istanbul, 02-04 Noiembrie, Istanbul, 2012.<\/p><p>2015<\/p><p>Uskent N. Sezer M. Remisie complet\u0103 indus\u0103 de Racatumomab la un pacient cu cancer mamar metastatic refractar la tratament. Congresul de Imunoterapie a Cancerului (CIMT), Abstr. 70, A-728 0001 00156. Mainz, Germania, 11-15 Mai 2015.<\/p><p>Uskent N. Sezer M. Infiltarea pneumonic\u0103 imun\u0103 asociat\u0103 cu Rituximab. Congresul de Imuno-Oncologie, Antalya, 2015.<\/p><p>2016<\/p><p>Uskent N. Molinas N. Testul citotoxic in vivo cu serul pacien\u021bilor hiperimuni este un instrument prognostic bun \u00een pacien\u021bii cu NSCLC vaccina\u021bi cu Racatumomab. Congresul Na\u021bional de Cancer Pulmonar, 24-27.11. 2016, Antalya.<\/p><p>Aykan F. Onat H. \u00dcskent N. Compararea virtual\u0103 a metodelor de mic\u0219orare a tumorilor bazate pe dimensiune \u0219i efectul heterogenit\u0103\u021bii tumorii. Ghent, Belgia, Simpozionul Celulelor Hallmarks of Cancer, Poster, Decembrie 2016.<\/p><p>2017<\/p><p>Karadurmu\u015f N., Payda\u015f S., Ocal R. Eficacitatea bendamustinei \u00een cazurile de limfom recidivant sau refractar: Un raport din Turcia\u2014Studiul Grupului Turkish de Oncologie (TOG). ASCO Abstr. 2017. DOI:10.1200\/JCO.2017.35.15 Suppl.e 19027.<\/p><p>Uskent N. Testele citolitice cu serul pacien\u021bilor hiperimuni sunt un instrument prognostic bun \u00een imunoterapia racotumomab \u00een cancerul pulmonar avansat non-microscop. Conferin\u021ba mondial\u0103 IASLC pe cancerul pulmonar, 15-18 Octombrie 2017, Yokohoma, Japonia. Journal of Thoracic Oncology, Vol:12, Nr:1152, S.1996, PI.07-003, 2017.<\/p><p>Prezent\u0103ri<\/p><p>T\u00fcrken O, Orhan B, \u00d6zt\u00fcrk A, Yaylac\u0131 M, Etiz D, \u00dcskent N. Un caz de leucemie mieloid\u0103 cronic\u0103 atipic\u0103 dezvoltat\u0103 dup\u0103 tratamentul leucemiei limfoblastice acute. XXVII-lea Congres Na\u021bional de Hematologie \u0219i IV. Curs de Formare Postuniversitar\u0103, 11-13 Noiembrie 1999, Istanbul. Poster Nr: P-027.<\/p><p>T\u00fcrken O, Orhan B, \u00d6zt\u00fcrk A, Etiz D, \u00dcskent N. Implicarea orbital\u0103 \u00een limfomul non-Hodgkin: un caz. XXVII-lea Congres Na\u021bional de Hematologie \u0219i IV. Curs de Formare Postuniversitar\u0103, 11-13 Noiembrie 1999, Istanbul. Poster Nr: P-028.<\/p><p>T\u00fcrken O, Orhan B, \u00d6zt\u00fcrk A, Yaylac\u0131 M, Etiz D, \u00dcskent N. Un caz de leucemie mieloblastic\u0103 acut\u0103 care a intrat \u00een remisie cu Amifostin\u0103. XXVII-lea Congres Na\u021bional de Hematologie \u0219i IV. Curs de Formare Postuniversitar\u0103, 11-13 Noiembrie 1999, Istanbul. Poster Nr: P-029.<\/p><p>T\u00fcrken O, Etiz D, Orhan B, \u00d6zt\u00fcrk A, \u00dcskent N. Dou\u0103 cazuri de anemie pernicioas\u0103 la tineri adul\u021bi cu simptome neurologice. XXVII-lea Congres Na\u021bional de Hematologie \u0219i IV. Curs de Formare Postuniversitar\u0103, 11-13 Noiembrie 1999, Istanbul. Poster Nr: P-067.<\/p><p>T\u00fcrken O, \u00d6zt\u00fcrk A, Orhan B, Etiz D, \u00dcskent N. Un caz de leucemie limfoblastic\u0103 acut\u0103 cu aspergiloz\u0103. XXVII-lea Congres Na\u021bional de Hematologie \u0219i IV. Curs de Formare Postuniversitar\u0103, 11-13 Noiembrie 1999, Istanbul. Poster Nr: P-086.<\/p><p>T\u00fcrken O, \u00d6zt\u00fcrk A, Orhan B, Yaylac\u0131 M, \u00dcskent N. Rolul receptorului de transferrin\u0103 solubil\u0103 \u00een diagnosticarea anemiei feriprive \u0219i \u00een diferen\u021bierea de anemia bolilor cronice. XXVIII-lea Congres Na\u021bional de Hematologie \u0219i Curs de Formare Postuniversitar\u0103, 1-4 Noiembrie 2000, Izmir.<\/p><p>T\u00fcrken O, \u00d6zt\u00fcrk A, Orhan B, Yaylac\u0131 M, \u00dcskent N. Un caz de trombofilie cu rezisten\u021b\u0103 la warfarin\u0103 (Coumadin) \u0219i heparin\u0103. XXVIII-lea Congres Na\u021bional de Hematologie \u0219i Curs de Formare Postuniversitar\u0103, 1-4 Noiembrie 2000, Izmir.<\/p><p>Orhan B, T\u00fcrken O, \u00d6zt\u00fcrk A, Uyano\u011flu A, Etiz D, Yaylac\u0131 M, \u00dcskent N. Un caz de limfom Hodgkin cu carcinom hepatocelular \u0219i metastaze osoase izolate. XXVIII-lea Congres Na\u021bional de Hematologie \u0219i Curs de Formare Postuniversitar\u0103, 1-4 Noiembrie 2000, Izmir.<\/p><p>\u00d6zt\u00fcrk A, T\u00fcrken O, Orhan B, Uyano\u011flu A, Yaylac\u0131 M, \u00dcskent N. Compararea eficacit\u0103\u021bii pentoxifilinei, ciprofloxacinei \u0219i deksametazonei cu amifostina la pacien\u021bii cu Leucemie Mieloide Acut\u0103 (LMA) \u0219i Sindrom Mielodisplastic. XXVIII-lea Congres Na\u021bional de Hematologie \u0219i Curs de Formare Postuniversitar\u0103, 1-4 Noiembrie 2000, Izmir.<\/p><p>Etiz D, \u00d6zt\u00fcrk A, T\u00fcrken O, Orhan B, Ardal\u0131 Y, \u00c7ermik H, Yaylac\u0131 M, \u00dcskent N. Plasmozitomul pulmonar extramedular dezvoltat dup\u0103 radioterapie. XXVIII-lea Congres Na\u021bional de Hematologie \u0219i Curs de Formare Postuniversitar\u0103, 1-4 Noiembrie 2000, Izmir.<\/p><p>T\u00fcrken O, Orhan B, \u00d6zt\u00fcrk A, Etiz D, Yaylac\u0131 M, \u00dcskent N. Pacien\u021bii cu sindroame mielodisplazice beneficiaz\u0103 de terapie cu Amifostin\u0103, pentoxifilin\u0103 \u0219i ciprofloxacin\u0103 cu deksametazon\u0103. Congresul Societ\u0103\u021bii Americane de Hematologie, Carte de Abstrac\u021bii, Blood 98(11): 276b, 2001.<\/p><p>Hatemi G, Mandel N. Demir G, \u00dcskent N. Efectul chimioterapiei asupra activit\u0103\u021bii telomerazei \u00een celulele mononucleare din s\u00e2ngele periferic la pacien\u021bii cu cancer mamar \u0219i ovarian. Procedurile ESMO, Abstr. Nr: 66, 19, 2002.<\/p><p>\u00dcskent N. Contribu\u021bia inhibitorilor VEGF la tratamentul cancerelor pulmonare non-mici cu celule. Congresul Cancerului Pulmonar, Izmir, 16-19 Octombrie 2008.<\/p><p>\u00dcskent N. Angiogeneza \u0219i inhibitori ai angiogenezei \u00een cancerul mamar. Congresul Na\u021bional de Cancer Mamar, Istanbul, 24-26 Octombrie 2008.<\/p><p>\u00dcskent N. Direc\u021bion\u0103ri moleculare \u00een tratamentul sistemic al cancerului mamar metastatic. I Congres al Cancerului Mamar din Marea Neagr\u0103, Samsun 2011.<\/p><p>\u00dcskent N. Progrese \u00een Malignit\u0103\u021bile Hematologice. A doua Conferin\u021b\u0103 ISC pe Terapii Inovatoare, Istanbul, 02-04 Noiembrie, Istanbul 2012.<\/p><p>\u00dcskent N. C\u0103r\u0103rile de semnalizare \u0219i tratamentele \u021bintite \u00een malignit\u0103\u021bile hematologice. 4. Congres Na\u021bional de Limfom-Myelom, 3-5 Mai, Side 2013.<br \/>Uskent N. Genetic\u0103 \u00een cancerul colorectal. 3rd International Gastrointestinal Cancer Conference, 13-15 Decembrie, Gloria Hotel, Antalya, 2013.<br \/>\u00dcskent N. Ce este nou \u00een tratamentul NSLC avansat. 22. \u00cent\u00e2lnirea anual\u0103 a Societ\u0103\u021bii Asiatice pentru Chirurgie Cardiovascular\u0103 \u0219i Toracic\u0103 (ASCVTS14). 04.04.2014, Centrul de Congresuri din Istanbul, Harbiye, Istanbul.<br \/>\u00dcskent N. La cine \u0219i cum s\u0103 aplic\u0103m tratamentul sistemic neoadjuvant \u00een cancerul mamar. 3. Congres de Boli Mamare din Marea Neagr\u0103, 26-29 Martie, 2015, Samsun.<br \/>\u00dcskent N. Tratamentul non-transplant al limfoamelor non-Hodgkin refractare\/recidivante. Congres de Limfom-Myelom, Antalya, 10-12 Aprilie 2015.<br \/>\u00dcskent N, Sezer M. Hemoragie intraarticular\u0103 sever\u0103 ap\u0103rut\u0103 \u00een timpul tratamentului cu Sunitinib la un pacient asimptomatic cu deficit de factor WVB u\u0219or. Congres Na\u021bional de Cancer, 22-26 Aprilie 2015, Antalya.<br \/>\u00dcskent N. Tratamentul sistemic neo-adjuvant al cancerului mamar. Simpozion Interna\u021bional de Cancer Mamar. Centrul de \u0218tiin\u021be ale S\u0103n\u0103t\u0103\u021bii Anadolu, Auditoriul Efes, Gebze, Kocaeli, 12.09.2015.<br \/>\u00dcskent N. Tratamente sistemice \u00een tumorile cerebrale metastatice. Simpozion Multi-Disciplinar de Neuro-Oncologie. 06-07.11.2015, Hyatt Regency Hotel Istanbul.<br \/>Uskent N. De la teorie la practic\u0103: imunoterapia cancerului. Simpozion Interna\u021bional de Imunoterapie a Cancerului, Experien\u021ba Karolinska: Focaliz\u00e2ndu-se pe GBM \u0219i cancerul pancreatic. Centrul de \u0218tiin\u021be ale S\u0103n\u0103t\u0103\u021bii Anadolu, Auditoriul Efes, Gebze, Kocaeli, 06.09.2015.<br \/>\u00dcskent N. Tratamentele \u021bintite \u00een limfomul non-Hodgkin \u0219i mielomul multiplu, Curs de Malignit\u0103\u021bi Hematologice al Asocia\u021biei de Oncologie Medical\u0103. Adana, 07-09 Noiembrie 2015.<\/p><p>Editorial Boards on which he is a consultant<\/p><p>Journal of Turkish Oncology<br \/>Drugs<br \/>Journal of Advances in Modern Oncology Research (AMOR). PiscoMed Publishing Pte Ltd<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-88271ee elementor-widget elementor-widget-triumf_lightbox\" data-id=\"88271ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-88271ee-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"88271ee\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. \u015eeref K\u00f6m\u00fcrc\u00fc<\/h2><p><strong>Specialty<\/strong><\/p><p>Oncology Center (Cancer Center)<br \/>Chemotherapy<br \/>Solid Cancer<br \/>Breast Cancer<br \/>Colorectal and Lung Cancer<br \/>Palliative Medicine<br \/>Supportive Treatments in Cancer<\/p><p><strong>Education<\/strong><\/p><p>University<br \/>Hacettepe Faculty of Medicine, Ankara 1980-1983<br \/>G\u00fclhane Military Medical Academy, Ankara 1983-1986<\/p><p>Specialist Training<br \/>G\u00fclhane Military Medical Academy, Department of Internal Medicine, Ankara 1989-1993<br \/>G\u00fclhane Military Medical Academy, Department of Medical Oncology, Ankara 1994-1996<\/p><p>Fellowship<br \/>Cleveland Clinic Foundation, Department of Medical Oncology, USA (1997-1998)<\/p><p>Assistant Lecturer<br \/>G\u00fclhane Military Medical Academy, Department of Medical Oncology, Ankara 1996-1999<\/p><p>Associate Professor<br \/>G\u00fclhane Military Medical Academy, Department of Medical Oncology, Ankara 1999-2008<\/p><p>Professor<br \/>G\u00fclhane Military Medical Academy, Department of Medical Oncology, Ankara 2008-2011<\/p><p><strong>Institutions he worked at<\/strong><\/p><p>Anadolu Medical Center, Gebze-Kocaeli (2016-- )<br \/>Memorial Hospital, Ankara (2013-2016)<br \/>Bay\u0131nd\u0131r S\u00f6\u011f\u00fct\u00f6z\u00fc Hospital, Ankara (2007-2013)<br \/>G\u00fclhane Medical Faculty Hospital, Ankara (1994-2011)<\/p><p><strong>Awards<\/strong><\/p><p>GATA Education and Teaching Success Award, 2003<br \/>GATA Internal Medical Sciences 3rd Place Award, 2005<br \/>Exceptional Service Award 2009, GATA, March 4, 2009<\/p><p><strong>Institutional Membership<\/strong><\/p><p>American Society of Clinical Oncology (ASCO)<br \/>European Society of Medical Oncology (ESMO)<br \/>Multinational Association for Supportive Care in Cancer (MASCC)<br \/>Turkish Oncology Group<br \/>Medical Oncology Association<br \/>Lung Cancer Association<br \/>Medical Communication Association<br \/>Breast Disease Association<\/p><p><strong>Course Attendance<\/strong><\/p><p>EPEC-O and Calvary Hospital, USA. June 2005<br \/>ECFMG Certificate (USA) 1993<br \/>ESMO Medical Oncology Certificate (Europe) 1999<\/p><p><strong>Scientific Publications<\/strong><\/p><p>Over 110 articles published in international or national journals<br \/>Over 250 presentations given at international and national congresses<br \/>Over 100 speeches given at scientific symposia or congresses<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c0a925a elementor-widget elementor-widget-triumf_lightbox\" data-id=\"c0a925a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-c0a925a-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"c0a925a\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>MD. Sinan Karaaslan<\/h2><p><strong>Specialty<\/strong><\/p><p>Oncology Center (Cancer Center)<\/p><p>Chemotherapy<br \/>Breast Cancer<br \/>Colorectal and Urogenital System Cancers<\/p><p>Other System Cancers<\/p><p><strong>Education<\/strong><\/p><p>University<\/p><p>Istanbul University, Istanbul Faculty of Medicine, Istanbul 1997<\/p><p><strong>Specialized Training<\/strong><\/p><p>Haseki Education and Research Hospital, Internal Medicine Clinic 1, Istanbul 2002<\/p><p><strong>Specialized Training in the Field<\/strong><\/p><p>Istanbul University, Cerrahpa\u015fa Faculty of Medicine, Department of Internal Medicine, Department of Medical Oncology, Istanbul 2009<\/p><p><strong>Institutions Worked At<\/strong><\/p><p>Haseki E\u011fitim ve Ara\u015ft\u0131rma Hastanesi<br \/>Bayrampa\u015fa State Hospital<br \/>Istanbul University, Cerrahpa\u015fa Faculty of Medicine<br \/>Erzurum Regional Education and Research Hospital<br \/>Derince Education and Research Hospital, Kocaeli<br \/>Park Medical Hospital<br \/>Anadolu Medical Center<\/p><p><strong>Membership of the Institution<\/strong><\/p><p>Turkish Physicians Union<br \/>Association Turkish Society of Medical Oncology<br \/>Turkish Lung Cancer Association<\/p><p><strong>Scientific Publications<\/strong><\/p><p>2 International Publications<br \/>4 National Publications<br \/>1 Poster Presentation<br \/>1 Book Chapter Translation<br \/>1 Review<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-232142c elementor-widget elementor-widget-triumf_lightbox\" data-id=\"232142c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-232142c-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"232142c\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. Ye\u015fim Y\u0131ld\u0131r\u0131m<\/h2><p><strong>Specialty<\/strong><\/p><p>Oncology Center (Cancer Center)<br \/>Chemotherapy<br \/>Breast Cancer<br \/>Colorectal Cancer<br \/>Lung Cancer<br \/>Malignant Melanoma<br \/>Liver Cancer<br \/>Renal and Urological Tumors<br \/>Ovarian - Uterine Tumors<br \/>Sarcomas<br \/>Testicular Cancer<br \/>Head Cancer<br \/>Throat Cancer<\/p><p><strong>Education<\/strong><\/p><p>Faculty of Medicine, Hacettepe University, Ankara 1999<br \/>Department of Internal Medicine, Gazi University, Ankara 2004<br \/>Subspecialty of Medical Oncology, Ba\u015fkent University, Ankara 2007<br \/>Associate Professor, Ac\u0131badem University, Department of Internal Medicine, 2011<br \/>Associate Professor 2011<br \/>Master in Health Management, Bilgi University, 2018<br \/>Professor, Department of Internal Medicine, Faculty of Medicine, Hali\u00e7 University, 2021<\/p><p><strong>Institutions he works for<\/strong><\/p><p>Ba\u015fkent University Department of Medical Oncology<br \/>Numune Hospital Sivas<br \/>Ac\u0131badem Kozyata\u011f\u0131 Hospital<br \/>Ac\u0131badem Maslak Hospital<br \/>Ac\u0131badem University<br \/>Anadolu Health Center<\/p><p>Administrative Positions<br \/>Head of Oncology Clinic of Numune Sivas Hospital (2009-2010) Marmara Region Regional Representative of the Turkish Medical Oncology Association: 2013 Member of the Personnel Rights Commission of the Turkish Medical Oncology Association 2013 Member of the Education Planning and Organization Committee of the Turkish Medical Oncology Association 2013<\/p><p><strong>Awards<\/strong><\/p><p>From MECC, for the Advanced Training Program in Oncology at Rambam Medical Center, from December 2, 2004 - December 30, 2004, Haifa, Israel.<\/p><p>Hans Wyder Scholarship for the ESO Advanced Course: \"Immunology for Oncologists\", April 16-18, 2005, Ascona, Switzerland.<\/p><p>Orazio Rudell Fellowship for the Colorectal Conference, 2-3 December 2005, London, UK.<\/p><p>5th Masterclass in Medical Oncology, 11-17 February 2006, Malta.<\/p><p>December 2015: Immuno-Oncology Clinic, Mount Vernon Cancer Center, London, UK.<\/p><p><strong>Institutional Membership<\/strong><\/p><p>ESMO: European Society of Medical Oncology<\/p><p>ESO: European School of Oncology<\/p><p>TTOD: Turkish Association of Medical Oncology<\/p><p><strong>Course Attendance<\/strong><\/p><p>Advanced Education Course in Oncology, Rambam Medical Center Haifa\/Israel, December 2004<br \/>Immunology for Oncologists, Ascona, Switzerland, April 2005<br \/>Colorectal Conference, London, UK, December 2005<br \/>5th Masterclass in Medical Oncology, Malta, February 2006<br \/>Antiangiogenic Mechanisms, UCLA Los Angeles, USA, January 2010<br \/>Head and Neck Cancer Course, Lausanne, Switzerland, May 2013<\/p><p>\u00a0<\/p><p>Scientific publications<br \/>International hakemli dergilerde yayamlanan makaleler:<\/p><p>A1. Sancak B, Coskun U, Gunel N, Onuk E, Cihan A, Karamercan A, Yildirim Y, Ozkan S. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of<\/p><p>breast carcinoma after surgery. Intern Med J. 2004 Jun;34(6):310-5.<\/p><p>A2. Coskun U, Gunel N, Onuk E, Yilmaz E, Bayram O, Yamac D, Cihan A, Ucan B, Yildirim Y, Celenkoglu G, Ozkan S. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer. Neoplasm. 2003;50(3):210-6.<\/p><p>A3. Coskun U, Gunel N, Yildirim Y, Memis L, Boyacioglu ZM. Primary mediastinal yolk sac tumor in a 66-year-old woman. Med Princ Pract. 2002 Oct-Dec;11(4):218-20.<\/p><p>A4. Coskun U, G\u00fcnel N, Yildirim Y. Long term survival in a patient with malignant pleural mesothelioma after gemcitabine treatment. Case Reports and Clinical Practice Reviews, 4, 2-3 (2003).<\/p><p>A5. Co\u015fkun U, G\u00fcnel N, Yildirim Y, Dursun A. Pulmonary resection in a metastatic breast cancer patient with fourteen years survival: A case report. Case Reports and Clinical Practice Review, 5, 12-13 (2004)<\/p><p>A6. Co\u015fkun U, G\u00fcnel N, Yildirim Y. Gemcitabine induced pulmonary injury. Case Reports and Clinical Practice Review, 5, 178-179 (2004).<\/p><p>A7. Yildirim Y, Akcali Z, Ozyilkan O. Controversy in folinic acid administration after Fluorouracil. J Clin Oncol: 23,16,3862 (2005)<\/p><p>A8. Yildirim Y, Akcali Z, Bilezikci B, Ozyiklan O. Primary Gastric Squamous Cell Carcinoma of the Stomach: A Case Report. Tumors: ;91:440-442 (2005)<\/p><p>A9. Yildirim Y. Ozyilkan O, Akcali Z, Basturk B. Drug Interaction Between Capecitabine and warfarin: a case report and review of the literature. Int J Clin Pharmaco Ther 44;2:80-82 (2006)<\/p><p>A10. Yildirim Y, Ozyilkan O, Emiroglu R, Demirhan B, Karakayal\u0131 H, Haberal M. Early diagnosis of cancer in renal transplant patients: A single center experience. Asian Pas J Cancer Prev, 7 ,336-339 (2006)<\/p><p>A11. Yildirim Y, Akcay Y, Ozyilkan, Celasun B. Prostate Small Cell Carcinoma and Skin Metastases: A Rare Entity. Medical Principles and Practice, 2008;17(3):250-2.<\/p><p>A12. Yildirim Y, Gunel N, Coskun U, Pasaoglu H, Aslan S, Cetin A. Serum Neopterin levels in Patients with Breast Cancer. Med Oncol. 2008;25(4):403-407.<\/p><p>A13. Yildirim Y, Gunel N, Coskun U, Bukan N, Sancak B, Aslan S., Cetin A. Serum Big ET-1 levels in Female Patients with Breast Cancer. International Immunopharmacotherapy 2008;8(8):1119-23<\/p><p>A14. Karabulut Z, Yildirim Y, Abaci I, Ilgici D, Ozyilkan O. Signet-Ring Cell Carcinoma of the gallbladder: a case report. Advances in Therapy 2008; 25(5):520-523<\/p><p>A15. Yildirim Y, Ozyilkan O, Bilezikci B, Akcali Z, Haberal M. Lack of Influence of COX-2 Expression in Hepatocellular Carcinomas on Patient Survival. Asian Pas J Cancer Prev 2008;9: 295-298.<\/p><p>A16. Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Unal I, Ozyilkan O. The effect of Her-2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer. J Exp Clin Cancer Res 2009;28(1): 97<\/p><p>A17. Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Ozyilkan O. Prognostic significance of the C-erbB-2 expression in Turkish non-small cell lung cancer patients. Calikusu Z, Yildirim Y, Akcali Z, Sakalli H, Bal N, Ozyilkan O. Asian Pac J Cancer Prev. 2009;10(3):479-82.<\/p><p>A18. Yildirim Y, Ozyilkan O, Calikusu Z, Akcali Z, Akcay Y, Demirhan B. Management of Elderly patients with Advanced non-small cell lung cancer in Turkey. Asian Pac J Cancer Prev 2009;10:699-700.<\/p><p>A19. Yildirim Y, Akcali Z, Ozyilkan O. Signet-ring cell carcinoma of the colon with leptomeningeal involvement. J Clin Neurosci. 2010 Aug;17(8):1051-3. doi:10.1016\/j.jocn.2009.10.014.<\/p><p>A20. Yildirim Y, Elagoz S, Koyuncu A, Aydin C, Karadayi K. Management of neuroendocrine carcinomas of the breast: A rare entity. Oncol Lett. 2011 Sep 1;2(5):887-890.<\/p><p>A21. Aksoy Ozcan U, Tezcanli E, Yildirim Y, Garipagaoglu M. The great mimicker: zona zoster at the mastectomy site causing contralateral intramammary lymph node enlargement. Case Rep Oncol Med. 2012;2012:468576. two: 10.1155\/2012\/468576.<\/p><p>A22. Sapmaz F, Lakadamyali H, Katrancioglu O, Yildirim Y, Dongel I. Malignant mesothelioma: Clinical, pathological and radiological findings. J Clin Anal Med 2012, 3(1):51-55<\/p><p>A23. Aksoy Ozcan U, Saglican Y, Yildiz ME, Yildirim Y, Ozveri H, Ocak F, Karaaslan E. Evaluation of testicular tumor calcification with digital orchiography. Eur Rad. 2013 23(11) 3178-84<\/p><p>A24. Yildirim Y., Onat H. Targeted therapies in metastatic thyroid cancer. MOJ 2013, 1:13-19.<\/p><p>A25. Saime Sezgin Ramadan, H. Baloglu, Y. Yildirim, C, Uygur. Urachal adenocarcinoma: A rare case report and revival of the literature. Virchows Archiv The European Journal of Pathology. 2014 Vol:465, suppl 1, pp:103<\/p><p>Yaz\u0131lan utlar\u0131\u015flar\u0131 k\u0131tablardaki bijler<\/p><p>1.1. Yildirim Yesim, Ozyilkan O: Other Problems: Hiccup, Bleeding, Sweating, Prevention and Treatment of Thromboembolic Complications, Chapter 17, pp196-200. In Handbook of Advanced Cancer Care, Catane R, Cherny NI, Kloke M, TannebergerS, Schrijver D, eds. UK, 2006. Taylo&amp;Francis<\/p><p>1.2. C. Hizel, S. Tuzmen, A. Amirfallah, G. C. Kocal, D. Abbasoglu, H. Onat, Y. Y. Yildirim, Y. Baskin. Chapter 5: Precision medicine for colorectal cancer pp49-87. In Precision Medicine in cancers and non-communicable diseases, Debmalya Barh, ed. CRC press, Taylor &amp; Francis Group, 2019.<\/p><p>The sections in the national books were written:<\/p><p>2.1. Yesim Y\u0131ld\u0131r\u0131m. H. Onat. Gebelik ve Kanser. B\u00f6l\u00fcm 31, 331-337. Kanser Hastas\u0131na Yaklas\u0131m (Tan\u0131, Tevadi, Takipte Sorunlar) Editorler: H.Onat, N.M.Mandel 2012, Nobel,<\/p><p>2.2. Yesim Yildirim, Meral Gunaldi, Sinan Karaslan. Klinik olarak yararli chemotherapy ve molecularernhedefe l\u00e4tt\u00e4 tr\u00e4vede sinidlama, kullanim ve toksisite Kanser Kemoterapia El kitabi. (Ceviri Editoru. H. Onat) 33. Bolum. 693-843.2013.<\/p><p>Ulusal hakemli dergilerde yayamlanan makaleler:<\/p><p>1. Yildirim Y, Coskun O, Coskun U, Kutlu G, Uysal H, U\u00e7ler S, Inan LI, Gunel N. invasive Thymoma and Myestania Gravis: a case report: Turkish Journal of Neurology. 2003;9(1):113-117.<\/p><p>2. Coskun U, YildirimY, Gunel N. Importance of Biphosphanates In Treatment of Breast Cancer. The Turkish Journal of Hematology-Oncology. 2003; 13 (2):109-116.<\/p><p>3. Coskun U, YildirimY, Yamac D, Celenkoglu G, Gunel N. Efficacy of carcinoembryonic antigen in the detection of recurrence in colorectal cancer. T\u00fcrkiye Klinikleri Journal of Gastroenterohepatology 2003;14(1):1-5.<\/p><p>4. Coskun U, Yildirim Y, Ceyhan K, Erekul S, Gunel N. Kikuchi-Fujimoto Disease. T\u00fcrkiye Klinikleri Journal of Medical Sciences. 2004;24(1): 106-108.<\/p><p>5. Coskun U, YildirimY, Gunel N. Orbital MALT Lymphoma. Medical Journal of Ankara Training and Research Hospital. 2002;34: 67-68.<\/p><p>6. Yildirim Y, Uner A, Coskun U, Gunel N. Current Management of Malignant Pleural Effusions. Medical Journal of Ankara Training and Research Hospital. In press.<\/p><p>7. Karakoc A, Toruner F, Ayvaz G, Yetkin I, Yildirim Y, Cakir N, Arslan M. Relationship of Anthropometrical Measurement With Adrenal Hormones and Atherogenic Risk Factors In Obese Patients. T\u00fcrkiye Klinikleri Journal of Medical Sciences: 2003.<\/p><p>8. Yesim Yildirim, Ozgur Ozyilkan. Complementary and alternative treatment in cancer. Progress;5:225-230 (2004)<\/p><p>9. Yildirim Y, Sar\u0131tas S, Ozyilkan O, Demirhan B. Solid pseudopapillary carcinoma of the Pancreas: a case report. Erciyes Medical Journal, 2007;29(6):474-477.<\/p><p>10. Ye\u015fim Y\u0131ld\u0131r\u0131m, \u00d6zg\u00fcr \u00d6zyilkan, Hamdi Karakayal\u0131, Mehmet Haberal. Management of hepatocellular carcinoma 2008;4(18):248-53.<\/p><p>11. Ye\u015fim Y\u0131ld\u0131r\u0131m, \u00d6zg\u00fcr \u00d6zyilkan. Thromboembolic complications of cancer and management. Acta Oncologica Turcica: 2009:42:86-91.<\/p><p>12. Yesim Yildirim. HER2 express eden breast cancer treatment. Onkovital Dergisi 2011.<\/p><p>13. Yesim Yildirim, Atilla Cakmak, Fatih Agalar, Cagatay Demir, Serdar Turhal, Melih Ozel. Kolon Kanseri, Vital, 2015 sayi:29. 7-10<\/p><p>14. Yesim Yildirim, Fatih Gucer. Cervix Cancers. Vital, 2016 sayi:31<\/p><p>15. Ye\u015fim Y\u0131ld\u0131r\u0131m. Cancer patients. Medivision, 2018, 54-55.<\/p><p>Projects:<\/p><p>Y\u00fcksek Lisans Proje: Sa\u011fl\u0131k Hizmetleri Pazarlamas\u0131nda N\u00f6ro Pazarlama\u011f\u0131n Yeri Var(m\u0131)d\u0131r? Bilimsel ve Etik Y\u00f6nleri ile De\u011ferlendirme<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8281e68 elementor-widget elementor-widget-triumf_lightbox\" data-id=\"8281e68\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-8281e68-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"8281e68\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Prof. H\u00fcseyin Balo\u011flu<\/h2><p><strong>Specialty<\/strong><\/p><p>Molecular Pathology<\/p><p>Surgical Pathology<\/p><p>Tumor Biology<\/p><p><strong>Education<\/strong><\/p><p>University<\/p><p>GATA Faculty of Medicine, Ankara 1986<\/p><p>Specialty Training<\/p><p>GATA Department of Pathology 1992<\/p><p>Associate Professor<\/p><p>GATA, Department of Pathology 1997<\/p><p>Professor<\/p><p>GATA, Department of Pathology 2004<\/p><p>GATA<\/p><p>Albert Einstein College of Medicine New York-USA<\/p><p>Memorial Sloan Kettering Cancer Center New York-USA<\/p><p>University of Heidelberg Heidelberg, Germany<\/p><p><strong>Institutions he works for<\/strong><\/p><p>Anadolu Health Center<\/p><p><strong>Membership of the institution<\/strong><\/p><p>International Academy of Pathology<\/p><p>Academy of Pathology of the United States and Canada<\/p><p>European Society of Pathology<\/p><p>Turkish Society of Pathology<\/p><p><strong>Scientific Publications<\/strong><\/p><p>Over 600 Medical Articles and Books<br \/>Over 600 Websites<br \/>1 Patent: Molecular diagnosis of papillary thyroid cancer<\/p><p>\u00a0<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3550686 elementor-widget elementor-widget-triumf_lightbox\" data-id=\"3550686\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"triumf_lightbox.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div id=\"triumf-lightbox-opener-3550686-content\"\n\t\t\tclass=\"triumf-lightbox__content\"\n\t\t\tstyle=\"--color-overlay: #00000033;--color-content: #ffffff;--color-text: #333333;--color-close: #000000;--width-content: 40rem;--border-content: 2rem;\">\n\t\t\t<a href=\"#\" class=\"triumf-lightbox__closer\" data-light-box=\"3550686\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24\" height=\"24\" viewBox=\"0 0 256 256\"><path fill=\"currentColor\" d=\"M205.66 194.34a8 8 0 0 1-11.32 11.32L128 139.31l-66.34 66.35a8 8 0 0 1-11.32-11.32L116.69 128L50.34 61.66a8 8 0 0 1 11.32-11.32L128 116.69l66.34-66.35a8 8 0 0 1 11.32 11.32L139.31 128Z\"\/><\/svg>\n<\/a>\n\t\t\t<div class=\"triumf-lightbox__inner\">\n\t\t\t\t<h2>Assoc. Prof. Kezban Berbero\u011flu<\/h2><p><strong>Specialty<\/strong><\/p><p>Nuclear Oncology<br \/>Nuclear Cardiology<br \/>Member of the Turkish Nuclear Medicine Association<\/p><p><strong>Education<\/strong><\/p><p>University<\/p><p>Trakya University Faculty of Medicine, Edirne 1997<\/p><p>Johns Hopkins University School of Medicine, Division of Nuclear Medicine, Department of Radiology and Radiological Sciences Russel H. Morgan, Baltimore-USA, 2003 (February-April) ;<\/p><p>Specialty Training<\/p><p>Istanbul University Faculty of Medicine, Department of Nuclear Medicine, Istanbul 2004<br \/><br \/><strong>Institutions she works for<\/strong><\/p><p>Alt\u0131nda\u011f Health Center no. 1 of \u0130zmir Bornova<br \/>Istanbul University Istanbul Faculty of Medicine<br \/>Anadolu Health Center<\/p><p><strong>Institutional Membership<\/strong><\/p><p>Turkish Nuclear Medicine Association<br \/>Turkish Nuclear Medicine Association, Cardiology and Oncology Working Group Member<br \/>European Nuclear Medicine Association<\/p><p><strong>Course Attendance<\/strong><\/p><p>The Role Of PET\/CT and SPECT\/CT Imaging In Medical, Radiation, Surgical and Nuclear Oncology: Johns Hopkins Medical Institutes, Baltimore-USA <br \/>Imaging and Targeting Receptors: Two Decades of Progress.; Johns Hopkins Medical Institutes, Baltimore- USA.<br \/>European School of Nuclear Medicine (ESNM), (15th Seminar)<br \/>15th National Congress of Turkish Society of Nuclear Medicine, Bone Mineral Densitometry Course<br \/>15th National Congress of Turkish Society of Nuclear Medicine, Cardiology for Nuclear Medicine<br \/>Turkish Society of Nuclear Medicine, Clinical Problem Solving in Oncology Cases<br \/>Turkish Society of Nuclear Medicine, Brain Perfusion SPECT Course<br \/>Turkish Society of Nuclear Medicine, Gated SPECT Course<br \/>Turkish Society of Nuclear Medicine, Nuclear Cardiology: Basic Concepts and Clinical Applications Course<br \/>Istanbul University Oncology Institute, Pediatric Oncology Department, Postgraduate Education Course; Diagnostic Approach Training Course in Childhood Cancers<br \/>Turkish Society of Nuclear Medicine, Basic Radiopharmacy Course<br \/>EANM Learning Course on PET\/CT in Oncology, August 27-28, 2005<br \/>SNM CT Case Review Workshop, Philadelphia PA, June 10 - July 10, 2007<br \/>Integrated Management System Course, Document No: 3398, December 12, 2005<br \/>Nuclear Medicine Business Management Program, Siemens Academy, 2007<br \/>Participated in the JCI Accreditation Process and reaccreditation process<br \/>Correlative Imaging and Reporting Course, Isparta, February 25-27, 2011<br \/>Patient-Centered Care, Leadership Training; Susan B. Frampton, Ph. D. President of Planetree<br \/>Advancing Patient-Centered Care. April 23, 2016<\/p><p><strong>Scientific publications<\/strong><br \/><strong>Uluslararas\u0131 yay\u0131nlar<\/strong><\/p><p>1. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Eroglu A1, Mudun A, Berbero\u011flu K, Aso\u011flu O, \u00d6zmen V, M\u00fcsl\u00fcmano\u011flu M, Bozfakio\u011flu Y, Yavuz E, Tuzlal\u0131 S, Cantez S. Clin Nucl Med. 2004 May; 29(5):306-11.<\/p><p>2. Acute pulmonary embolism due to hydatid cyst. T\u00fcrkmen C1, Unal SN, Berbero\u011flu K, Gen\u00e7hella\u00e7 H, Unal Z, Cantez S. Clin Nucl Med. 2004 Nov;29 (11):760-1.<\/p><p>3. Primary lymphoma of the small bowel detected with red blood cell scintigraphy. Sanli Y1, Adalet I, T\u00fcrkmen C, Kapran Y, Berbero\u011flu K, Cantez S. Clin Nucl Med. 2005 Jul;30(7):490-1.<\/p><p>4. Role of 99mTc-hexakis-2-methoxyisobutylisonitrile for detecting marrow metastases in childhood solid tumours. Berbero\u011flu K1, \u00dcnal SN, Kebudi R, T\u00fcrkmen C, Cantez S. Nucl Med Commun. 2005 Dec;26(12):1075-80.<\/p><p>5. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Ertugrul MB1, Baktiro\u011flu S, Salman S, \u00dcnal S, Aksoy M, Berbero\u011flu K, Calangu S. Diabet Med. 2006 Jun;23(6):649-53.<\/p><p>6. The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Sanli Y1, Berbero\u011flu K, T\u00fcrkmen C, \u00d6zmen V, M\u00fcsl\u00fcmano\u011flu M, Igci A, Aso\u011flu O, Kecer M, Tuzlal\u0131 S, Cantez S, Mudun A. Clin Nucl Med. 2006 Nov;31(11):690-3.<\/p><p>7. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors. Erten N1, Saka B, Berbero\u011flu K, T\u00fcrkmen C, \u00dcnal S, Bakir B, Yekeler E, Besisik SK. Ann Hematol. 2007 Nov;86(11):805-13. Epub 2007 Aug 8.<\/p><p>8. Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. Ertugrul MB1, Baktiroglu S, Salman S, \u00dcnal S, Aksoy M, Berbero\u011flu K, Calangu S. J Am Podiatr Med Assoc. 2008 Jul-Aug;98(4):290-5.<\/p><p>9. [18F]FDG hot spot in lung disappearing on repeat study. Dogan AS1, Berbero\u011flu K. Nuklearmedizin. 2008;47(4):N37.<\/p><p>10. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission. \u00c7orap\u00e7\u0131o\u011flu F, \u00d6ncel S, Berbero\u011flu K, Kl\u00e7 SC, Aydo\u011fan A, Do\u011fan S. J Pediatr Hematol Oncol. 2009 Jan;31(1):74-5. doi:10.1097\/MPH.0b013e31818bba1b.<\/p><p>11. Contribution of PET-CT to staging, gross tumour volume definition, planning and response assessment in IMRT for nasopharyngeal carcinoma. Metin G\u00fcdena1, Cemile Ceylan, Kezban Berbero\u011flu a2, Semih Do\u011fana2, Nadir K\u00fc\u00e7\u00fcka1, Hande Ba\u015fa1, Ayhan K\u0131l\u0131\u00e7a1 and Kay\u0131han Engina1 Journal of Radiotherapy in Practice 10(04):272 - 282 \u00b7 December 2011.<\/p><p>12. Robotic Radiosurgery for Liver Metastases. Kayihan Engin , Nadir Kucuk , Murat D\u00f6kd\u00f6k , Tayfun Enunlu , Kezban Berbero\u011flu , Hande Ba\u015f. Ayata , Cemile Ceylan , Ayhan K\u0131l\u0131\u00e7 , Metin G\u00fcden. Cureus.December 11, 2012. DOI: 10.7759\/cureus.77.<\/p><p>13. PET-CT and CT Alone Comparison for Target Volume Definition in Radiation Treatment in Patients with Lung Cancer. Hande Ba\u015f Ayata, Metin G\u00fcden, Kezban Berbero\u011flu, Cemile Ceylan, Ayhan K\u0131l\u0131\u00e7, Kay\u0131han Engin. International Journal of Engineering Research &amp; Science (IJOER) ISSN: [2395-6992] [Vol-2, Issue-3 March- 2016].<\/p><p><strong>Ulusal yay\u0131nlar<\/strong><\/p><p>1. Kemoterapiye cevab\u0131n izlenmesinde PET'in yeri. Kezban Berbero\u011flu, Remisyon, g\u00fcncel onkoloji dergisi, Y\u0131l 2005, cilt 7, say\u0131 4.<\/p><p>2. Radyoterapi planlamas\u0131nda PET Remisyon, G\u00fcncel Onkoloji Dergisi, Y\u0131l 2005, cilt 7, say\u0131 4.<\/p><p>3. Akci\u011fer t\u00fcm\u00f6rl\u00fc hastalarda hedef vol\u00fcm\u00fcn belirlenmesinde PET-BT ve BT g\u00f6r\u00fcnt\u00fc kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. Hande Ba\u015f Ayata,1 Metin G\u00fcden,1 Kezban Berbero\u011flu,2 Nadir K\u00fc\u00e7\u00fck,1 Cemile Ceylan,1 Ayhan K\u0131l\u0131\u00e7,1 Semih Do\u011fan,2 Kay\u0131han Engin. T\u00fcrk Onkoloji Dergisi. 2010, Cilt 25, Say\u0131 1, Sayfa(lar) 011-019.<\/p><p>4. Use Of Pet In Radiationtreatment Planning For Thoracic Malingnancies. Kezban Berbero\u011flu . Toraks Cerrahisi Bulteni, June 2015, Volume 6, pp 192-206; doi:10.5152\/tcb.2015.061.<\/p><p>5. Use of PET\/CT in Radiation Treatment Planning for Lung Cancer. Kezban Berbero\u011flu. Moleculer Imaging and Radinulide Theraphy 2016; 25:50-62.<\/p><p><strong>Kitap yazarl\u0131\u011f\u0131<\/strong><\/p><p>1. Onkolojide PET\/BT: Edit\u00f6r: Prof Dr Berna Pollack<\/p><p>2. Radyoterapi Planlamada PET\/BT kullan\u0131m\u0131<\/p><p><strong>Uluslararas\u0131 bildiriler<\/strong><\/p><p>1. Berbero\u011flu K., Mudun A., Tas F., \u00c7aml\u0131ca H., Demirk\u00fcrek C., Karman R., Cantez S., Kurul S. Interval lymph nodes in melanoma: true or false ? 5th International congress of Nuclear Oncology. 1-5 May 2002 Ku\u015fadas\u0131. Turk J Nucl Med 2002; 11:9.<\/p><p>2. Berbero\u011flu K., Mudun A., Ta\u015f F., \u00c7aml\u0131ca H., Demirk\u00fcrek C., Karaman R., Cantez S., Kurul S. Melanoma of the trunk: Are unexpected lymphatic drainage patterns related to the site on the trunk? Europan Association of Nuclear Medicine Congres, 31 August- 4 September 2002, Vienna- Eur J Nucl Med 2002; 29:S99 (oral presantation).<\/p><p>3. Ero\u011flu A., Mudun A., Berbero\u011flu K, Aso\u011flu O, \u00d6zmen V, M\u00fcsl\u00fcmano\u011flu M, Bozfakio\u011flu Y., Cantez S. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. 5th International Congress of Nuclear Oncology. 1-5 May 2002 Ku\u015fadas\u0131. Turk J Nucl Med 2002; 11:9.<\/p><p>4. Mudun A., Ero\u011flu A., Berbero\u011flu K., Aso\u011flu O., \u00d6zmen V., M\u00fcsl\u00fcmano\u011flu M., Bozfakio\u011flu Y., Cantez S. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. 8th Congress of the World Federation of Nuclear medicine&amp;Biology,Santiago,Chile 29 September-October 2002.:World Journal of Nuclear medicine 2002; 1: S123.<\/p><p>5. Berbero\u011flu K., T\u00fcrkmen C., \u00dcnal S., Kebudi R., Ayan \u0130., Ta\u015f\u00e7\u0131o\u011flu C., Saka B., Be\u015f\u0131\u015f\u0131k S., Erten N., Cantez S. Potential role of Tc-99m MIBI for detecting bone marrow metastases in adult and childhood malignancies. Europan Association of Nuclear Medicine Congress, 23-27 August, 2003 Amsterdam. Eur J Nucl Med 30: 285, 2003.<\/p><p>6. Cemile Ceylan, Metin G\u00fcden, Hande Ba\u015f Ayata, Kezban Berbero\u011flu , Ayhan K\u0131l\u0131\u00e7, Kay\u0131han Engin. PET\/CT Guided IMRT for Locally Advanced Pancreatic Cancer. ESTRO-2011, poster bildiri.<\/p><p>7. Necdet \u00dcskent, Muzaffer Sezer, K. Berbero\u011flu. Anti-idiotypic vaccine Racotumomab against NGcGM3 gangloside stabilize disease in rapidly progressing treatment refractory metastatic breast cancer .13th Annual Meeting, May 11-13, 2015. Rheingoldhalle Congress Center Mainz, Germany.<\/p><p>8. A. Serap Yal\u0131n, Erdem T\u00fcremen, Mithat B\u0131y\u0131kl\u0131, Omer Ayd\u0131ner, \u00d6zg\u00fcr Sar\u0131ca, Saime Ramadan, Kezban Berbero\u011flu . European Congress of Endocrinology, 16-20 May 2015, Dublin, Irealand.<\/p><p>9. Hande Ba\u015f, Metin G\u00fcden, Kezban Berbero\u011flu, \u0130brahim Egehan, Nadir K\u00fc\u00e7\u00fck, Cemile Ceylan, Ayhan K\u0131l\u0131\u00e7, Kay\u0131han Engin. PET-CT and CT alone comparison for target volume definition in radiation treatment in patients with lung cancer.<\/p><p>10. Saime Sezgin Ramadan, O. Yap\u0131c\u0131er, K. Berbero\u011flu , M Sezer, H. Onat, Z G\u00fclba\u015f. Bone marrow metastasis of signet ring cell carcinoma with an unknown primary site.24th European Congress of Pathology.<\/p><p><strong>Ulusal bildiriler<\/strong><\/p><p>1. Berbero\u011flu K., Mudun A., M\u00fcsl\u00fcmano\u011flu M., \u0130\u011fci A., Yavuz E., Tokmak H., \u015eanl\u0131 Y., Tuzlal\u0131., \u0130plik\u00e7i A., Cantez S. Erken Meme Kanserinde Lenfosintigrafi ile Sentinel Lenf Nodunu Saptamada Kombine Subdermal ve Perit\u00fcm\u00f6ral Tekni\u011fin Etkinli\u011fi.16. Ulusal N\u00fckleer T\u0131p Kongresi 10-14 May\u0131s 2003 Samsun. T\u00fcrk N\u00fckleer T\u0131p Dergisi 2003; 12:37.<\/p><p>2. Sayg\u0131l\u0131 Y., \u00c7elik A., Tokmak H., Berbero\u011flu K., \u015eanl\u0131 Y., Kurul S.,Cantez S., Mudun A. Malign Melanomda Lenfosintigrafi ve Gamma Prob ile Sentinel Lenf Nodu Biyopsi Y\u00f6nteminde Ba\u015far\u0131y\u0131 Art\u0131ran Fakt\u00f6rler. 16. Ulusal N\u00fckleer T\u0131p Kongresi 10-14 May\u0131s 2003 Samsun.T\u00fcrk N\u00fckleer T\u0131p Dergisi 2003; 12: 44.<\/p><p>3. \u00c7elik A., Sayg\u0131l\u0131 Y., Berbero\u011flu K., Tokmak H., \u015eanl\u0131 Y., Cantez S., Mudun A. Meme Kanserinde Lenfosintigrafi ve Sentinel Lenf Nodu Biyopsi Y\u00f6nteminde Ba\u015far\u0131y\u0131 Art\u0131ran Fakt\u00f6rler. 16.Ulusal N\u00fckleer T\u0131p Kongresi 10-14 May\u0131s 2003 Samsun. 2003; 12: 44.<\/p><p>4. \u015eanl\u0131 Y., Umman B., Mudun A., Adalet I., \u00dcnal S., Cantez S., Tokmak H., Berbero\u011flu K., T\u00fcrkmen C. Yanl\u0131\u015f Pozitif Miyokard Perf\u00fczyon SPECT\u2019i Perf\u00fczyon Defektleri ile Risk Fakt\u00f6rleri Aras\u0131ndaki \u0130li\u015fkinin Ara\u015ft\u0131r\u0131lmas\u0131. XVI. Ulusal N\u00fckleer T\u0131p Kongresi, 10-14 May\u0131s 2003 Samsun, T\u00fcrk N\u00fckleer T\u0131p Dergisi. 12 (1): 51, 2003.<\/p><p>5. Berbero\u011flu K, Do\u011fan AS, G\u00fcden M, Ceylan C, K\u00fc\u00e7\u00fck N, Engin K. Ba\u015f-boyun kanserli 5 olgunun PET\/CT ile Yo\u011funluk Ayarl\u0131 Radyoterapi (YART) planlamas\u0131 sonu\u00e7lar\u0131. N\u00fckleer T\u0131p PET sempozyumu. 30 Nisan-3 May\u0131s 2005, Ankara.<\/p><p>6. PET\/CT ile Radyoterapi Planlama Prosed\u00fcr\u00fc, Say\u0131n S, Sa\u011fd\u0131\u00e7 N, Do\u011fan C, Ba\u015f H, Berbero\u011flu K, Do\u011fan AS, Engin K. N\u00fckleer T\u0131p PET sempozyumu. 30 Nisan-3 May\u0131s 2005, Ankara.<\/p><p>7. G\u00fcden M., Ba\u015f H, Berbero\u011flu K, Ceylan C., K\u00fc\u00e7\u00fck N., K\u0131l\u0131\u00e7 A., Egehan \u0130., Engin K. Primer RT ile tedavi edilen akci\u011fer t\u00fcm\u00f6rl\u00fc hastalarda \u00f6zofagusun ald\u0131\u011f\u0131 dozlar\u0131n 18FDGPET -BT similat\u00f6r ve BT planlamalar\u0131 ile kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. VII. Ulusal Radyasyon Onkoloji Kongresi, 19-23 Nisan 2006. Poster sunum 008. Kongre kitap\u00e7\u0131\u011f\u0131 85-86. sayfa.<\/p><p>8. Ba\u015f H, G\u00fcden M., Berbero\u011flu K, Ceylan C., K\u00fc\u00e7\u00fck N., K\u0131l\u0131\u00e7 A., Egehan \u0130., Engin K. Akci\u011fer t\u00fcm\u00f6rl\u00fc hastalarda hedef ve kritik organlar\u0131n belirlenmesinde BT ve FDG PET\/BT g\u00f6r\u00fcnt\u00fc e\u015fle\u015ftirilmesinin \u00f6nemi. VII. Ulusal Radyasyon Onkoloji Kongresi,19-23 Nisan 2006. S\u00f6zel bildiri. Kongre kitap\u00e7\u0131\u011f\u0131 77-78 sayfa.<\/p><p>9. G\u00fcden M., Ba\u015f H, Berbero\u011flu K, Ceylan C., K\u00fc\u00e7\u00fck N., K\u0131l\u0131\u00e7 A., Egehan \u0130., Engin K. Primer Radyoterapi ile Tedavi Edilen Akci\u011fer T\u00fcm\u00f6rl\u00fc Hastalarda Med\u00fclla Spinalisin Ald\u0131\u011f\u0131 Dozlar\u0131n F 18 FDG PET-BT Simulat\u00f6r ve Bilgisayarl\u0131 Tomografi Planlamalar\u0131 ile kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131. VII. Ulusal Radyasyon Onkoloji Kongresi,19-23 Nisan 2006. Poster sunum 009. Kongre kitap\u00e7\u0131\u011f\u0131 84-85. sayfa.<\/p><p>10. Ceylan C., G\u00fcden M., Berbero\u011flu K., Do\u011fan A. S., Ba\u015f H., K\u0131l\u0131\u00e7 A., K\u00fc\u00e7\u00fck N. &amp; Engin K.: Intens\u0131ty Modulated Radiation Therapy uygulanan nazofarenks hastalar\u0131nda FDG-PET\/BT g\u00f6r\u00fcnt\u00fclemenin hedef hacim belirlenmesine ve tedavi planlamas\u0131na katk\u0131s\u0131 \u2013 ilk 14 hastam\u0131z\u0131n de\u011ferlendirilmesi. 21. Ulusal N\u00fckleer T\u0131p Kongresi2-5 May\u0131s 2009 S\u00f6zel bildiri. Turkish Journal of Nuclear Medicine, 18 (1), pp.6; 2009.<\/p><p>11. Ceylan C., G\u00fcden M., Ba\u015f Ayata H., K\u00fc\u00e7\u00fck N., Berbero\u011flu K. &amp; Engin K.: The contribution of PET-CT to target volume definition and treatment planning in nasopharyngeal cancer patients treated with IMRT \u2013 Early outcome evaluation with PET-CT scanning. 9. National Radiation Oncology Congress (UROK 2010); Abstract Book: pp. 132; April 21 \u2013 25, 2010; Turkish Republic of Northern Cyprus, 2010.<\/p><p>12. Kezban Berbero\u011flu, Saime Sezgin Ramadan, Kemal Ra\u015fa, \u00d6zlem Yap\u0131c\u0131er, Metin \u00c7akmak\u00e7\u0131. Erken Evre Meme Kanserinde FDG_PET\/BT\u2019nin Aksiller evrelemeye Katk\u0131s\u0131. 23.Ulusal N\u00fckleer T\u0131p Kongresi UNTK 2011, s\u00f6zl\u00fc sunum.<\/p><p>13. Saime Sezgin Ramadan, \u00d6zlem Yap\u0131c\u0131er, \u00d6mer Ayd\u0131ner, Kutlay Karaman, Kezban Berbero\u011flu, Kemal Ra\u015fa, Muzaffer Sezer, Haluk Onat, Metin \u00c7akmak\u00e7\u0131. Multipl Karaci\u011fer Absesi ile Prezente Olan Primer \u0130yi Diferensiye N\u00f6roendokrin Karsinom: Olgu Sunumu ve Literat\u00fcr Tekrar\u0131. 21. Ulusal Patoloji Kongresinde poster bildiri.<\/p><p>14. Berbero\u011flu K., K\u00fc\u00e7\u00fck N., G\u00fcden M., Engin K. Cyberknife Radyocerrahi uygulanm\u0131\u015f karaci\u011fer metastazlar\u0131n\u0131n FDG-PET\/CT ile de\u011felendirilmesi 24. Ulusal Nukleer T\u0131p Kongresi UNTK 2012. Poster sunum, PS61.<\/p><p><strong>Konu\u015fmalar<\/strong><\/p><p>1. Tehran University of Medical Sciences (TUMS) Nuclear Medicine Research Centre and Cancer Institue. Tuesday 11 May 2010 (21 Ordibehesht 1389) 10:00-10:45 AM Lecture Dr. Kezban BERBERO\u011eLU PET\/CT IN ONCOLOGY<\/p><p>2. ISTANBUL CYBERKNIFE COALITION - Akci\u011fer Kanserinde CK Kullan\u0131m\u0131 -10 Haziran 2011- Konu\u015fmac\u0131<\/p><p>3. CK uygulamalar\u0131nda PET\u2019in rol\u00fc \u2013 \u00d6neriler: Dr. Kezban Berbero\u011flu-Anadolu Sa\u011fl\u0131k Merkezi.<\/p><p>4. Anadolu Sa\u011fl\u0131k Merkezi Onkolojik Bilimler Sempozyumu: Rektum kanseri tan\u0131 ve tedavide geli\u015fmeler Uzm Dr Kezban Berbero\u011flu: Rektal t\u00fcm\u00f6rlerde PET\/BT'nin rol\u00fc 23.06.2012.<\/p><p>5. Multidisciplinary Comprehensive Approach to Cancer; Tiblis, Georgia. 15 June 2013.<\/p><p>6. Differentiated Thyroid Cancer: Initial Management and Radioiodine Therapy. Tiblis, Georgia. 11 Sep. 2014.<\/p><p>7. Radyoterapi Planlamada PET\/BT kullan\u0131m\u0131 - Olgu sunumlar\u0131. 27. Ulusal N\u00fckleer T\u0131p Kongresi, saat 14 00 -15 00; Adana 03.04.2015.<\/p><p><strong>Kongreler<\/strong><\/p><p>1. 5th International Congress of Nuclear Oncology. 1-5 May 2002 Ku\u015fadas\u0131.<\/p><p>2. 15th Annual Congress of the Europan Association of Nuclear Medicine, 31 August- 4 September 2002, Vienna.<\/p><p>3. 16. Ulusal N\u00fckleer T\u0131p Kongresi 10-14 May\u0131s 2003 Samsun.<\/p><p>4. N\u00fckleer T\u0131p PET sempozyumu. 30 Nisan-3 May\u0131s 2005, Ankara.<\/p><p>5. 18th Annual Congress of the Europan Association of Nuclear Medicine, 15-19 October 2005, \u0130stanbul.<\/p><p>6. 7th International Congress of Nuclear Oncology&amp;18th National Congress of The Turkish Society of Nuclear Medicine. 13-17 May 2006.<\/p><p>7. Gastrointestinal Kanserler Sempozyumu. 23-24 Mart 2007, \u0130stanbul.<\/p><p>8. Klinik Onkolojide PET ve Molek\u00fcler G\u00f6r\u00fcnt\u00fcleme Sempozyumu. 7-9 Aral\u0131k 2007, Ankara.<\/p><p>9. \u0130stanbul Meme Kanseri Konferans\u0131 ve Ulusal Meme Kanseri Konsensus Toplant\u0131s\u0131. 21-25.10.2008, \u0130stanbul.<\/p><p>10. Klinik Onkolojide PET\/BT: Tedaviye Yan\u0131t\u0131n De\u011ferlendirilmesi. 21 Kas\u0131m 2008, \u0130zmir.<\/p><p>11. 21. Ulusal N\u00fckleer T\u0131p Kongresi 2-5 May\u0131s 2009, Antalya.<\/p><p>12. 22nd Annual Congress of the Europan Association of Nuclear Medicine, 10-14 October 2009, Barcelona.<\/p><p>13. 23. Ulusal N\u00fckleer T\u0131p Kongresi 27 Nisan-01 May\u0131s 2011, \u0130zmir.<\/p><p>14. Tiroid Kanseri Tan\u0131 ve Tedavisi Sempozyomu. 23-25 Eyl\u00fcl 2011, Ankara.<\/p><p>15. 1st Balkan Congress of Nuclear Medicine. 4-8 April 2012, Antalya.<\/p><p>16. 25th Annual Congress of the Europan Association of Nuclear Medicine, 27-31 October 2012, Milan.<\/p><p>17. N\u00fckleer Kardiyoloji Sempozyumu. 12-13 Aral\u0131k 2014, \u0130stanbul.<\/p><p>18. 26. Ulusal N\u00fckleer T\u0131p Kongresi 16-20 Nisan 2014 Antalya.<\/p><p>19. 27. Ulusal N\u00fckleer T\u0131p Kongresi 01-05 Nisan 2015 Adana.<\/p><p>20. New Horizons in Oncology: Breast Cancer, 12th September 2015<\/p><p>21. 27. Ulusal N\u00fckleer T\u0131p Kongresi 06-10 Nisan 2016, \u0130zmir.<\/p>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e7cbcbb e-grid e-con-full e-con e-child\" data-id=\"e7cbcbb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2512456 triumf-lightbox__opener-801c49f elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"2512456\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/ilker-7785804.webp\" class=\"attachment-full size-full wp-image-17438\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. \u0130lker Tinay<\/h3><p class=\"elementor-image-box-description\">Urology Department<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b5d98f6 triumf-lightbox__opener-cdf47b9 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"b5d98f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/muhammed-7103851.webp\" class=\"attachment-full size-full wp-image-17439\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">MD. Surgeon Muhammed Sulukaya<\/h3><p class=\"elementor-image-box-description\">Urology Department<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cbddc6c triumf-lightbox__opener-f6d228c elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"cbddc6c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/hale-basak-9183938.webp\" class=\"attachment-full size-full wp-image-17440\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. Hale Ba\u015fak \u00c7a\u011flar<\/h3><p class=\"elementor-image-box-description\">Radiation Oncology Department<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d0bdf3b triumf-lightbox__opener-528a4a9 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"d0bdf3b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/eda-8444670.webp\" class=\"attachment-full size-full wp-image-17441\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Assoc. Prof. Eda Tanr\u0131kulu \u015eim\u015fek<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d0dafd2 triumf-lightbox__opener-84b07f6 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"d0dafd2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/bulent-6705914.webp\" class=\"attachment-full size-full wp-image-17442\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. B\u00fclent Karag\u00f6z<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fb0ea1d triumf-lightbox__opener-2dc27eb elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"fb0ea1d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/necdet-2805594.webp\" class=\"attachment-full size-full wp-image-17443\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. Necdet \u00dcskent<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-af8b94c triumf-lightbox__opener-88271ee elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"af8b94c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/seref-7060106.webp\" class=\"attachment-full size-full wp-image-17447\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. \u015eeref K\u00f6m\u00fcrc\u00fc<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5e5ec1e triumf-lightbox__opener-c0a925a elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"5e5ec1e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/sinan-9170158.webp\" class=\"attachment-full size-full wp-image-17448\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">MD. Sinan Karaaslan<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-650d16c triumf-lightbox__opener-232142c elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"650d16c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/yesim-4459517.webp\" class=\"attachment-full size-full wp-image-17449\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. Ye\u015fim Y\u0131ld\u0131r\u0131m<\/h3><p class=\"elementor-image-box-description\">Medical Oncology<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9501f8d triumf-lightbox__opener-8281e68 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"9501f8d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/huseyin-6648743.webp\" class=\"attachment-full size-full wp-image-17450\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Prof. H\u00fcseyin Balo\u011flu<\/h3><p class=\"elementor-image-box-description\">Pathology Department<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d9b2e42 triumf-lightbox__opener-3550686 elementor-position-top elementor-widget elementor-widget-image-box\" data-id=\"d9b2e42\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-box.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-image-box-wrapper\"><figure class=\"elementor-image-box-img\"><img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"250\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/kezban-4682623.webp\" class=\"attachment-full size-full wp-image-17451\" alt=\"\" \/><\/figure><div class=\"elementor-image-box-content\"><h3 class=\"elementor-image-box-title\">Assoc. Prof. Kezban Berbero\u011flu<\/h3><p class=\"elementor-image-box-description\">Nuclear Medicine Department<\/p><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ff8ce82 e-flex e-con-boxed e-con e-parent\" data-id=\"ff8ce82\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-1ed590f e-con-full e-flex e-con e-child\" data-id=\"1ed590f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b07a1d1 elementor-widget elementor-widget-heading\" data-id=\"b07a1d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Why Anadolu Medical Center?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-14f946b elementor-widget elementor-widget-text-editor\" data-id=\"14f946b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>Multidisciplinary Urooncology Board:<\/strong> Your case is discussed by a team of urologists, oncologists, radiologists, pathologists, and other specialists to decide on the best treatment.<\/li><li><strong>State-of-the-art Technology:<\/strong> We use advanced imaging and robotic surgery systems for precise treatment.<\/li><li><strong>Personalized Case Management:<\/strong> Our nurse case managers coordinate every aspect of your care and support you throughout your journey.<\/li><li><strong>International Patient Services:<\/strong> We provide translation, travel assistance, and accommodation support.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d7a0a5e e-con-full e-flex e-con e-child\" data-id=\"d7a0a5e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-15d4b51 elementor-widget elementor-widget-image\" data-id=\"15d4b51\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"492\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/01\/Da-Vinci-Anadolu.png\" class=\"attachment-large size-large wp-image-12762\" alt=\"Da Vinci Anadolu\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/01\/Da-Vinci-Anadolu.png 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/01\/Da-Vinci-Anadolu-600x369.png 600w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d136a86 e-flex e-con-boxed e-con e-parent\" data-id=\"d136a86\" data-element_type=\"container\" data-e-type=\"container\" id=\"testimonials\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-72b25b2 elementor-widget elementor-widget-heading\" data-id=\"72b25b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">PATIENT TESTIMONIALS<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c18472d e-grid e-con-full e-con e-child\" data-id=\"c18472d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d80e74b elementor-widget elementor-widget-video\" data-id=\"d80e74b\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=nnlVVQ2RUJk&amp;t=27s&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9978cdc elementor-widget elementor-widget-video\" data-id=\"9978cdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=qUolFQI4wWo&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4eb0347 elementor-widget elementor-widget-video\" data-id=\"4eb0347\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=Fr3boD4HObI&amp;t=92s&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96eeebe elementor-widget elementor-widget-video\" data-id=\"96eeebe\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=wXXi1MatNtQ&amp;t=1s&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e4b86c9 elementor-widget elementor-widget-video\" data-id=\"e4b86c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=1TYWuaAtMWQ&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-20e111b elementor-widget elementor-widget-video\" data-id=\"20e111b\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=eFAfXwSGunU&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-467d3b0 e-flex e-con-boxed e-con e-parent\" data-id=\"467d3b0\" data-element_type=\"container\" data-e-type=\"container\" id=\"about\" data-settings=\"{&quot;background_background&quot;:&quot;gradient&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-c827d50 e-con-full e-flex e-con e-child\" data-id=\"c827d50\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fe4cb61 elementor-widget elementor-widget-heading\" data-id=\"fe4cb61\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">About Anadolu Medical Center in \u0130stanbul, Turkey<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b5cf3a8 elementor-widget elementor-widget-text-editor\" data-id=\"b5cf3a8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Anadolu Medical Center is a state-of-the art, multispecialty, acute care hospital in Istanbul. It was established by the Anadolu Foundation in 2005 and has two major characteristics: its non-profit status and its unique affiliation with the globally recognized Johns Hopkins Medicine USA.<\/p><p>The Center\u2019s affiliation with the Johns Hopkins Medicine USA positions the Center on the level with the best hospitals in the world. This affiliation provides continuous access to the latest innovations, unmatched expertise, and technological advancements. This affiliation allows its staff an opportunity to continuously improve their skills, knowledge, and training to ensure outstanding care and top-notch expertise.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c3adc85 e-con-full e-flex e-con e-child\" data-id=\"c3adc85\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4e6cf9b elementor-widget elementor-widget-image\" data-id=\"4e6cf9b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"483\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/03\/Anadolu31-1024x618.jpg\" class=\"attachment-large size-large wp-image-16411\" alt=\"\" srcset=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/03\/Anadolu31-1024x618.jpg 1024w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/03\/Anadolu31-600x362.jpg 600w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/03\/Anadolu31-768x464.jpg 768w, https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/03\/Anadolu31.jpg 1449w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4f1fd3c prostatelpform e-flex e-con-boxed e-con e-parent\" data-id=\"4f1fd3c\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-fc991c5 e-con-full e-flex e-con e-child\" data-id=\"fc991c5\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-920c537 elementor-widget elementor-widget-heading\" data-id=\"920c537\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">You can apply to receive a free of charge medical opinion now!<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c79dd6d elementor-widget elementor-widget-heading\" data-id=\"c79dd6d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">You will receive a specialized medical opinion within 48 hours!<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7c9a67c elementor-widget elementor-widget-shortcode\" data-id=\"7c9a67c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f22518-o2\" lang=\"en-US\" dir=\"ltr\" data-wpcf7-id=\"22518\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/lp\/wp-json\/wp\/v2\/pages\/17325#wpcf7-f22518-o2\" method=\"post\" class=\"wpcf7-form init\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"22518\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.1.6\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"en_US\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f22518-o2\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<style>\n.iti__selected-country {padding: 0 3px !important;}\n.wpcf7-form div.label {z-index:9 !important;}\n.wpcf7-form div.label {border-radius: 5px !important; }\n.select2-container--default .select2-selection--single, input.wpcf7-form-control, select.wpcf7-form-control {border-radius: 11px !important; border: 1px solid #dedede !important;}\n.select2-container--default .select2-selection--single .select2-selection__rendered {line-height: 24px !important;}\n.select2-container--default .select2-selection--single .select2-selection__arrow, .select2-container--default .select2-selection--single, .select2-container--default .select2-selection--single .select2-selection__rendered {height: 40px !important;}\n.select2-container--default .select2-selection--single .select2-selection__arrow b:before {display: none !important;}\n.wpcf7-list-item-label {color: #fff !important;}\n<\/style>\n<div class=\"mzr-row mb-0 mt-5\">\n\t<div class=\"col-md-5 mb-0\">\n\t\t<div class=\"mzr-row\">\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Firstname <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-firstname\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"text\" name=\"your-firstname\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Lastname <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-lastname\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"text\" name=\"your-lastname\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Email <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-email\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"email\" name=\"your-email\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-4\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Phone <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-phone\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-tel wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-tel mzrcf7-phone\" aria-required=\"true\" aria-invalid=\"false\" value=\"\" type=\"tel\" name=\"your-phone\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-0\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Country <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-country\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required mzrcf7-country\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Country...\" value=\"\" type=\"text\" name=\"your-country\" \/><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t<div class=\"col-md-7 mb-0\">\n\t\t<div class=\"mzr-row\">\n\t\t\t<div class=\"col-md-12 mb-2\">\n\t\t\t\t<div class=\"label\">\n\t\t\t\t\t<p>Message <sup>(*)<\/sup>\n\t\t\t\t\t<\/p>\n\t\t\t\t<\/div>\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-message\"><textarea cols=\"40\" rows=\"10\" maxlength=\"2000\" class=\"wpcf7-form-control wpcf7-textarea wpcf7-validates-as-required mzrcf7-textarea\" aria-required=\"true\" aria-invalid=\"false\" name=\"your-message\"><\/textarea><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-2\">\n\t\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-agreements\"><span class=\"wpcf7-form-control wpcf7-acceptance\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"your-agreements\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I authorize Anadolu Medical Center to use and store my personal data.<\/span><\/label><\/span><\/span><\/span>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"col-md-12 mb-0\">\n\t\t\t\t<p><input type=\"hidden\" name=\"action\" value=\"mzr_store_the_lead\" \/><input type=\"hidden\" name=\"your-source\" value=\"UK\" \/><input type=\"hidden\" name=\"your-url\" value=\"https:\/\/\" \/><input class=\"wpcf7-form-control wpcf7-submit has-spinner btn btn-style-default btn-style-round btn-color-primary btn-submit\" type=\"submit\" value=\"SEND MESSAGE\" \/>\n\t\t\t\t<\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-43760e2 e-flex e-con-boxed e-con e-parent\" data-id=\"43760e2\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0646a81 e-con-full e-flex e-con e-child\" data-id=\"0646a81\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-915f35c elementor-widget elementor-widget-image\" data-id=\"915f35c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"230\" height=\"80\" src=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2025\/05\/logo-white-1-svg.png\" class=\"attachment-large size-large wp-image-17419\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ce55c1f e-con-full e-flex e-con e-child\" data-id=\"ce55c1f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5af21a1 e-grid-align-right elementor-shape-circle e-grid-align-mobile-center elementor-grid-0 elementor-widget elementor-widget-social-icons\" data-id=\"5af21a1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"social-icons.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-social-icons-wrapper elementor-grid\" role=\"list\">\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-youtube elementor-repeater-item-b2029b6\" href=\"https:\/\/www.youtube.com\/@AnadoluMedicalCenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Youtube<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-youtube\" viewBox=\"0 0 576 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-facebook elementor-repeater-item-4209e29\" href=\"https:\/\/www.facebook.com\/AnadoluMedicalCenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Facebook<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-facebook\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256C504 119 393 8 256 8S8 119 8 256c0 123.78 90.69 226.38 209.25 245V327.69h-63V256h63v-54.64c0-62.15 37-96.48 93.67-96.48 27.14 0 55.52 4.84 55.52 4.84v61h-31.28c-30.8 0-40.41 19.12-40.41 38.73V256h68.78l-11 71.69h-57.78V501C413.31 482.38 504 379.78 504 256z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-instagram elementor-repeater-item-cd6498c\" href=\"https:\/\/www.instagram.com\/anadolumedicalcenter?igsh=OG1wNWV5NWk4ZmNt\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Instagram<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-instagram\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-tiktok elementor-repeater-item-ddae380\" href=\"https:\/\/www.tiktok.com\/@anadolumedicalcenter\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Tiktok<\/span>\n\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fab-tiktok\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M448,209.91a210.06,210.06,0,0,1-122.77-39.25V349.38A162.55,162.55,0,1,1,185,188.31V278.2a74.62,74.62,0,1,0,52.23,71.18V0l88,0a121.18,121.18,0,0,0,1.86,22.17h0A122.18,122.18,0,0,0,381,102.39a121.43,121.43,0,0,0,67,20.14Z\"><\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b9fce2e e-con-full e-flex e-con e-child\" data-id=\"b9fce2e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5d46ccd elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"5d46ccd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1d418f8 e-con-full e-flex e-con e-child\" data-id=\"1d418f8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-fa1163a e-con-full e-flex e-con e-child\" data-id=\"fa1163a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b1ab75e elementor-widget elementor-widget-heading\" data-id=\"b1ab75e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Rapid navigation<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ce97de0 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"ce97de0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#about\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-right\" viewBox=\"0 0 320 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">About Us<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#doctors\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-right\" viewBox=\"0 0 320 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Doctors<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#testimonials\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-right\" viewBox=\"0 0 320 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Patient Testimonials<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-920b3e2 e-con-full e-flex e-con e-child\" data-id=\"920b3e2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8882adc elementor-widget elementor-widget-heading\" data-id=\"8882adc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Contact Us<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-524a66f elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"524a66f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-map-marker-alt\" viewBox=\"0 0 384 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M172.268 501.67C26.97 291.031 0 269.413 0 192 0 85.961 85.961 0 192 0s192 85.961 192 192c0 77.413-26.97 99.031-172.268 309.67-9.535 13.774-29.93 13.773-39.464 0zM192 272c44.183 0 80-35.817 80-80s-35.817-80-80-80-80 35.817-80 80 35.817 80 80 80z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Istanbul \/ Turkey<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"tel:+905373180696\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-phone-alt\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M497.39 361.8l-112-48a24 24 0 0 0-28 6.9l-49.6 60.6A370.66 370.66 0 0 1 130.6 204.11l60.6-49.6a23.94 23.94 0 0 0 6.9-28l-48-112A24.16 24.16 0 0 0 122.6.61l-104 24A24 24 0 0 0 0 48c0 256.5 207.9 464 464 464a24 24 0 0 0 23.4-18.6l24-104a24.29 24.29 0 0 0-14.01-27.6z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">+90 537 318 0696<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d01909e e-flex e-con-boxed e-con e-parent\" data-id=\"d01909e\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-74c9a0b elementor-widget elementor-widget-heading\" data-id=\"74c9a0b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\">Copyright 2025 Anadolu Medical Center in Affiliation with Johns Hopkins Medicine. All rights reserved by AMC.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Welcome to Anadolu Medical Center &#8211; Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696 Menu Comprehensive Care Prostate Cancer Treatment Our doctors Our patients\u2019 stories About Us Contact Us Menu Comprehensive Care Prostate Cancer Treatment Our doctors Our patients\u2019 stories About Us Contact Us From [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_canvas","meta":{"footnotes":""},"class_list":["post-17325","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine<\/title>\n<meta name=\"description\" content=\"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/anadolumedicalcenter.uk\/lp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine\" \/>\n<meta property=\"og:description\" content=\"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696\" \/>\n<meta property=\"og:url\" content=\"https:\/\/anadolumedicalcenter.uk\/lp\/\" \/>\n<meta property=\"og:site_name\" content=\"Anadolu Medical Center affiliated with Johns Hopkins Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AnadoluMedicalCenter\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-30T12:30:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"433\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"114 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\",\"url\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\",\"name\":\"Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/1200px-Anadolu_Medical_Center_logo.svg_.png\",\"datePublished\":\"2025-05-20T12:29:41+00:00\",\"dateModified\":\"2025-10-30T12:30:25+00:00\",\"description\":\"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \\\/ Turkey +90 537 318 0696\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/1200px-Anadolu_Medical_Center_logo.svg_.png\",\"contentUrl\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/1200px-Anadolu_Medical_Center_logo.svg_.png\",\"width\":1200,\"height\":433,\"caption\":\"pdf anadolu\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prostate Cancer Center\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#website\",\"url\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\",\"name\":\"Anadolu Medical Center\",\"description\":\"For Your Health\",\"publisher\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#organization\",\"name\":\"Anadolu Medical Center\",\"url\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Logo-Anadolu-Medical-Center.png\",\"contentUrl\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Logo-Anadolu-Medical-Center.png\",\"width\":263,\"height\":150,\"caption\":\"Anadolu Medical Center\"},\"image\":{\"@id\":\"https:\\\/\\\/anadolumedicalcenter.uk\\\/lp\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AnadoluMedicalCenter\",\"https:\\\/\\\/www.youtube.com\\\/@AnadoluMedicalCenter\",\"https:\\\/\\\/www.instagram.com\\\/anadolumedicalcenter\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine","description":"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/anadolumedicalcenter.uk\/lp\/","og_locale":"en_US","og_type":"article","og_title":"Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine","og_description":"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696","og_url":"https:\/\/anadolumedicalcenter.uk\/lp\/","og_site_name":"Anadolu Medical Center affiliated with Johns Hopkins Medicine","article_publisher":"https:\/\/www.facebook.com\/AnadoluMedicalCenter","article_modified_time":"2025-10-30T12:30:25+00:00","og_image":[{"width":1200,"height":433,"url":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png","type":"image\/png"}],"twitter_misc":{"Est. reading time":"114 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/","url":"https:\/\/anadolumedicalcenter.uk\/lp\/","name":"Prostate Cancer Center | Anadolu Medical Center affiliated with Johns Hopkins Medicine","isPartOf":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#primaryimage"},"image":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#primaryimage"},"thumbnailUrl":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png","datePublished":"2025-05-20T12:29:41+00:00","dateModified":"2025-10-30T12:30:25+00:00","description":"Welcome to Anadolu Medical Center - Prostate Cancer Center Youtube Facebook Instagram Tiktok Send Free Inquiry Address \u0130stanbul \/ Turkey +90 537 318 0696","breadcrumb":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/anadolumedicalcenter.uk\/lp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#primaryimage","url":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png","contentUrl":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/1200px-Anadolu_Medical_Center_logo.svg_.png","width":1200,"height":433,"caption":"pdf anadolu"},{"@type":"BreadcrumbList","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/anadolumedicalcenter.uk\/lp\/"},{"@type":"ListItem","position":2,"name":"Prostate Cancer Center"}]},{"@type":"WebSite","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#website","url":"https:\/\/anadolumedicalcenter.uk\/lp\/","name":"Anadolu Medical Center","description":"For Your Health","publisher":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/anadolumedicalcenter.uk\/lp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#organization","name":"Anadolu Medical Center","url":"https:\/\/anadolumedicalcenter.uk\/lp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#\/schema\/logo\/image\/","url":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/Logo-Anadolu-Medical-Center.png","contentUrl":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-content\/uploads\/2020\/02\/Logo-Anadolu-Medical-Center.png","width":263,"height":150,"caption":"Anadolu Medical Center"},"image":{"@id":"https:\/\/anadolumedicalcenter.uk\/lp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AnadoluMedicalCenter","https:\/\/www.youtube.com\/@AnadoluMedicalCenter","https:\/\/www.instagram.com\/anadolumedicalcenter\/"]}]}},"_links":{"self":[{"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/pages\/17325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/comments?post=17325"}],"version-history":[{"count":149,"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/pages\/17325\/revisions"}],"predecessor-version":[{"id":22521,"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/pages\/17325\/revisions\/22521"}],"wp:attachment":[{"href":"https:\/\/anadolumedicalcenter.uk\/lp\/wp-json\/wp\/v2\/media?parent=17325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}